Form 10-Q - Quarterly report [Sections 13 or 15(d)]

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q


☑						QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2023


☐						TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission file number 0-15946

Ebix, Inc.

(Exact name of registrant as specified in its charter)



Delaware		77-0021975
(State or other jurisdiction of incorporation or		(I.R.S. Employer Identification No.)
organization)

1 Ebix Way
Johns Creek,	Georgia	30097
(Address of principal executive offices)		(Zip Code)

Registrant’s telephone number, including area code: 678-281-2020


Securities registered pursuant to Section 12(b) of the Act:
Title of each class	Trading symbols	Name of each exchange on which registered
Common stock, $0.10 par value per share	EBIX	Nasdaq Stock Market

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☑ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☑ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Table of Contents

Large accelerated filer

☐

Accelerated filer

☑

Non-accelerated filer

☐

Smaller reporting company

☐

Emerging growth company

☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☑

As of August 7, 2023 the number of shares of common stock outstanding was 30,901,440.

“The Registrant’s subsidiary, EbixCash Limited has filed a draft red herring prospectus with the Securities and Exchange Board of India and is in the process of executing an initial public offering of its equity shares, subject to market conditions and regulatory approvals. The financial information of EbixCash Limited consolidated into our financial statements as of and for the six months ended June 30, 2023 is summary, indicative and not final. Further such financial information has not been audited or reviewed by the auditors of such company.”

FORM 10-Q

FOR THE QUARTER ENDED JUNE 30, 2023

INDEX


PART I — FINANCIAL INFORMATION

Item 1. Consolidated Financial Statements

Condensed Consolidated Statements of Income for the three and six months ended June 30, 2023 and 2022 (unaudited)			2

Condensed Consolidated Statements of Comprehensive Income for the three and six months ended June 30, 2023 and 2022 (unaudited)			3

Condensed Consolidated Balance Sheets at June 30, 2023 (unaudited) and December 31, 2022			4

Condensed Consolidated Statement of Stockholders’ Equity for the three and six months ended June 30, 2023 and 2022 (unaudited)			6

Condensed Consolidated Statements of Cash Flows for the six months ended June 30, 2023 and 2022 (unaudited)			8

Notes to Condensed Consolidated Financial Statements (unaudited)			10

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations			32

Item 3. Quantitative and Qualitative Disclosures About Market Risk			42

Item 4. Controls and Procedures			43

PART II — OTHER INFORMATION

Item 1. Legal Proceedings			43

Item 1A. Risk Factors			44

Item 2. Repurchases of Equity Securities			44

Item 3. Defaults upon Senior Securities			45

Item 4. Mine Safety Disclosures			45

Item 5. Other Information			45

Item 6. Exhibits			45

EXHIBITS INDEX			46

SIGNATURES			47


Exhibit 31.1
Exhibit 31.2
Exhibit 32.1
Exhibit 32.2
Exhibit 101

Table of Contents

PART I — FINANCIAL INFORMATION

Item 1: CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

Ebix, Inc. and Subsidiaries

Condensed Consolidated Statements of Income

(In thousands, except per share data)

(Unaudited)


	Three Months Ended1				Six Months Ended
	June 30,				June 30,
	2023		2022		2023		2022
Operating revenue	$	118,430	$	250,781	$	361,191	$	537,034

Operating expenses:
Cost of services provided	33,757		169,330		190,236		380,173
Product development	10,947		10,223		20,930		20,481
Sales and marketing	3,582		4,511		6,913		8,276
General and administrative, net	36,110		31,736		73,577		58,649
Amortization and depreciation	4,893		4,874		9,909		9,238
Total operating expenses	89,289		220,674		301,565		476,817

Operating income	29,141		30,107		59,626		60,217
Interest income	52		66		133		128
Interest expense	(24,614)		(11,664)		(46,877)		(21,915)
Non-operating (loss) income	(3,647)		(408)		(3,977)		(1,142)

Foreign currency exchange gain (loss)	(840)		3,229		(2,060)		4,123
Income before income taxes	92		21,330		6,845		41,411
Income tax (expense) benefit	(164)		(2,478)		(787)		(4,182)
Net income including noncontrolling interest	(72)		18,852		6,058		37,229
Net loss attributable to noncontrolling interest	(380)		(491)		(1,323)		(1,305)
Net income attributable to Ebix, Inc.	$	308	$	19,343	$	7,381	$	38,534

Basic earnings per common share attributable to Ebix, Inc.	$	0.01	$	0.63	$	0.24	$	1.25

Diluted earnings per common share attributable to Ebix, Inc.	$	0.01	$	0.63	$	0.24	$	1.25

Basic weighted average shares outstanding	30,866		30,745		30,854		30,729

Diluted weighted average shares outstanding	30,869		30,756		30,856		30,756

See accompanying notes to the condensed consolidated financial statements.

1 Beginning April 1, 2023 Prepaid card revenues are presented on a net basis (based on new contractual changes) while periods preceding April 1, 2023 reflect prepaid card revenues on a gross basis. Please see (non- GAAP financials) table with both periods recast on a net basis, for comparison purposes under heading "Condensed Consolidated Statements of Income prepared on Net Basis for Comparative Purposes Only (Non GAAP)".

Table of Contents

Ebix, Inc. and Subsidiaries

Condensed Consolidated Statements of Income prepared on Net Basis for Comparative Purposes Only (Non GAAP)

(In thousands, except per share data)

(Unaudited)


	Three Months Ended				Six Months Ended
	June 30,				June 30,
	2023		2022		2023		2022
Operating revenue	$	118,430	$	114,924	$	234,503	$	214,444

Operating expenses:
Cost of services provided	33,757		33,473		63,549		57,583
Product development	10,947		10,223		20,930		20,481
Sales and marketing	3,582		4,511		6,913		8,276
General and administrative, net	36,110		31,736		73,577		58,649
Amortization and depreciation	4,893		4,874		9,909		9,238
Total operating expenses	89,289		84,817		174,878		154,227

Operating income	29,141		30,107		59,625		60,217
Interest income	52		66		133		128
Interest expense	(24,614)		(11,664)		(46,877)		(21,915)
Non-operating (loss) income	(3,647)		(408)		(3,977)		(1,142)

Foreign currency exchange gain (loss)	(840)		3,229		(2,060)		4,123
Income before income taxes	92		21,330		6,844		41,411
Income tax (expense) benefit	(164)		(2,478)		(787)		(4,182)
Net income including noncontrolling interest	(72)		18,852		6,057		37,229
Net loss attributable to noncontrolling interest	(380)		(491)		(1,323)		(1,305)
Net income attributable to Ebix, Inc.	$	308	$	19,343	$	7,380	$	38,534

Basic earnings per common share attributable to Ebix, Inc.	$	0.01	$	0.63	$	0.24	$	1.25

Diluted earnings per common share attributable to Ebix, Inc.	$	0.01	$	0.63	$	0.24	$	1.25

Basic weighted average shares outstanding	30,866		30,745		30,854		30,729

Diluted weighted average shares outstanding	30,869		30,756		30,856		30,756

Table of Contents

Ebix, Inc. and Subsidiaries

Condensed Consolidated Statements of Comprehensive Income

(In thousands)

(Unaudited)


	Three Months Ended				Six Months Ended
	June 30,				June 30,
	2023		2022		2023		2022

Net income including noncontrolling interest	$	(72)	$	18,852	$	6,058	$	37,229
Other comprehensive income (loss):
Foreign currency translation adjustments	2,393		(43,343)		10,113		(54,627)
Total other comprehensive income (loss)	2,393		(43,343)		10,113		(54,627)
Comprehensive income	2,321		(24,491)		16,171		(17,398)
Comprehensive loss attributable to noncontrolling interest	(380)		(491)		(1,323)		(1,305)
Comprehensive income attributable to Ebix, Inc.	$	2,701	$	(24,000)	$	17,494	$	(16,093)

See accompanying notes to the condensed consolidated financial statements.

Table of Contents

Ebix, Inc. and Subsidiaries

Condensed Consolidated Balance Sheets

(In thousands, except share amounts)


	June 30, 2023		December 31, 2022
ASSETS	(Unaudited)
Current assets:
Cash and cash equivalents	$	62,165	$	110,637
Receivables from service providers	542		4,223
Short-term investments	14,392		17,438
Restricted cash	8,282		8,210
Fiduciary funds - restricted	1,735		2,092
Trade accounts receivable, less allowances of $18,885 and $18,167, respectively	163,166		154,533

Other current assets	98,598		87,387
Total current assets	348,880		384,520

Property and equipment, net	53,695		52,448
Right-of-use assets	8,695		9,636
Goodwill	887,101		881,676
Intangibles, net	47,995		50,900
Indefinite-lived intangibles	16,647		16,647
Capitalized software development costs, net	15,886		15,342
Deferred tax asset, net	124,289		96,290
Other assets	37,320		30,096
Total assets	$	1,540,508	$	1,537,555

LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable and accrued liabilities	$	95,617	$	99,194
Payables to service agents	18,737		11,299
Accrued payroll and related benefits	13,367		10,652
Working capital facility	5,043		3,367
Fiduciary funds - restricted	1,735		2,092
Revolving line of credit	444,902		449,902
Short-term debt	608		3,000


Current portion of long term debt and financing lease obligations, net of deferred financing costs of $934 and $469, respectively	172,857		190,866
Contract liabilities	37,769		32,029
Lease liability	3,024		3,354



Other current liabilities	25,629		25,783
Total current liabilities	819,288		831,538

Revolving line of credit	—		—
Long term debt and financing lease obligations, less current portion, net of deferred financing costs of $0 and $0, respectively	87		160
Contingent liability for accrued earn-out acquisition consideration	2,315		2,298
Contract liabilities	7,717		14,098
Lease liability	6,002		6,612
Deferred tax liability, net	1,150		1,150
Other liabilities	27,092		22,259
Total liabilities	863,651		878,115

Table of Contents




Stockholders’ equity:
Preferred stock, $0.10 par value, 500,000 shares authorized, no shares issued and outstanding at June 30, 2023 and December 31, 2022	—		—
Series Y Convertible preferred stock, $0.10 par value, 350,000 shares authorized, no shares issued and outstanding at June 30, 2023 and December 31, 2022	—		—
Common stock, $0.10 par value, 220,000,000 shares authorized, 30,877,258 issued and outstanding, at June 30, 2023, and 30,819,533 issued and outstanding at December 31, 2022	3,088		3,082
Additional paid-in capital	20,041		18,801

Retained earnings	822,162		814,781
Accumulated other comprehensive loss	(209,326)		(219,439)
Total Ebix, Inc. stockholders’ equity	635,965		617,225
Noncontrolling interest	40,892		42,215
Total stockholders’ equity	676,857		659,440
Total liabilities and stockholders’ equity	$	1,540,508	$	1,537,555

See accompanying notes to the condensed consolidated financial statements.

Table of Contents

Ebix, Inc. and Subsidiaries

Condensed Consolidated Statements of Stockholders’ Equity

(unaudited)

(In thousands except for share figures)


	Common Stock
	Issued Shares	Amount		Additional Paid-in Capital		Retained Earnings		Accumulated Other Comprehensive Loss		Noncontrolling interest		Total

Balance, April 1, 2023	30,851,314	$	3,085	$	19,418	$	821,854	$	(211,719)	$	41,272	$	673,910
Net income attributable to Ebix, Inc.	—	—		—		308		—		—		308
Net loss attributable to noncontrolling interest	—	—		—		—		—		(380)		(380)
Cumulative translation adjustment	—	—		—		—		2,393		—		2,393

Vesting of restricted stock	26,917	3		(3)		—		—		—		—

Share based compensation	—	—		644		—		—		—		644
Forfeiture of certain shares to satisfy exercise costs and the recipients income tax obligations related to stock options exercised and restricted stock vested	(973)	—		(18)		—		—		—		(18)

Common stock dividends paid, $0.000 per share	—	—		—		—		—		—		—
Balance, June 30, 2023	30,877,258	$	3,088	$	20,041	$	822,162	$	(209,326)	$	40,892	$	676,857


	Common Stock
	Issued Shares	Amount		Additional Paid-in Capital		Retained Earnings		Accumulated Other Comprehensive Loss		Noncontrolling interest		Total

Balance, January 1, 2023	30,819,533	3,082		18,801		814,781		(219,439)		42,215		$	659,440
Net income attributable to Ebix, Inc.	—	—		—		7,381		—		—		7,381
Net loss attributable to noncontrolling interest	—	—		—		—		—		(1,323)		(1,323)
Cumulative translation adjustment	—	—		—		—		10,113		—		10,113

Vesting of restricted stock	60,007	6		(6)		—		—		—		—

Share based compensation	—	—		1,288		—		—		—		1,288
Forfeiture of certain shares to satisfy exercise costs and the recipients income tax obligations related to stock options exercised and restricted stock vested	(2,282)	—		(42)		—		—		—		(42)

Common stock dividends paid, $0.000 per share	—	—		—		—		—		—		—
Balance, June 30, 2023	30,877,258	$	3,088	$	20,041	$	822,162	$	(209,326)	$	40,892	$	676,857

Table of Contents


	Common Stock
	Issued Shares	Amount		Additional Paid-in Capital		Retained Earnings		Accumulated Other Comprehensive Loss		Noncontrolling interest		Total

Balance, April 1, 2022	30,722,267	3,072		$	15,994	$	776,081	$	(133,306)	$	43,418	$	705,259
Net income attributable to Ebix, Inc.	—	—		—		19,343		—		—		19,343
Net loss attributable to noncontrolling interest	—	—		—		—		—		(491)		(491)
Cumulative translation adjustment	—	—		—		—		(43,343)		—		(43,343)

Vesting of restricted stock	34,183	3		(3)		—		—		—		—

Share based compensation	—	—		970		—		—		—		970
Forfeiture of certain shares to satisfy exercise costs and the recipients income tax obligations related to stock options exercised and restricted stock vested	(950)	—		(30)		—		—		—		(30)

Common stock dividends paid, $0.075 per share	—	—		—		(2,318)		—		—		(2,318)
Balance, June 30, 2022	30,755,500	$	3,075	$	16,931	$	793,106	$	(176,649)	$	42,927	$	679,390


	Common Stock
	Issued Shares	Amount		Additional Paid-in Capital		Retained Earnings		Accumulated Other Comprehensive Loss		Noncontrolling interest		Total

Balance, January 1, 2022	30,683.393	$	3,068	$	15,068	$	759,208	$	(122,022)	$	44,232	$	699,554
Net income attributable to Ebix, Inc.	—	—		—		38,534		—		—		38,534
Net loss attributable to noncontrolling interest	—	—		—		—		—		(1,305)		(1,305)
Cumulative translation adjustment	—	—		—		—		(54,627)		—		(54,627)

Vesting of restricted stock	74,164	7		(7)		—		—		—		—

Share based compensation	—	—		1,934		—		—		—		1,934
Forfeiture of certain shares to satisfy exercise costs and the recipients' income tax obligations related to stock options exercised and restricted stock vested	(2,057)	—		(64)		—		—		—		(64)

Common stock dividends paid, $0.075 per share	—	—		—		(4,636)		—		—		(4,636)
Balance, June 30, 2022	30,755,500	$	3,075	$	16,931	$	793,106	$	(176,649)	$	42,927	$	679,390

See accompanying notes to the condensed consolidated financial statements.

Table of Contents

Ebix, Inc. and Subsidiaries

Condensed Consolidated Statements of Cash Flows

(In thousands)

(Unaudited)


	Six Months Ended
	June 30,
	2023		2022
Cash flows from operating activities:
Net income attributable to Ebix, Inc.	$	7,381	$	38,534
Net loss attributable to noncontrolling interest	(1,323)		(1,305)
Adjustments to reconcile net income to net cash provided by operating activities:
Amortization and depreciation	9,909		9,238
Provision (benefit) for deferred taxes	(27,654)		(24,354)
Share-based compensation	1,288		1,934
(Benefit) provision for doubtful accounts	1,832		1,702

Amortization of right-of-use assets	2,051		1,765


Amortization of capitalized software development costs	103		1,511



Changes in assets and liabilities, net of effects from acquisitions:
Accounts receivable	(9,322)		(16,223)
Receivables from service providers	3,681		(2,194)
Payables to service agents	7,438		1,174
Other assets	(5,749)		(9,826)
Accounts payable and accrued expenses	14,620		8,525
Accrued payroll and related benefits	2,617		1,004
Contract liabilities	(786)		8,766
Lease liabilities	(2,080)		(1,670)
Reserve for potential uncertain income tax return positions	—		—
Other liabilities	4,433		2,863
Net cash provided by operating activities	8,439		21,444

Cash flows from investing activities:






Capitalized software development costs	(546)		(4,170)
Maturities (purchases) of unrestricted marketable securities, net	(870)		(3,214)
Capital expenditures	(7,921)		(9,607)
Net cash (used in) provided by investing activities	(9,337)		(16,991)

Cash flows from financing activities:
Prepayments related to Debt Refinancing	(7,704)		—
Proceeds from term loan	—		—
Principal payments of term loan obligation	(40,961)		(15,933)


Forfeiture of certain shares to satisfy exercise costs and the recipients' income tax obligations related to stock options exercised and restricted stock vested	(42)		(64)
Dividend payments	—		(4,636)

Payments of debt obligations, net	(2,780)		(1,672)
(Payments) of/Borrowings under working capital facility, net	1,660		(1,704)
Payments of financing lease obligations, net	(86)		(106)
Net cash used in financing activities	(49,913)		(24,115)
Effect of foreign exchange rates on cash	2,251		(11,767)
Net change in cash and cash equivalents, and restricted cash	(48,560)		(31,429)
Cash and cash equivalents, and restricted cash at the beginning of the period	124,959		114,764
Cash and cash equivalents, and restricted cash at the end of the period	$	76,399	$	83,335
Supplemental disclosures of cash flow information:
Interest paid	$	36,283	$	19,088
Income taxes paid	$	25,055	$	24,222

See accompanying notes to the condensed consolidated financial statements.

Table of Contents

Supplemental schedule of noncash financing activities:

During the six months ended June 30, 2023, there were 2,282 shares, totaling $42 thousand, used to satisfy exercise costs and the recipients' income tax obligations related to stock options exercised and restricted stock vesting.

During the six months ended June 30, 2022, there were 2,057 shares, totaling $64 thousand, used to satisfy exercise costs and the recipients' income tax obligations related to stock options exercised and restricted stock vesting.

Table of Contents

Ebix, Inc. and Subsidiaries

Notes to Condensed Consolidated Financial Statements

Note 1: Description of Business and Summary of Significant Accounting Policies

Description of Business — Ebix, Inc., and its subsidiaries, (“Ebix” or the “Company”, "we", "us", and "our") is a leading international supplier of on-demand infrastructure exchanges to the insurance, financial services, travel, and healthcare industries. In the insurance industry, the Company’s main focus is to develop and deploy a wide variety of insurance and reinsurance exchanges on an on-demand basis using software-as-a-service ("SaaS") enterprise solutions in the areas of customer relationship management ("CRM"), front-end and back-end systems, and outsourced administrative and risk compliance. The Company's products feature fully customizable and scalable software solutions designed to streamline the way insurance and financial industry professionals manage distribution, marketing, sales, customer service, and accounting activities. With a "Phygital” strategy that combines physical distribution outlets in India and many Association of Southeast Asian Nations ("ASEAN") countries to an Omni-channel online digital platform, the Company’s EbixCash financial exchange portfolio of software and services encompasses domestic and international money remittance, foreign exchange ("Forex"), travel, pre-paid gift cards, utility payments, lending, and wealth management in India and other ASEAN markets. The Company has its headquarters in Johns Creek, Georgia and also conducts operating activities in Australia, Brazil, Canada, India, Indonesia, New Zealand, the Philippines, Singapore, the United Arab Emirates, and the United Kingdom. International revenue accounted for 78.8% and 85.2% of the Company’s total revenue for the six months ended June 30, 2023 and 2022, respectively.

Summary of Significant Accounting Policies

Basis of Presentation — The accompanying unaudited condensed consolidated financial statements and these notes have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission ("SEC") and in accordance with U.S. Generally Accepted Accounting Principles ("GAAP") with the effect of inter-company balances and transactions eliminated. Certain information and note disclosures normally included in annual financial statements prepared in accordance with GAAP and SEC rules have been condensed or omitted as permitted by and pursuant to those rules and regulations, although the Company believes that the disclosures made are adequate to make the information not misleading. These unaudited condensed consolidated financial statements contain adjustments (consisting only of normal recurring items) necessary to fairly present the consolidated financial position of the Company and its consolidated results of operations and cash flows. Operating results for the three and six months ended June 30, 2023 and 2022 are not necessarily indicative of the results that may be expected for future quarters or the full year of 2023. The condensed consolidated December 31, 2022 balance sheet included in this interim period filing has been derived from the audited financial statements at that date, but does not necessarily include all of the information and related notes required by GAAP for complete financial statements. These condensed interim financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022.

Use of Estimates — The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements and reported amounts of revenue and expenses during those reporting periods. Management has made material estimates primarily with respect to revenue recognition and contract liabilities, accounts receivable, acquired intangible assets, annual impairment reviews of goodwill and indefinite-lived intangible assets, contingent earn out liabilities in connection with business acquisitions, and the provision for income taxes. Actual results may be different from those estimates.

Reclassification — Certain prior year amounts have been reclassified to be consistent with current year presentation within our financial statements.

Cash and Cash Equivalents — The Company considers all highly liquid investments with original maturity of three months or less at the time of purchase to be cash equivalents. Such investments are stated at cost, which approximates fair value. The Company does maintain cash balances in banking institutions in excess of federally insured amounts and therefore is exposed to the related potential credit risk associated with such cash deposits.

Short-Term Investments — The Company's primary short-term investments consist of certificates of deposit with established commercial banking institutions in international markets that have readily determinable fair values. Ebix accounts for such investments that are reasonably expected to be realized in cash, sold, or consumed during the year as short-term investments that are available-for-sale. The carrying amount of investments in marketable securities approximates their fair value. The carrying value of short-term investments was $14.4 million and $17.4 million at June 30, 2023 and December 31, 2022, respectively.

Table of Contents

Restricted Cash — The carrying value of our restricted cash in current assets was $8.3 million and $8.2 million at June 30, 2023 and December 31, 2022, respectively. The June 30, 2023 balance consists of fixed deposits (many in the form of certificates of deposit) pledged with banks for issuance of bank guarantees and letters of credit related to our international operations for our working capital facilities.

The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within the condensed consolidated balance sheets to the amounts shown in the condensed consolidated statements of cash flows:



	As of
	June 30,
	2023		2022
	(In thousands)
Cash and cash equivalents	$	62,165	$	67,511
Restricted cash	8,282		9,415
Restricted cash included in other long-term assets	$	5,952	$	6,409
Total cash, cash equivalents, and restricted cash shown in the condensed consolidated statement of cash flows	$	76,399	$	83,335

Fiduciary Funds - Restricted — Due to EbixHealth JV being a third party administrator ("TPA"), the Company collects premiums from insureds and, after deducting its fees, remits these premiums to insurance companies. Unremitted insurance premiums and/or claim funds established for the benefit for various carriers are held in a fiduciary capacity until disbursed by the Company. The use of premiums collected from insureds but not yet remitted to insurance companies is restricted by law in certain states. The total assets held on behalf of others, $1.7 million and $2.1 million at June 30, 2023 and December 31, 2022, respectively, are recorded as an asset and offsetting fiduciary funds - restricted liability.

Advertising — Advertising costs amounted to $1.8 million and $3.1 million for the three and six month period ended June 30, 2023, respectively, and $2.4 million and $4.3 million for the three and six month period ended June 30, 2022, respectively. The costs are included in sales and marketing expenses in the accompanying condensed consolidated statements of income. The Company expenses advertising costs as incurred.

Fair Value of Financial Instruments — The Company follows the relevant GAAP guidance regarding the determination and measurement of the fair value of assets/liabilities in which fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction valuation hierarchy, which requires and entity to maximize the use of observable inputs when measuring fair value. This guidance establishes a three-level hierarchy for disclosure of assets and liabilities recorded at fair value. The hierarchy reflects the degree to which objective data from external active markets are available to measure fair value. The classification of assets and liabilities within the hierarchy is based on whether the inputs to the valuation methodology used for measurement are observable or unobservable. The classifications are as follows:

•Level 1 Inputs - Unadjusted quoted prices available in active markets for identical investments to the reporting entity at the measurement date.

•Level 2 Inputs - Other than quoted prices included in Level 1 inputs, which are observable for the asset or liability, either directly or indirectly, for substantially the full term of the asset or liability.

•Level 3 Inputs - Unobservable inputs, which are used to the extent that observable inputs are not available, and used in situations where there is little or no market activity for the asset or liability and wherein the reporting entity makes estimates and assumptions related to the pricing of the asset or liability, including assumptions regarding risk.

A financial instrument's level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement.

As of June 30, 2023, the Company had the following financial instruments to which it had to consider both fair values and make fair value assessments:

•Short-term investments (commercial bank certificates of deposits and mutual funds), for which the fair values are measured as a Level 1 instrument for mutual funds and a Level 2 instrument for certificates of deposit.

Table of Contents

•Contingent accrued earn-out business acquisition consideration liabilities, for which fair values are measured as Level 3 instruments. These contingent consideration liabilities were recorded at fair value on the acquisition date and are re-measured quarterly based on the then assessed fair value and adjusted if necessary. The increases or decreases in the fair value of contingent consideration can result from changes in anticipated revenue levels and changes in assumed discount periods and rates. As the fair value measure is based on significant inputs that are not observable in the market, they are categorized as Level 3.

Other financial instruments not measured at fair value on the Company's unaudited Condensed Consolidated Balance Sheet at June 30, 2023 that require disclosure of fair values include: cash and cash equivalents, restricted cash, fiduciary funds, accounts receivable, receivables from service providers, accounts payable and accrued expenses, accrued payroll and related benefits, payables to service agents, finance lease obligations, working capital facilities, the revolving line of credit, and term loan debt. The Company believes that the estimated fair value of such instruments at June 30, 2023 and December 31, 2022 approximates their carrying value as reported on the Company's condensed consolidated balance sheets.

Additional information regarding the Company's assets and liabilities that are measured at fair value on a recurring basis is presented in the following tables:


	Fair Values at Reporting Date Using*
Descriptions	Balance, June 30, 2023		Quoted Prices in Active Markets for Identical Assets or Liabilities (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
	(In thousands)
Assets
Commercial bank certificates of deposits ($10.2 million is recorded in the long term asset section of the condensed consolidated balance sheets in "Other assets")	$	32,730	$	—	$	32,730	$	—
Mutual funds (recorded in the long term asset section of the condensed consolidated balance sheets in "Other assets")	106		106		—		—
Total assets measured at fair value	$	32,836	$	106	$	32,730	$	—

Liabilities


Contingent accrued earn-out acquisition consideration (a)	$	2,315	$	—	$	—	$	2,315
Total liabilities measured at fair value	$	2,315	$	—	$	—	$	2,315

(a) The income valuation approach is applied and the valuation inputs include the contingent payment arrangement terms, projected revenues and cash flows, rate of return, and probability assessments.
* During the six months ended June 30, 2023, there were no transfers between fair value Levels 1, 2, or 3.

Table of Contents


	Fair Values at Reporting Date Using*
Descriptions	Balance, December 31, 2022		Quoted Prices in Active Markets for Identical Assets or Liabilities (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
	(In thousands)
Assets
Commercial bank certificates of deposits ($6.4 million is recorded in the long term asset section of the condensed consolidated balance sheets in "Other assets")	$	37,434	$	—	$	37,434	$	—
Mutual funds	$	98	$	98	$	—	$	—
Total assets measured at fair value	$	37,532	$	98	$	37,434	$	—

Liabilities


Contingent accrued earn-out acquisition consideration (a)	$	2,299	$	—	$	—	$	2,299
Total liabilities measured at fair value	$	2,299	$	—	$	—	$	2,299

(a) The income valuation approach is applied and the valuation inputs include the contingent payment arrangement terms, projected revenues and cash flows, rate of return, and probability assessments.
* During the year ended December 31, 2021, there were no transfers between fair value Levels 1, 2, or 3.

For the Company's assets and liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3), the following table provides a reconciliation of the beginning and ending balances for each category therein, and gains or losses recognized during the six months ended June 30, 2023 and during the year ended December 31, 2022:

Table of Contents


Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
Contingent Liability for Accrued Earn-out Acquisition Consideration	June 30, 2023		December 31, 2022
	(In thousands)

Beginning balance	$	2,299	$	—

Total remeasurement adjustments:

Remeasurement against goodwill	—		2,299
Foreign currency translation adjustments **	16		—

Acquisitions and settlements
Business settlements	—		—

Ending balance	$	2,315	$	2,299

The amount of total (gains) losses for the period included in earnings or changes to net assets, attributable to changes in unrealized gains relating to assets or liabilities still held at period-end.	$	—	$	—


** recorded as a component of other comprehensive income within stockholders' equity

Quantitative Information about Level 3 Fair Value Measurements

The significant unobservable inputs used in the fair value measurement of the Company's contingent consideration liabilities designated as Level 3 are as follows:

(In thousands)

Fair Value at June 30, 2023

Valuation Technique

Significant
Unobservable
Input

Contingent acquisition consideration:

$2,315

Discounted cash flow

Projected revenue and
probability of achievement

(In thousands)

Fair Value at December 31, 2022

Valuation Technique

Significant
Unobservable
Input

Contingent acquisition consideration:

$2,299

Discounted cash flow

Projected revenue and
probability of achievement

Sensitivity to Changes in Significant Unobservable Inputs

As presented in the table above, the significant unobservable inputs used in the fair value measurement of contingent consideration related to business acquisitions are projected revenue forecasts, as developed by the relevant members of Company's management team and considers the probability of achievement of those revenue forecasts. The Company applies these inputs in its calculation and determination of the fair value of contingent earn-out liabilities for purchased businesses. During 2022, certain of the Company's contingent earn-out liabilities were adjusted because of changes to anticipated future revenues from these acquired businesses or as a result of finalizing purchase price allocations that were previously preliminary.

Table of Contents

Revenue Recognition and Contract Liabilities — The Company derives its revenues primarily from software subscription and transaction fees, software license fees, financial transaction fees, risk compliance solution services fees, and professional service fees, including associated fees for consulting, implementation, training, and project management provided to customers with installed systems and applications. Sales and value-added taxes are not included in revenues, but rather are recorded as a liability until the taxes assessed are remitted to the respective taxing authorities.

The Company determines revenue recognition by applying the following steps:

•identification of the contract, or contracts, with a customer;

•identification of the performance obligations in the contract;

•determination of the transaction price;

•allocation of the transaction price to the performance obligations in the contract; and

•recognition of revenue when, or as, we satisfy a performance obligation.

The Company analyzes its different services individually to determine the appropriate basis for revenue recognition, as further described below. Additionally, certain services exist in multiple channels. As Ebix derives revenues from two product/service channels, Exchanges - EbixCash and Insurance, and Risk Compliance Solutions, for policy disclosure purposes, contracts are discussed in conjunction with the channel to which they are most significant.

The Company assesses the terms of customer contracts, including termination rights, penalties (implied or explicit), and renewal rights.

EbixCash Exchanges

EbixCash revenues are primarily derived from the sales of prepaid gift cards and consideration paid by customers for financial transaction services, including services for transferring or exchanging money. The significant majority of EbixCash revenue is for a single performance obligation and is recognized at a point in time. These revenues vary by transaction based upon channel, send and receive locations, the principal amount sent, whether the money transfer involves different send and receive currencies, and speed of service, as applicable.

Gift Cards

EbixCash sells general purpose prepaid gift cards to corporate customers and consumers that can be later redeemed at various merchants. The gift cards are co-branded between EbixCash and its card-issuing banking partners and are affiliated with major payment associations such as VISA, MasterCard, and Rupay. The gift cards are sold to a diversified set of corporate customers from various industries. The gift cards are used by corporate customers to disburse incentives to the end users, which are primarily their employees, agents, and business associates. The gift cards sold by EbixCash are not reloadable, cannot be used at ATMs or for any other cash-out or funds transfer transactions, and are subject to maximum limits per card (currently INR10,000 or approximately $122). Gift cards issued by EbixCash are valid for a period of fifteen months from the date of issuance for virtual cards and three years for physical cards. EbixCash has entered into arrangements with banks and financial institutions to settle payments to merchants based on utilization of the gift cards.

Company Subsidiary Ebix Payment Services Private Limited received ‘a letter of displeasure’ from Reserve Bank of India (‘RBI’) dated March 21, 2023 (‘RBI Letter’), regarding certain of its co-branding arrangements in which RBI observed that the role of Ebix Payment Services as the non-bank entity exceeded the activities permitted under the Master Directions on Issuance and Operation of Prepaid Payment Instruments dated October 11, 2017 and Master Directions on Prepaid Payment Instruments dated August 27, 2021 (collectively, “MD-PPI”). Further, a circular dated April 19, 2023 was also issued by RBI to all approved/authorized PPI Issuers, according to which, RBI noted that as per the contractual arrangements between the banks (‘PPI Issuer’) and non-bank entities, the non-bank entities is inter-alia responsible for funds management, handling of KYC processes, transaction settlement, risk management, liabilities arising out of fraudulent transaction, all types of cards liabilities from customer and corporate’s points of view, etc, which exceeds the activities permitted under the MD-PPI applicable for aforementioned co-branding arrangements. As per the MD-PPI, the role of Ebix Payment Services Private Limited is to be limited to only marketing / distribution of the prepaid payment instruments or providing access to the prepaid payment instrument holders to services that are offered. Therefore, Ebix Payment Services Private Limited has been asked by RBI to suitably amend the co-branding arrangements/ agreements with the banks within one month of the aforesaid communications and strictly comply with the provisions of MD-PPI. Based on its assessment of the RBI letter, Company management is of the view that there will be no material financial impact of the modifications proposed by the RBI on the financial statements for the year ended December 31, 2022.

Table of Contents

Consequent to prospective amendments made/proposed to the co-branding arrangements with banks subsequent to year end, the Ebix Payment Services Private Limited would cease to be a principal under the amended arrangements and would act as an agent for the Banks /PPI Issuers. As a result, the revenue to be recognized for services provided by the EbixCash group post such amendments to the agreements would be recognized on net basis in the financial statements. Further, adjustments arising on recognition of revenue on net basis has been considered while presenting consolidated financial information. There is no impact on profits earned

EbixCash Travel Exchanges

EbixCash Travel revenues are primarily derived from commissions and transaction fees received from various travel providers and international exchanges involved in the sale of travel to the consumer. EbixCash Travel revenue is for a single performance obligation and is recognized at a point in time. Travel revenues include: (i) reservation commissions, segment fees from global travel exchange providers, and transaction net revenues (i.e., the amount charged to travelers less the amount owed to travel service providers) in connection with our reservation services; (ii) ancillary fees, including travel insurance-related revenues and certain reservation booking fees; and (iii) credit card processing rebates and customer processing fees. EbixCash Travel services include the sale of hotel rooms, airline tickets, bus tickets, and train tickets. EbixCash Travel revenue is also derived from ticket sales, wherein the commissions payable to EbixCash Travel, along with any transaction fees paid by travel providers and travel exchanges, is recognized as revenue after completion of the service. The transaction price on such services is agreed upon at the time of the purchase.

EbixCash Travel revenue for the corporate meetings, incentives, conferences, and exhibitions ("MICE") packages is recognized at full purchase value at the completion of the obligation, with the corresponding costs recorded under cost of services provided. For MICE revenues, EbixCash Travel acts as the principal in transactions and, accordingly, reports revenue on a gross basis. EbixCash Travel controls the service at all times prior to transfer to the customer, is responsible for fulfilling the customer contracts, has the risk of loss, and has the ability to establish transaction prices.

EbixCash Money Transfer

For the EbixCash money transfer business, EbixCash has one performance obligation whereupon the customer engages EbixCash to perform one integrated service. This typically occurs instantaneously when the beneficiary entitled to receive the money transferred by the sender visits the EbixCash outlet and collects the money. Accordingly, EbixCash recognizes revenue upon completion of the following: (i) the customer’s acknowledgment of EbixCash’s terms and conditions and the receipt of payment information; (ii) the money transfer has been processed; (iii) the customer has received a unique transaction identification number; and (iv) funds are available to be picked up by the beneficiary. The transaction price is comprised of a transaction fee and the difference between the exchange rate set by EbixCash to the customer and the rate available in the wholesale foreign exchange market, as applicable, both of which are readily determinable at the time the transaction is initiated.

Foreign Exchange and Outward Remittance Services

For EbixCash’s foreign exchange and payment services, customers agree to terms and conditions for all transactions, either at the time of initiating a transaction or signing a contract with EbixCash to provide payment services on the customer’s behalf. In the majority of EbixCash’s foreign exchange and payment services transactions, EbixCash makes payments to the recipient to satisfy its performance obligation to the customer, and, therefore, EbixCash recognizes revenue on foreign exchange and payment when this performance obligation has been fulfilled.

Consumer Payment Services

EbixCash offers several different bill payment services that vary by considerations, including among other factors: (i) who pays the fee to EbixCash (consumer or biller); (ii) whether the service is offered to all consumers; (iii) whether the service is restricted to existing biller relationships of EbixCash; and (iv) whether the service utilizes a physical agent network offered for consumers’ convenience. The determination of which party is EbixCash’s customer for revenue recognition purposes is based on these considerations for each of EbixCash’s bill payment services. For all transactions EbixCash’s customers agree to EbixCash’s terms and conditions, either at the time of initiating a transaction (where the consumer is determined to be the customer for revenue recognition purposes) or upon signing a contract with EbixCash to provide services on the biller’s behalf (where the biller is determined to be the customer for revenue recognition purposes). As with consumer money transfers, customers engage EbixCash to perform one integrated service - collecting money from the consumer and processing the bill payment transaction. This service provides the billers real-time or near real-time information regarding their customers’

Table of Contents

payments and simplifies the billers’ collection efforts. The transaction price on bill payment services is contractual and determinable. Certain biller agreements may include per-transaction or fixed periodic rebates, which EbixCash records as a reduction to revenue.

EbixCash Technology Services

EbixCash also offers on-demand technology to various providers in the area of lending, wealth and asset management, and travel across the world. Additionally, EbixCash provides IT and call center outsourcing services to companies in a variety of industries, both in India and globally. The EbixCash technology software solutions are generally delivered on a SaaS subscription and/or transaction based pricing model. Please see below under "Insurance Exchanges" a description of revenue recognition policies for SaaS, Subscription, and Transaction Fees, which are similar to how EbixCash technology software solutions revenues are recognized. For IT and call center outsourcing services provided by EbixCash businesses, revenues are generally recognized on a time and materials or fixed fee basis. Revenues for time and materials are recognized as such services are rendered, while fixed fee revenues are recognized based on the input method driven by the expected hours to complete the project measured against the actual hours completed to date.

Insurance Exchanges

Insurance Exchanges revenues are primarily derived from consideration paid by customers related to our SaaS platforms, related services, and the licensing of software. A typical contract for our SaaS platform will also include services for setup, customization, transaction processing, maintenance, and/or hosting. Determining whether products and services are considered distinct performance obligations that should be accounted for separately may require significant judgment. Set-up and customization services related to our SaaS platforms are not considered to be distinct from the usage fees associated with the SaaS platform and, accordingly, are accounted for as a single performance obligation. These services, along with the usage or transaction fees, are recognized over the contract duration, which considers the significance of the upfront fees in the context of the contract and which may, therefore, exceed the initial contracted term. A customer's transaction volume tends to remain fairly consistent during the contract period without significant fluctuations. The invoiced amount is a reasonable approximation of the revenue that would be allocated to the related period under the variable consideration guidelines in ASC 606-10-32-40. To the extent that a SaaS contract includes subscription services or professional services, apart from the upfront customization, these are considered separate performance obligations. The Company also has separate software licensing (on premise/perpetual), unrelated to the SaaS platforms, which is recognized at a point in time when the license is transferred to the customer.

Contracts generally do not contain a right of return or refund provisions. Our contracts often contain overage fees, contingent fees, or service level penalties which are accounted for as variable consideration. Revenue accounted for as variable consideration is immaterial and is recognized using the “right to invoice” practical expedient when the invoiced amount equals the value provided to the customer.

Software-as-a-Service

The Company allocates the transaction price to each distinct performance obligation using the relative stand-alone selling price. Determining the stand-alone selling price may require significant judgment. The stand-alone selling price is the price at which an entity has sold or would sell a promised good or service separately to a customer. The Company determines the stand-alone selling price based on observable price of products or services sold separately in comparable circumstances, when such observable prices are available. When standalone selling price is not directly observable, the Company estimates the stand-alone selling price using the market assessment approach by considering historical pricing and other market factors.

Software Licenses

Software license revenues attributable to a software license that is a separate performance obligation are recognized at the point in time that the customer obtains control of the license.

Subscription Services

Subscription services revenues are associated with performance obligations that are satisfied over specific time periods and primarily consist of post-contract support services. Revenue is generally recognized ratably over the contract term. Our subscription contracts are generally for an initial three-year period with subsequent one-year automatic renewals.

Transaction Fees

Table of Contents

Transaction revenue is comprised of fees applied to the volume of transactions that are processed through our SaaS platforms. These fees are typically based on a per-transaction rate and are invoiced for the same period in which the transactions were processed and as the performance obligation is satisfied. The amount invoiced generally equals the value provided to the customer, and revenue is typically recognized when invoiced using the as-invoiced practical expedient.

Professional Services

Professional service revenue primarily consists of fees for setup, customization, training, or consulting services. Professional service fees are generally on a time and materials basis or a fixed fee basis. Revenues for time and materials are recognized as such services are rendered, while fixed fee revenues are recognized based on the input method that is driven by the expected hours to complete the project measured against the actual hours completed to date. Professional services, particularly related to SaaS platforms, may have significant dependencies on the related licensed software and may not be considered a distinct performance obligation.

Risk Compliance Solutions ("RCS")

RCS revenues consist of two revenue streams - certificates of insurance ("COI") and consulting services. COI revenues are derived from consideration paid by customers for the creation and tracking of certificates of insurance. These revenues are transaction-based. Consulting services revenues are driven by distinct consulting service engagements rendered to customers, for which revenues are recognized using the output method on a time and material basis as the services are performed.

COI Creation and Tracking

The Company provides services to issue and track certificates of insurance in the U.S. and Australian markets. Revenue is derived from transaction fees for each certificate issued or tracked. The Company recognizes revenue at the issuance of each certificate or over the period the certificate is being tracked.

Consulting Services

The Company provides consulting services to clients around the world for project management and development. Consulting services fees are generally earned on a time and materials basis or a fixed fee basis. Revenues for time and materials are recognized using an output method as the services are rendered, while fixed fee revenues are recognized based on the input method that is driven by the expected hours to complete the project measured against the actual hours completed to date.

Disaggregation of Revenue

The following tables present revenue disaggregated by primary geographical regions and product/service channels for the three and six months ended June 30, 2023 and 2022:


	Three Months Ended June 30,				Six Months Ended June 30,
Revenue:	2023		2022		2023		2022
	(In thousands)
North America	37,720		39,645		76,590		79,671
International	80,710		213,061		284,601		457,363
	$	118,430	$	250,781	$	361,191	$	537,034

The reported figures have been summarized as compared to those presented thus for better understanding of the quantum of business undertaken in the United States and other countries. Further, the product/service channels, EbixCash Exchange and Insurance Exchange have been merged as Exchange.

Table of Contents

Geographical regions on net basis for comparative purposes (Non GAAP) for the three and six months ended June 30, 2023 and 2022:


	Three Months Ended June 30,				Six Months Ended June 30,
Revenue:	2023		2022		2023		2022
	(In thousands)
North America	37,720		39,645		76,590		79,671
International	80,710		75,279		157,913		134,773
	$	118,430	$	114,924	$	234,503	$	214,444

The Company’s revenues are derived from two product/service groups: Exchanges and Risk Compliance Solutions.

Presented in the table below is the breakout of our revenue groups for each of those product/service channels for the three and six months ended June 30, 2023 and 2022.


	Three Months Ended				Six Months Ended
	June 30,				June 30,
	2023		2022		2023		2022
	(In thousands)

Exchanges	98,078		230,943		319,944		498,859
Risk Compliance Solutions	20,352		19,838		41,247		38,175
Totals	$	118,430	$	250,781	$	361,191	$	537,034

Product/Services channels on net basis for Comparative purposes (Non GAAP) for the three and six months ended June 30, 2023 and 2022:


	Three Months Ended				Six Months Ended
	June 30,				June 30,
	2023		2022		2023		2022
	(In thousands)

Exchanges	98,078		95,086		193,256		176,269
Risk Compliance Solutions	20,352		19,838		41,247		38,175
Totals	$	118,430	$	114,924	$	234,503	$	214,444

Costs to Obtain and Fulfill a Contract

The Company’s capitalized costs are primarily derived from the fulfillment of SaaS-related setup and customizations, from which the customer receives benefit through continued access to and use of the SaaS product platforms. In accordance with the guidance in ASC 340-40-25-5, we capitalize the costs directly related to the setup and development of these customizations, which satisfy the Company’s performance obligation with respect to access to the Company’s underlying product platforms. The capitalized costs primarily consist of the salaries of the developers directly involved in fulfilling the project and are solely based on the time spent on that project. The Company amortizes the capitalized costs ratably over the expected useful life of the related customizations, matching our treatment for the related revenue, and the capitalized costs are recoverable from profit margin included in the contract. At June 30, 2023 and December 31, 2022, the Company had $474

Table of Contents

thousand and $486 thousand, respectively, of contract costs in “Other current assets” and $752 thousand and $797 thousand, respectively, in “Other assets” on the Company's condensed consolidated balance sheets.


	June 30, 2023		December 31, 2022
	(Unaudited)
	(In thousands)
Balance, beginning of period	$	1,284	$	1,822
Costs recognized from the beginning balance	(265)		(968)
Additions, net of costs recognized	208		430
Balance, end of period	$	1,227	$	1,284

Contract Liabilities

Contract liabilities include payments or billings that have been received or made prior to performance. In certain cases, cash collections pertain to maintenance and support fees, initial setup or registration fees under hosting agreements, software license fees received in advance of delivery and acceptance, and software development fees paid in advance of completion and delivery. Approximately $9.4 million and $8.0 million of contract liabilities were included in billed accounts receivable as of June 30, 2023 and December 31, 2022, respectively.

The Company records contract liabilities when it receives payments or invoices in advance of the performance of services. A significant portion of this balance relates to contracts where the customer has paid in advance for the use of the Company's SaaS platforms over a specified period of time. This portion is recognized as the related performance obligation is fulfilled (generally less than one year). Part of our performance obligation for these contracts consists of the requirement to provide our customers with continued access to, and use of, our SaaS platforms and associated customizations. Without continued access to the SaaS platform, the customizations have no separate benefit to the customer. Our customers simultaneously receive and consume the benefits as we provide access over time. The remaining portion of the contract liabilities balance consists primarily of customer-specific customizations that are not distinct from related performance obligations that transfer over time. This portion is recognized over the expected useful life of the customizations.


	June 30, 2023		December 31, 2022
	(Unaudited)
	(In thousands)
Balance, beginning of period	$	46,127	$	41,357
Revenue recognized from beginning balance	(26,392)		(30,460)

Additions, net of revenue recognized and currency translation	25,751		35,230
Balance, end of period	$	45,486	$	46,127

Accounts Receivable and the Allowance for Doubtful Accounts — As of June 30, 2023, reported accounts receivable of $163.2 million (net of $18.9 million allowance for doubtful accounts receivable) includes $52.8 million of contract assets. As of December 31, 2022, reported accounts receivable of $154.5 million (net of $18.2 million allowance for doubtful accounts receivable) includes $55.2 million of contract assets. The Company records a contract asset when revenue recognized on a contract exceeds the billings. The contract asset is transferred to receivables when the entitlement to payment becomes unconditional. These contract assets are primarily related to project-based revenue where we recognize revenue using the input method calculated using expected hours to complete the project measured against the actual hours completed to date. Management specifically analyzes accounts receivable, historical bad debts, write-offs, customer concentrations, customer credit-worthiness, current economic trends, and changes in our customer payment terms when evaluating the adequacy of the allowance for doubtful accounts. The Company recognized bad debt expense (recovery) in the amount of $1.4 million and $1.8 million for the three and six month period ended June 30, 2023 and $2.1 million and $1.7 million for the three and six month period ended June 30, 2022.

Table of Contents

enhance our software products, after general market release of the services using the products, are expensed in the period they are incurred. The periodic expense for the amortization of previously capitalized software development costs is included in cost of services provided. See Note 10 "Capitalized Software Development Costs" for further details.

Cost of Services Provided — Cost of services provided consist of data processing costs, customer support costs (including personnel costs to maintain our proprietary databases), costs to provide customer call center support, hardware and software expense associated with transaction processing systems and exchanges, telecommunication and computer network expense, and occupancy costs associated with facilities where these functions are performed. Cost of services provided also includes the direct expenses associated with our services businesses, including the cost of prepaid gift cards, the cost of travel services provided and the cost of foreign exchange and remittance transactions. Depreciation expense is not included in cost of services provided.

Goodwill and Indefinite-Lived Intangible Assets — Goodwill represents the cost in excess of the fair value of the identifiable net assets from the businesses that we acquire. In accordance with ASC 350, “Goodwill and Other Intangible Assets" and ASU No. 2011-08, “Testing Goodwill for Impairment”, goodwill is tested for impairment at the reporting unit level on an annual basis or on an interim basis if an event occurred or circumstances change that would indicate that fair value of our reporting unit decreased below its carrying value. Potential impairment indicators include a significant change in the business climate, legal factors, operating performance indicators, competition, customer retention, and the sale or disposition of a significant portion of the business. The Company applies the accounting guidance concerning goodwill impairment evaluation, whereby the Company first assesses certain qualitative factors to determine whether the existence of events or circumstances would indicate that it is more likely than not that the fair value of a reporting unit was less than its carrying amount. If after assessing the totality of events and circumstances, we were to determine that it is more likely than not that the fair value of a reporting unit is less than its carrying amount, then we would perform quantitative impairment testing.

We perform our annual goodwill impairment evaluation and testing as of October 1st of each year or, when events or circumstances dictate, more frequently. No goodwill impairments occurred or were recognized in the year ended December 31, 2022 or in the six months ended June 30, 2023.

The Company considered the guidance within ASC 350 “Goodwill and Other Intangible Assets” and ASC 280 “Segment Reporting” in concluding that Ebix effectively operates as one operating and reportable segment and one reporting unit.

The Company’s indefinite-lived assets are primarily associated with the estimated fair value of the contractual customer relationships existing with the property and casualty ("P&C") insurance carriers in Australia using the Company's P&C data exchange. Indefinite-lived intangible assets are not amortized, but rather are tested for impairment annually and tested on an interim basis if a triggering event has occurred.

Finite-lived Intangible Assets — Purchased intangible assets represent the estimated acquisition date fair value of customer relationships, developed technology, trademarks, non-compete agreements, and other intangibles described below obtained in connection with the businesses we acquire. We amortize these intangible assets on a straight-line basis over their estimated useful lives, as follows:


Category						Life (yrs)
Airport contracts						4 - 20
Brand						3 - 15
Customer relationships						9
Database						5
Dealer networks						15 - 20
Developed technology						3 - 15
Non-compete agreements						3 - 15
Store networks						5 - 7
Trademarks						10

Foreign Currency Translation — The functional currency is the U.S. Dollar for the Company's foreign subsidiaries in Dubai and Singapore.

Table of Contents

During the three months ended June 30, 2023, the net change in the cumulative foreign currency translation account, which is a component of accumulated other comprehensive loss within stockholders’ equity, was an unrealized gain of $2.4 million, which was primarily caused by the weakening of the international currencies.

The functional currency of the Company's other foreign subsidiaries is the local currency of the country in which the subsidiary operates. The assets and liabilities of these foreign subsidiaries are translated into U.S. dollars at the rates of exchange at the balance sheet dates. Income and expense accounts are translated at the average exchange rates in effect during the period. Gains and losses resulting from translation adjustments are included as a component of accumulated other comprehensive income in the accompanying condensed consolidated balance sheets, and are included in the condensed consolidated statements of comprehensive income. Foreign exchange transaction gains and losses that are derived from transactions denominated in a currency other than the subsidiary's functional currency are included in the determination of net income.

The Company applies the relevant Financial Accounting Standards Board ("FASB") accounting guidance on accounting for uncertainty in income taxes positions. This guidance clarifies the accounting for uncertainty in income taxes by prescribing the minimum recognition threshold a tax position is required to meet before being recognized in the financial statements. In this regard we recognize the tax benefit from uncertain tax positions only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position.

Recent Relevant Accounting Pronouncements — Since December 31, 2022 there have not been any new released accounting pronouncements that are material to our unaudited condensed consolidated financial statements, or are expected to have a material impact on our business.

Note 2: Earnings per Share

A reconciliation between basic and diluted earnings per share ("EPS") is as follows:


	Three Months Ended				Six Months Ended
	June 30,				June 30,
	2023		2022		2023		2022
	(In thousands, except per share data)
Net income attributable to Ebix, Inc.	$	308	$	19,343	$	7,381	$	38,534
Basic weighted average shares outstanding	30,866		30,745		30,854		30,729
Dilutive effect of stock options and restricted stock awards	3		11		2		27
Diluted weighted average shares outstanding	30,869		30,756		30,856		30,756
Basic earnings per common share	$	0.01	$	0.63	$	0.24	$	1.25
Diluted earnings per common share	$	0.01	$	0.63	$	0.24	$	1.25

The number of potential issuable shares with respect to stock options, which could dilute EPS in the future but which were excluded from the diluted EPS calculation because presently their effect is anti-dilutive for the three and six month period ended June 30, 2023 were 180,000 and for the three and six month period ended June 30, 2022 were 138,000.

Note 3: Business Combinations

As part of its comprehensive business growth and expansion strategy, the Company seeks to execute accretive business acquisitions that are, in most cases, complementary to Ebix's existing products and services.

During the six months ending June 30, 2023, the Company completed no business acquisitions.

Table of Contents

During the twelve months ended December 31, 2022, the Company completed no business acquisitions.

A significant component of the purchase price consideration for many of the Company's business acquisitions is a potential subsequent cash earn-out payment based on reaching certain specified future revenue targets. The terms for the contingent earn-out payments in most of the Company's business acquisitions typically address the GAAP recognizable revenues achieved by the acquired entity over a one-, two-, and/or three-year period subsequent to the effective date of their acquisition by Ebix. These terms typically establish a minimum threshold revenue target to achieve over the agreed upon period post acquisition to earn the specified cash earn out payment. The Company applies these terms in its calculation and determination of the fair value of contingent earn out liabilities for purchased businesses as part of the related valuation and purchase price allocation exercise for the corresponding acquired assets and liabilities. The Company recognizes these potential obligations as contingent liabilities and are reported as such on its condensed consolidated balance sheets. As discussed in more detail in Note 1, these contingent consideration liabilities are recorded at fair value on the acquisition date and are remeasured quarterly based on the then assessed fair value and adjusted if necessary. As of both June 30, 2023 and December 31, 2022, the total of these contingent consideration liabilities was $2.3 million.

Consideration paid by the Company for the businesses it purchases is allocated to the assets and liabilities acquired based upon their estimated fair values as of the date of the acquisition. The excess of the purchase price over the estimated fair values of assets acquired (including identified intangible assets acquired) and liabilities assumed is recorded as goodwill.

Note 4: Debt

The Company maintains a senior secured syndicated credit facility, dated August 5, 2014, among Ebix, Inc., as borrower, its subsidiaries party thereto from time to time as guarantors, Regions Bank (as administrative agent and collateral agent) and the lenders party thereto from time to time (as amended from time to time, the "Credit Facility") that provides a $450 million revolving line of credit (the "Revolver") as well as a term loan (the "Term Loan"), which at June 30, 2023 had a balance of $171.9 million. The Credit Facility was set to mature on February 2023; however, in May 2023, the company entered into Amendment No. 14 to its Credit Facility, which provides for, among other things, an extension of the maturity date from May 23, 2023 to September 30, 2023 ("Credit Facility Maturity Date"), as discussed in more details below. At June 30, 2023 the outstanding balance of the Credit Facility, $616.8 million, was classified as a current liability. The Company expects to address the Credit Facility maturity prior to the Credit Facility Maturity Date, and intends to do so in conjunction with the resolution of the anticipated IPO of EbixCash, as further described within Item 2 "Management's Discussion and Analysis of Financial Conditions and Results of Operations - Liquidity and Capital Resources". The refinancing of the Credit Facility will require the Company to successfully access the debt and/or equity capital markets in the U.S. or internationally. However, there are no assurances that such financing will be available in amounts or on terms acceptable to us, if at all, or that the proceeds received by Ebix, Inc. from the IPO of EbixCash will be in the amount currently expected. Further, no assurances can be given when the IPO will be completed, if at all, or if it will be completed on terms acceptable to the Company.

On July 21, 2023, the Company entered into an amendment No. 15 that specifically provided for, among other things, the deletion of the event of default deadline for the mandatory public opening of subscription to investors of the shares of the Company’s subsidiary EbixCash on the Indian stock market on or by prior to July 31, 2023. Also, Amendment 15 that changed the possible additional amendment fee (the “Amendment Fee”) that had been included as part of Amendment No. 14, as discussed below, from an amount equal to 1.50% of the aggregate principal amount of the outstanding term loan (the “Term Loan and the lenders’ commitments under the revolving line of credit (the “Revolver”), whether or not utilized, to 2%. The Amendment Fee will be waived if all of the Revolver has been terminated and the Term Loan and all other obligations due the lenders are fully repaid on or before August 31, 2023.

On May 23, 2023, the company signed an amendment (“Amendment No. 14”) to its existing credit agreement, extending the maturity date to September 30, 2023. Amendment No. 14 provided for, among other things, an extension of the maturity date for both the Revolver and the term loan the Term Loan, each as existing under the Credit Agreement. It was conditioned, among other things, upon the Company (i) making a $5,000,000 payment of the Term Loan by June 30, 2023 and (ii) paying a customary consent fee which will be payable over time and partially waived if certain conditions are met.

Amendment No. 14 also specifically provided for the application of a certain percentage of the proceeds from certain liquidity events towards payment of outstanding principal and interest obligations at that time. These events would have included the public listing of the shares of the Company’s subsidiary EbixCash on the Indian stock market by July 31, 2023, the proceeds from the issuance of any additional debt and/or securities if raised by the Company and the proceeds from the monetization of any asset sale, if carried out by the Company.

Table of Contents

Amendment No. 14 (i) increased the applicable margin for the facilities under the Credit Agreement to (x) 7.50% per annum for SOFR loans and letter of credit fees, (y) 6.50% per annum for base rate loans, and (ii) further increases the applicable margin for the facilities under the Credit Agreement on August 31, 2023 to (x) 8.00% per annum for SOFR loans and letter of credits fees, and (y) 7.00% per annum for base rate loans. Amendment 14 also included the Amendment Fee of 1.50%.

On February 21, 2023, the company entered into Amendment No. 13 to its Credit Facility, which provides for, among other things, an extension of the maturity date from February 21, 2023 to May 23, 2023 ("Credit Facility Maturity Date"). Amendment No. 13 to the Credit Facility required the Company to make a $5 million prepayment of the Revolver on February, 21, 2023 and a $5 million amortization payment on the Term Loan on March 31, 2023. Any repayments under the Revolver will be accompanied by a corresponding reduction in the aggregate revolving commitments. Lastly, amendment No. 13 modified certain other provisions within the Credit Agreement and has resulted in an approximately 1% per annum interest rate increase beginning February 21, 2023.

On April 9, 2021, The Company entered into Amendment No. 12 to its Credit Facility. Amendment No. 12 provided for, among other things, a waiver of any potential event of default arising under the Credit Facility from the failure to timely deliver the Company's audited financial consolidated financial statements and related compliance certificate for the year ended December 31, 2020, provided that there is no good faith determination by the requisite lenders under the Credit Facility of a "Material Circumstance" (as defined and further described in Amendment No. 12), which determination (if any) may only be made within a specified period described in Amendment No. 12 and is subject to certain cure rights of the Company. Amendment No. 12 also modified the applicable margin that applies from the date of the amendment forward, modified certain mandatory prepayment provisions, as well as certain other covenants related to restricted payments, investments and certain reporting requirements.

On March 31, 2021, Ebix entered into Amendment No. 11 to the Credit Facility. Amendment No. 11 provided, for, among other things, a limited waiver through April 10, 2021, of any potential event of default arising under the Credit Facility from failure to deliver the Company's audited consolidated financial statements and related compliance certificate for the year ended December 31, 2020. Amendment No. 11 also modified certain covenants contained in the Credit Facility, including with respect to certain permitted restricted payments and investments.

As of June 30, 2023, the Company's condensed consolidated balance sheets include $2.3 million of remaining deferred financing costs in connection with the Credit Facility, which are being amortized as a component of interest expense through the Credit Facility Maturity Date. $1.4 million of such deferred financing costs pertain to the Revolver, and $0.9 million pertains to the Term Loan, which is netted against the current portion of the Term Loan as reported on the condensed consolidated balance sheets. At December 31, 2022, the Company's Consolidated Balance Sheets included $1.2 million of remaining deferred financing costs in connection with the Credit Facility, with $0.7 million pertaining to the Revolver, and $0.5 million pertaining to the Term Loan, of which $0.5 million was netted against the current portion of the Term Loan.

As of June 30, 2023, the outstanding balance on the Revolver was $444.9 million and the Revolver carried an interest rate of 11.95% at June 30, 2023. The balance on the Revolver is included in the current liabilities section of the condensed consolidated balance sheets. During the six months ended June 30, 2023, the average and maximum outstanding balances of the revolving line of credit component of the Credit Facility were both $444.9 million. At December 31, 2022, the outstanding balance on the Revolver was $449.9 million and the Revolver carried an interest rate of 9.69%.

As of June 30, 2023, the outstanding balance on the Term Loan was $171.9 million, of which $171.9 million is due within the next twelve months. $17.5 million of principal payments were made during the six months ended June 30, 2023, of which $0.0 million were scheduled amortization payments. This Term Loan also carried an interest rate of 11.95% at June 30, 2023. The Term Loan is included in the current liabilities section of the condensed consolidated balance sheets at June 30, 2023. At December 31, 2022, the outstanding balance on the Term Loan was $189.4 million, of which $189.4 million was due within twelve months. The Term Loan also carried an interest rate of 9.69% at December 31, 2022.

The Company maintains working capital debt facilities with banks in international markets for working capital funding requirements to support our foreign exchange and payment remittance businesses. We are required to extend short term credits to franchisee networks (B2B) and corporate customers. Additionally we are required to maintain minimum levels of foreign currency inventory across branches and airport operations. Typically, these facilities carry interest rates of 9.00% to 10%, are rupee-denominated working capital lines, and are collateralized against the receivables of these businesses and existing foreign currency inventory on hand.

Table of Contents

As of June 30, 2023 and December 31, 2022, the total of these working capital facilities was $5.0 million and $3.4 million, respectively, and is included in current liabilities in the Company's condensed consolidated balance sheets.

Note 5: Commitments and Contingencies

On February 22, 2021, Christine Marie Teifke, a purported purchaser of Ebix securities, filed a putative class action in the United States District Court for the Southern District of New York, captioned Teifke v. Ebix, Inc., et. al., Case No. 1:21-cv-01589-JMF, on behalf of herself and others who purchased or acquired Ebix securities between November 9, 2020 and February 19, 2021. The complaint asserts claims against the Company, Robin Raina, and Steven M. Hamil (“Defendants”), for purported violations of Section 10(b) of the Securities Exchange Act of 1934, alleging that Ebix made false and misleading statements and failed to disclose material adverse facts about an audit of the company's gift card business in India and its internal controls over the gift and prepaid card revenue transaction cycle. The complaint alleges that Ebix's stock price fell as a result of the revelation that Ebix's independent auditor, RSM US LLP (“RSM”), had resigned, citing concerns with the company's internal controls and disagreements over other accounting issues. The complaint also asserts a claim against Robin Raina and Steven M. Hamil for purported violations of Section 20(a) of the Exchange Act arising out of the same facts. The complaint seeks, among other relief, damages and attorneys' fees and costs. On May 11, 2021, the court issued an order appointing Rahul Saraf, another purported purchaser of Ebix, Inc. securities, as lead plaintiff in the action, and the caption in the action was changed to Saraf v. Ebix, Inc., et. al., Case No. 1:21-cv-01589-JMF (the "Class Action"). On July 17, 2023, the Court dismissed the Class Action in its entirety with prejudice for failure to state a claim.

On May 14, 2021, Javier Calvo, a purported shareholder of the Company, filed a derivative action in the United States District Court for the Southern District of New York on behalf of Ebix captioned Calvo v. Raina, et. al., Case No. 21-cv-4380-JMF (the "Calvo Action"), against individual defendants Robin Raina, Steven M Hamil, Hans U. Benz, Rolf Herter, Neil D. Eckert, Pavan Bhalla, Hans Ueli Keller, and George W. Hebard, and nominal defendant Ebix asserting claims related to the RSM resignation. On July 13, 2021, Peter Votto, another purported Ebix shareholder, filed an additional derivative action in the United States District Court for the Southern District of New York on behalf of Ebix, captioned Votto v. Raina, et. al., Case No. 21-cv-5982-JMF (the "Votto Action"), asserting claims against the same defendants as the Calvo Action. The complaint asserts claims relating to the RSM resignation against all of the individual defendants for breach of fiduciary duties, unjust enrichment, waste of corporate assets, and rescission under Section 29(b) of the Securities Exchange Act of 1934, and claims for contribution under Sections 10(b) and 21D of the Securities Exchange Act of 1934 against Robin Raina and Steven M Hamil. The Consolidated Derivative Action is currently stayed by agreement of the parties and order of the Court.

On November 5, 2021, Daniel Lilienfeld, a purported shareholder of the Company, filed a derivative action in the United States District Court for the Northern District of Georgia on behalf of Ebix captioned Lilienfeld v. Raina, et. al., Case No. 1:21-cv-04590-ELR (the "Lilienfeld Action"), asserting claims against the same defendants as the Consolidated Derivative Action. The complaint similarly asserts a claim of breach of fiduciary duty related to the RSM resignation against all of the individual defendants. On July 26, 2023, Mr. Lilienfeld dismissed the Lilienfeld Action without prejudice.

On December 29, 2021, Sunil Shah, a purported shareholder of the Company, filed a derivative action in the Superior Court of Fulton County of the State of Georgia on behalf of Ebix captioned Shah v. Raina, et. al., Civil Action File No. 2022-cv-358481 (the "Shah Action") against the same defendants as the Consolidated Derivative Action and Lilienfeld Actions. The complaint similarly asserts a claim of breach of fiduciary duty related to the RSM resignation against all of the individual defendants. The Shah Action was stayed by agreement of the parties and order of the Court. On July 26, 2023, Mr. Shah dismissed the Shah Action without prejudice.

The Company along with Ebix Singapore Pte. Ltd. (the “Ebix Group”) had purchased 80% Equity Shares of Ebix Payment Services Private Limited (“ItzCash”) with effect from April 1, 2017. During the Financial Year 2020, the erstwhile shareholders of ItzCash raised a dispute with the Ebix Group alleging breaches of the share purchase agreement and shareholders’ agreement entered into between the parties and demanding for termination of the shareholders’ agreement, payment of earn out consideration and buyout of minority shareholding. The matter is under arbitration in accordance with the rules of the Singapore International Arbitration Centre (“SIAC”). The arbitration proceedings have concluded, and the arbitral tribunal has passed a partial order dated June 1, 2023 (“Partial Award”) which inter alia states the following (i) the termination of the shareholders agreement executed amongst the Company, Ebix Singapore, Ebix World Money, Vyoman, Ashok Kumar Goel and Ebix Payment Services dated May 12, 2017 (“SHA”) by Vyoman and Mr. Goel was justified (ii) our Company and Ebix World Money (and failing performance, Ebix Singapore) are jointly and severally obliged to purchase the existing shareholding of Vyoman and Mr. Goel under the SHA at a price determined by an independent valuer, once such determination has been made in accordance with the relevant provisions of the SHA and (iii) Claimants were not entitled to specific performance to receive payment of the first and second earn-out thresholds under the aforementioned agreements; and (iv) our Company, Ebix Singapore, Ebix World Money and Ebix Payment Services were found in breach of certain clauses of the aforementioned agreements. Due to absence of explanation of how Claimants incurred or may have incurred losses pursuant to such breaches of the above mentioned agreements the Partial Award directed payment of nominal damages by the Respondents in an joint and several manner to the Claimants as follows: (i) SGD 200 each to Vyoman and Ashok Kumar Goel in respect to the breaches of the SHA and (ii) SGD 100 to each of the 17 other claimants in respect to breaches of the Promoter SPA,

Table of Contents

Employee SPA and Investor SPA. The Partial Award also states that the directions in relation to the arbitration costs will be dealt in the final award. The matter is currently pending.

The Company is involved in various other claims and legal actions arising in the ordinary course of business, which in the opinion of management, the ultimate likely disposition of these matters will not have a material adverse effect on the Company’s consolidated financial position, results of operations or liquidity.

Note 6: Income Taxes

The Company recorded a net income tax expense of $164 thousand and $787 thousand (12.74%) during the three and six months ended June 30, 2023, which included tax expense of $1.6 million and $1.8 million from certain discrete items related to stock compensation and uncertain tax positions. The income tax benefit, exclusive of discrete items, was $1.4 million and $971 thousand (15.67%) for the three and six months ended June 30, 2023. During the three and six months ended June 30, 2023 and June 30, 2022, there was an increase of $1.4 million and $146 thousand to this liability reserve, respectively. The Company expects its full year effective tax rate to be in the range of 8% to 10%.

As of June 30, 2023 and December 31, 2022 a liability of $7.8 million and $6.4 million for uncertain tax positions is included in other long-term liabilities of the Company's condensed consolidated balance sheets. The Company recognizes interest accrued and penalties related to unrecognized tax benefits as part of income tax expense.

Note 7: Geographic Information

The Company operates within one reportable segment in which the results are regularly reviewed by the Company's Chief Executive Officer, its chief operating decision maker, as to performance and allocation of resources. External customer revenues in the tables below are attributed to a particular country based on whether the customer had a direct contract with the Company which was executed in that particular country for the sale of the Company's products/services from an Ebix subsidiary located in that country.

The following enterprise-wide information relates to the Company's geographic locations:


	Six Months Ended		As of		Six Months Ended		As of
	June 30, 2023		June 30, 2023		June 30, 2022		December 31, 2022
	External Revenues		Long-lived assets		External Revenues		Long-lived assets
	(In thousands)
North America	76,590		388,113		79,671		374,891
International	284,601		803,515		457,363		785,746
	$	361,191	$	1,191,628	$	537,034	$	1,160,637

Enterprise-wide information relates to the Company's geographic locations on net basis for Comparative Purposes (Non GAAP)

Table of Contents


	Six Months Ended		As of		Six Months Ended		As of
	June 30, 2023		June 30, 2023		June 30, 2022		December 31, 2022
	External Revenues		Long-lived assets		External Revenues		Long-lived assets
	(In thousands)
North America	76,590		388,113		79,671		374,891
International	157,913		803,515		134,773		785,746
	$	234,503	$	1,191,628	$	214,444	$	1,160,637

Note 8: Investment in Joint Ventures

Effective February 2016, Ebix and Vayam Technologies Ltd ("Vayam") formed a joint venture named Ebix Vayam Limited JV. This joint venture was established to carry out IT projects in the government sector of the country of India, particularly in regards to the implementation of e-governance projects in the areas of education and healthcare. Ebix has a 51% equity interest in the joint venture, and Vayam has a 49% equity interest in the joint venture. Ebix is fully consolidating the operations of Ebix Vayam Limited JV into the Company's financial statements and separately reporting the Vayam minority, non-controlling interest in the joint venture's net income and equity. Vayam is also a customer of Ebix Vayam Limited JV, and, during the three and six months ended June 30, 2023, Ebix Vayam Limited JV recognized $105 thousand and $206 thousand, respectively, of revenue from Vayam. During the three and six months ended June 30, 2022, Ebix Vayam Limited JV recognized $245 thousand and $521 thousand, respectively, of revenue from Vayam. As of June 30, 2023, Ebix Vayam Limited JV had $11.8 million of accounts receivable with Vayam, net of the estimated allowance for doubtful accounts receivable in the amount of $5.7 million. As of December 31, 2022, Ebix Vayam Limited JV had $11.6 million of accounts receivable with Vayam, net of the estimated allowance for doubtful accounts receivable in the amount of $5.7 million.

Effective September 2015, Ebix and Independence Holding Company ("IHC") formed the joint venture EbixHealth JV. This joint venture was primarily established to promote and market an administrative data exchange for health insurance lines of business in the U.S. Ebix has a 51% equity interest in the joint venture and IHC has a 49% equity interest the joint venture. Ebix is fully consolidating the operations of EbixHealth JV into the Company's financial statements and separately reporting EbixHealth JV non-controlling interest in the joint venture's net income and equity. IHC is also a customer of EbixHealth JV, and, during the three and six months ended June 30, 2023, EbixHealth JV recognized $238 thousand and $491 thousand, respectively, of revenue from IHC. During the three and six months ended June 30, 2022, EbixHealth JV recognized $300 thousand and $614 thousand of revenue from IHC. As of June 30, 2023 and December 31, 2022, EbixHealth JV had $76 thousand and $74 thousand of accounts receivable from IHC, respectively. Furthermore, as a related party, IHC also has been and continues to be a customer of Ebix, and during the three and six months ended June 30, 2023 the Company recognized $26 thousand and $43 thousand, respectively, of revenue from IHC. During the three and six months ended June 30, 2022, the Company recognized $20 thousand and $40 thousand of revenue from IHC. As of June 30, 2023 and December 31, 2022, Ebix had $47 thousand and $44 thousand of accounts receivable with IHC. EbixHealth JV has a $1.8 million note due to IHC. The Company recorded $125 thousand in amortization expense related to the IHC customer relationship intangible during the six months ending June 30, 2023.

Note 9: Goodwill, Finite-Lived, and Indefinite-Lived Intangibles

Changes in the carrying amount of goodwill for the six months ended June 30, 2023 and the year ended December 31, 2022 are reflected in the following table:

Table of Contents


	June 30, 2023		December 31, 2022
	(Unaudited)
	(In thousands)
Beginning Balance	$	881,676	$	939,249
Additions	—		—
Purchase accounting adjustments	—		—
Foreign currency translation adjustments	$	5,425	(57,573)
Ending Balance	$	887,101	$	881,676

The carrying value of finite-lived and indefinite-lived intangible assets at June 30, 2023 and December 31, 2022 are as follows:


	June 30, 2023		December 31, 2022
	(Unaudited)
	(In thousands)
Finite-lived intangible assets:
Customer relationships	$	101,333	$	101,401
Developed technology	37,139		34,427
Dealer network	6,067		5,877
Airport contracts	4,021		3,992
Trademarks	2,667		2,651
Store networks	2,169		2,153
Brand	797		791
Non-compete agreements	704		702
Database	212		212
Backlog	140		140
Total intangibles	155,249		152,346
Accumulated amortization	(107,254)		(101,446)
Finite-lived intangibles, net	$	47,995	$	50,900

Indefinite-lived intangibles:	.
Customer/territorial relationships	16,647		16,647

Amortization expense recognized in connection with acquired intangible assets was $3.5 million and $7.0 million and for the three and six month period ended June 30, 2023, respectively, and $2.5 million and $5.0 million for the three and six month period ended June 30, 2022, respectively.

Note 10: Capitalized Software Development Costs

In accordance with ASC 350-40 “Internal-Use Software” and/or ASC 350-985 “Software”, the Company has capitalized certain software and product related development costs associated with the Company’s continuing medical education service offerings; development of the P&C underwriting insurance data exchange platform servicing the London markets; development of SaaS based Asset Management and Collection platforms having global application; development of single sign on agent and customer portal, including mobile application, and content development work related to the e-learning business. During the three and six months ended June 30, 2023, the Company capitalized $(0.4) million and $0.5 million, respectively. During the three and six months ended June 30, 2022, the Company capitalized $1.5 million and $4.2 million of such development costs. At June 30, 2023 and December 31, 2022, a total of $15.9 million and $15.3 million, respectively, of remaining unamortized development costs are reported on the Company’s condensed consolidated balance sheets.

Table of Contents

During the three and six months ended June 30, 2023, the Company recognized $0.1 million and $0.1 million, respectively, of amortization expense with regards to these capitalized software development costs. During the three and six months ended June 30, 2022, related amortization expense was $0.8 million and $1.5 million respectively.

Note 11: Other Current Assets

Other current assets at June 30, 2023 and December 31, 2022 consisted of the following:


	June 30, 2023		December 31, 2022
	(Unaudited)
	(In thousands)


Prepaid expenses	$	79,365	$	71,449
Sales taxes receivable from customers	5,723		3,289
Other third party receivables	678		1,034
Credit card merchant account balance receivable	712		704
Short term portion of capitalized costs to obtain and fulfill contracts	474		486
Accrued interest receivable	598		651
Other	11,048		9,774
Total	$	98,598	$	87,387

Note 12: Leases

The Company has operating and finance leases for office space, retail, data centers, and certain office equipment with expiration dates ranging through 2028 with various renewal options. Only renewal options that were reasonably assured to be exercised are included in the lease liability. At June 30, 2023, the maturity of lease liabilities under Topic 842 "Leases" are as follows:


Year	Operating Leases		Financing Leases		Total
	(in thousands)
2023	1,958		71		2,029
2024	2,979		133		3,112
2025	2,221		19		2,240
2026	1,394				1,394
2027	637		—		637
Thereafter	1,141		—		1,141
Total	10,330		223		10,553
Less: present value discount*	(1,304)		(9)		(1,313)
Present value of lease liabilities	9,026		214		9,240

Less: current portion of lease liabilities	(3,024)				(3,024)
Total long-term lease liabilities	$	6,002	$	214	$	6,216

* The discount rate used was the incremental borrowing rates respective to the country where the assets are located.

The Company's net assets recorded under operating and finance leases were $8.7 million and $9.6 million as of June 30, 2023, and December 31, 2022, respectively. The lease cost is recognized in our condensed consolidated statements of income in the category of general and administrative and is summarized as follows:

Table of Contents


	Three Months Ended				Six Months Ended
	June 30,				June 30,
	2023		2022		2023		2022
	(in thousands)				(in thousands)
Operating Lease Cost	$	1,063	$	989	$	2,129	$	1,980
Finance Lease Cost:
Amortization of Lease Assets	34		46		74		94
Interest on Lease Liabilities	3		6		7		13
Finance Lease Cost	37		52		81		107
Sublease Income	—		(23)		(24)		(46)
Total Net Lease Cost	$	1,100	$	1,018	$	2,186	$	2,041

Other information about lease amounts recognized in our condensed consolidated statement of income is summarized as follows:


	June 30, 2023
Weighted Average Lease Term - Operating Leases	1.62 years
Weighted Average Lease Term - Finance Leases	3.89 years
Weighted Average Discount Rate - Operating Leases	5.4	%
Weighted Average Discount Rate - Finance Leases	8.2	%

At June 30, 2023, our lease liability of $9.2 million does not include certain arrangements, which are primarily airport leases that do not meet the definition of a lease under Topic 842. Such arrangements represent further commitments of approximately $8.9 million as follows:


Year	Commitments
	(in thousands)
2023 (Remaining six months)	$	5,208
2024	3,214
Thereafter	$	516
Total	$	8,938

Finance leases range from three to five years and are primarily for office equipment. Rental expense for office and airport facilities and certain equipment subject to operating leases for the six months ended June 30, 2023 and 2022 was $10.3 million and $18.6 million, respectively.

Note 13: Concentrations of Credit Risk

The Company is potentially subject to concentrations of credit risk in its accounts receivable. Credit risk is the risk of an unexpected loss if a customer fails to meet its contractual obligations. The Company can be directly affected by the financial condition of its customers, the loss or substantial reduction in business activity with its customers, or the inability of customers to pay its invoices. While customer activity and financial condition could have a material impact on the Company’s financial statements, management does not believe significant credit risk exists at June 30, 2023.

Note 14: Other Current Liabilities

Other current liabilities at June 30, 2023 and December 31, 2022 consisted of the following:

Table of Contents


	June 30, 2023		December 31, 2022
	(Unaudited)
	(In thousands)
Customer advances (deposits)	$	24,023	$	23,630
Acquisition obligations (upfront purchase and contingent consideration)	1,606		2,153


Total	$	25,629	$	25,783

Note 15: Subsequent Events

None.

Table of Contents

Item 2: MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

As used herein, the terms “Ebix,” “the Company,” “we,” “our,” and “us” refer to Ebix, Inc., a Delaware corporation, and its consolidated subsidiaries as a combined entity, except where it is clear that the terms mean only Ebix, Inc.

Safe Harbor for Forward-Looking Statements — This Form 10-Q and certain information incorporated herein by reference contains forward-looking statements and information within the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934. This information includes assumptions made by, and information currently available to management, including statements regarding future economic performance and financial condition, liquidity and capital resources, acceptance of the Company’s products by the market, and management’s plans and objectives. In addition, certain statements included in this and our future filings with the SEC, in press releases, and in oral and written statements made by us or with our approval, which are not statements of historical fact, are forward-looking statements. Words such as “may,” “could,” “should,” “would,” “believe,” “expect,” “anticipate,” “estimate,” “intend,” “seeks,” “plan,” “project,” “continue,” “predict,” “will,” and other words or expressions of similar meaning are intended by the Company to identify forward-looking statements, although not all forward-looking statements contain these identifying words. These forward-looking statements are found at various places throughout this report and in the documents incorporated herein by reference. These statements are based on our current expectations about future events or results and information that is currently available to us, involve assumptions, risks, and uncertainties, and speak only as of the date on which such statements are made.

Our actual results may differ materially from those expressed or implied in these forward-looking statements. Factors that may cause such a difference include, but are not limited to, those discussed in Part I, Item 1A, “Risk Factors” in our Annual Report Form 10-K for the fiscal year ended December 31, 2022 which is incorporated herein by reference., and in Part II, Item 1A "Risk Factors" in this Form 10-Q, including but not limited to: the willingness of independent insurance agencies to outsource their computer and other processing needs to third parties; pricing and other competitive pressures and the Company’s ability to gain or maintain share of sales as a result of actions by competitors and others; changes in estimates in critical accounting judgments; changes in or failure to comply with laws and regulations, including accounting standards, taxation requirements (including tax rate changes, new tax laws and revised tax interpretations) in domestic or foreign jurisdictions; exchange rate fluctuations and other risks associated with investments and operations in foreign countries (particularly in India, Australia, Asia, Latin America, and Europe wherein we have significant and/or growing operations); fluctuations in the equity markets, including market disruptions and significant interest rate fluctuations, which may impede our access to, or increase the cost of, external financing; the impacts of the COVID-19 global pandemic on our operating performance; ability to secure additional financing to support capital requirements; the ability to refinance the Credit Facility by the Credit Facility Maturity Date as well as Credit Facility provisions that could materially restrict our business; costs and effects of litigation, investigations, or similar matters that could affect our business, operating results and financial condition; and international conflict, including terrorist acts. The Company undertakes no obligation to update any such factors, or to publicly announce the results of, or changes to any of the forward-looking statements contained herein to reflect future events, developments, changed circumstances, or for any other reason.

Other important factors that could cause actual results to differ materially from those in our specific forward-looking statements included in this Form 10-Q include, but are not limited to, the following:

•our future liquidity needs discussed under “Liquidity and Capital Resources” regarding our ability to replace our Credit Facility prior to or at the Credit Facility Maturity Date, generate cash from operating activities and any declines in our credit ratings or financial condition which could restrict our access to the capital markets or materially increase our financing costs (refer to Note 4 of the Condensed Notes to these Condensed Consolidated Financial Statements in this Form 10-Q, "Debt");

•uncertainties pertaining to the actual ultimate cost of our legal contingencies (refer to Note 5 of the Condensed Notes to these Condensed Consolidated Financial Statements in this Form 10-Q, “Commitments and Contingencies”, and “Contractual Obligations” in Management's Discussion and Analysis of Financial Condition and Results of Operation ("MD&A")); and

•the MD&A and the analysis of the six-month revenue trends regarding actual realized level of demand for our products during the immediately foreseeable future, and fluctuations thereof

Readers should carefully review the disclosures and the risk factors described in this and other documents we file from time to time with the SEC, including future reports on Forms 10-Q and 8-K, and any amendments thereto. You may obtain our SEC filings at our website, www.ebix.com under the “Investor Information” section, or over the Internet at the SEC’s website, www.sec.gov.

Table of Contents

The following information should be read in conjunction with the unaudited condensed consolidated financial statements and the notes thereto included in Part 1, Item 1 of this Quarterly Report, and the audited consolidated financial statements and notes thereto and MD&A contained in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022.

The Registrant’s subsidiary, EbixCash Limited has filed a draft red herring prospectus with the Securities and Exchange Board of India and is in the process of executing an initial public offering of its equity shares, subject to market conditions and regulatory approvals. The financial information of EbixCash Limited consolidated into our financial statements as of and for the six months ended June 30, 2023 is summary, indicative and not final. Further such financial information has not been audited or reviewed by the auditors of such company.

Company Overview

Ebix is a leading international supplier of on-demand infrastructure software exchanges and e-commerce services to the insurance, financial, travel, cash remittances, and healthcare industries. In the insurance sector, the Company’s main focus is to develop and deploy a wide variety of insurance and reinsurance exchanges on an on-demand basis using SaaS enterprise solutions in the areas of CRM, front-end and back-end systems, and outsourced administrative and risk compliance. The Company's products feature fully customizable and scalable on-demand software designed to streamline the way insurance and financial industry professionals manage distribution, marketing, sales, customer service, and accounting activities. With a "Phygital” strategy that combines over 650,000 physical distribution outlets in India and many ASEAN countries, to an Omni-channel online digital platform, the Company’s EbixCash Financial exchange portfolio of software and services encompasses domestic and international money remittance, Forex, travel, pre-paid gift cards, utility payments, lending, and wealth management in India and other primarily Southeast Asian Markets. The Company has its headquarters in Johns Creek, Georgia and also conducts operating activities in Australia, Brazil, Canada, India, Indonesia, New Zealand, the Philippines, Singapore, the United Arab Emirates, and the United Kingdom. International revenue accounted for 78.8% and 85.2% of the Company’s total revenue for the six months ended June 30, 2023 and 2022, respectively.

Ebix’s goal is to be a leading facilitator of insurance and financial transactions in the world. The Company’s technology vision is to focus on the convergence of all channels, processes, and entities in a manner such that data seamlessly flows once a data entry has initially been made. Ebix strives to work collaboratively with clients to develop innovative technology strategies and solutions that address specific business challenges and requirements. Ebix combines the newest technologies with its capabilities in consulting, systems design and integration, IT and business process outsourcing, application software, and web and application hosting to meet the individual needs of organizations.

Offices and Geographic Information

The Company’s corporate headquarters, including substantially all of our corporate administration functions, is located in Johns Creek, Georgia, where we own a commercial office building and campus facility. Additionally, the Company leases office space in New Zealand, Australia, Singapore, Dubai, Brazil, Canada, Indonesia, the Philippines, and the United Kingdom for support, operations, and sales offices. The Company also leases approximately 95 facilities across India, while owning six facilities in India.

Effects of COVID-19 and Other Global Events

The ongoing COVID-19 pandemic continues to affect economies and businesses around the world. The extent and duration of such effects remain uncertain and difficult to predict, particularly as virus variants continue to spread. We are actively monitoring and managing our response and assessing actual and potential impacts to our operating results and financial condition, as well as developments in our business, which could further impact the developments, trends and expectations described below. The U.S. government has announced that it will allow the national public health emergency declaration related to COVID-19 to expire on May 11, 2023 and the World Health Organization ended the global emergency status for COVID-19 on May 5, 2023.

During the fiscal years ended December 31, 2020, December 31, 2021, and December 31, 2022, we experienced a decrease in demand for certain of our solutions and services, particularly those related to the Company's travel, foreign exchange, remittance, e-learning and consulting business areas, after certain government restrictions were implemented. This decreased demand continued throughout 2022 in varying degrees for each business area, and still persists through the date of

Table of Contents

this filing for all of the above mentioned business areas. We expect that demand variability for our products and services will continue as a result of the COVID-19 pandemic, despite the end of the U.S. declaration of a national public health emergency and we cannot predict with any certainty when demand for these solutions/services will return to pre-COVID-19 levels.

Our reported results for the six-month period ended June 30, 2023 may not be reflective of current market conditions, or indicative of our results for any future periods, which may be negatively impacted by the COVID-19 pandemic or other global events or economic conditions to a greater extent than the reported period. The impact of the COVID-19 pandemic and other global events mentioned above may also exacerbate other risks discussed in this Quarterly Report. Refer to Item 1A, “Risk Factors” in our Annual Report on Form 10-K for the fiscal year ended December 31, 2022 for a complete description of the material risks that the Company currently faces.

Results of Operations

Operating Revenue

The Company derives its revenues primarily from subscription and transaction fees pertaining to products or services delivered over our exchanges or from our application service provider ("ASP") platforms, fees for business process outsourcing services, and fees for software development projects, including fees for consulting, implementation, training, and project management provided to customers with installed systems, e-governance solutions to governmental agencies in the health and education sectors, as well as foreign exchange, remittance (both inward and outward), and travel services from our financial exchanges.

Ebix’s revenue streams are derived from product/service channels. Presented in the table below is the breakout of our revenues for each of those product/service channels for the three and six months ended June 30, 2023 and 2022:


	Three Months Ended				Six Months Ended
	June 30,				June 30,
	2023		2022		2023		2022
	(In thousands)

Exchanges	98,078		230,943		319,944		498,859
Risk Compliance Solutions	20,352		19,838		41,247		38,175
Totals	$	118,430	$	250,781	$	361,191	$	537,034

Product/Services channels on net basis for Comparative purposes (Non GAAP) for the three and six months ended June 30, 2023 and 2022:


	Three Months Ended				Six Months Ended
	June 30,				June 30,
	2023		2022		2023		2022
	(In thousands)

Exchanges	98,078		95,086		193,256		176,269
Risk Compliance Solutions	20,352		19,838		41,247		38,175
Totals	$	118,430	$	114,924	$	234,503	$	214,444

Table of Contents


	Three Months Ended				Six Months Ended
	June 30,				June 30,
	2023		2022		2023		2022
Subscription	33	%	16	%	23	%	16	%
Transaction-Based	55	%	78	%	69	%	78	%
Professional Services/Consulting/Other	12	%	6	%	8	%	6	%

The table below provides an approximation (as a % of total revenue) of subscription-based and software maintenance revenue, transaction-based revenue, and professional services and consulting fee revenue on net basis for Comparative purposes (Non GAAP) for the three and six months ended June 30, 2023 and 2022:


	Three Months Ended				Six Months Ended
	June 30,				June 30,
	2023		2022		2023		2022
Subscription	33	%	35	%	35	%	38	%
Transaction-Based	55	%	52	%	53	%	48	%
Professional Services/Consulting/Other	12	%	13	%	12	%	14	%

Results of Operations — Three Months Ended June 30, 2023 and 2022

Operating Revenue

The company total revenues on GAAP basis decreased 52.8% year-over-year during the second fiscal quarter of 2023 versus Q2, 2022 and 50.8% on constant currency basis.

During the three months ended June 30, 2023, the company total operating revenues increased $3.5 million, or 3%, to $118.4 million as compared to $114.9 million during the second quarter of 2022 on Non-GAAP basis. Total revenues on a constant currency basis would have been $4.8 million higher in Q2 2023 at $123.2 million. On March 11, 2020, COVID-19 was declared a global pandemic by the World Health Organization. Across the U.S. and the world, governments and municipalities instituted measures in an effort to control the spread of COVID-19, including quarantines, shelter-in-place orders, school closings, travel restrictions, and the closure of non-essential businesses. Our travel, foreign exchange, remittance, e-learning, and financial technologies businesses continue to generate revenues below pre-COVID 19 operating levels, but the Company is seeing a material rebound in these businesses during 2023 year-to-date.

Total revenues increased year-over-year during the second fiscal quarter of 2023 due primarily to a year-over-year increase in international revenues by $5.1 million increase or 6.7%. over the second quarter of 2022 on Non GAAP basis. Reported revenues were negatively impacted by the weakening of foreign exchange rates in our operating geographies during the second quarter ended June 30, 2023. Specifically, the year-over-year impact from fluctuations of exchange rates in the countries that we operate, in the aggregate, decreased reported revenues by approximately $4.8 million for the three months ended June 30, 2023. This negative impact from foreign exchange rate movements was the most pronounced negative impact on the Company's quarterly revenues in the past five fiscal years. International revenue accounted for 69.3% and 84.9% (65.5% on Non-GAAP basis) of the Company’s total revenue for the three months ended June 30, 2023 and 2022, respectively.

Cost of Services Provided

Cost of Services includes costs associated with customer support, consulting, implementation, and training services. The cost of services decreased by 80.1% in second fiscal quarter year over year versus Q2, 2022 on GAAP basis. However, cost of services provided increased $0.3 million, or 1%, to $33.8 million in the second quarter of 2023 as compared to $33.5 million

Table of Contents

in the second quarter of 2022 on Non-GAAP basis. For the three months ended June 30, 2023, cost of services as a percentage of total revenues decreased to 28.5% of total revenues as compared to 67.5% (29.1% on Non-GAAP basis) for the three months ended June 30, 2022. The decrease in the Company’s cost of services provided as a percentage of total revenues is primarily due to revenue mix changes year-over-year.

Product Development Expenses

The Company’s product development efforts are focused on the development of new technologies for insurance carriers, brokers, and agents, the development of new data exchanges for use in domestic and international insurance markets, as well as the Forex and travel sectors. Product development expenses decreased $0.7 million, or 7%, to $10.9 million during the second quarter of 2023 as compared to $10.2 million during the second quarter of 2022. The year-over-year increase in product development expenses in the second quarter of 2023 was driven by increased labor costs.

Sales and Marketing Expenses

Sales and marketing expenses of $3.6 million in the second quarter of 2023 decreased compared to $4.5 million in the second quarter of 2022.

General and Administrative Expenses

General and administrative expenses increased $4.4 million, or 14%, to $36.1 million in the second quarter of 2023 as compared to $31.7 million in the second quarter of 2022. The year-over-year increase is primarily due to increased legal and professional costs related to debt refinancing of approximately $6.1 million, personnel costs, including travel expenses, and an increase in rent expenses, the second quarter of 2023 versus the comparable prior year period.

Amortization and Depreciation Expenses

Amortization and depreciation expenses increased $0.0 million, or 0%, to $4.9 million in the second quarter of 2023 as compared to $4.9 million in the second quarter of 2022, primarily due to the impact from increased capital expenditures over the past several quarters, and certain reclassifications and useful life adjustments made by the Company in the first quarter of 2023 that were not material to the overall financial condition of the Company.

Interest Income

Interest income decreased $14 thousand, or 21%, to $52 thousand in the second quarter of 2023 as compared to $66 thousand in the second quarter of 2022. The increase resulted from both a higher interest rate environment and increased amounts of interest-bearing short term investments and restricted cash balances in 2023 versus the comparable period in 2022.

Interest Expense

Interest expense of $24.6 million in the second quarter of 2023 increased 111% as compared to $11.7 million in the second quarter of 2022. While the average outstanding balance under the Company's Credit Facility decreased year-over-year by approximately $22.3 million from approximately $640.1 million to approximately $617.8 million, the Company's interest rate increased by approximately 6.5% year-over-year. The increased interest rate environment, coupled with increased amortization of deferred financing costs in the second quarter of 2023 versus the comparable prior year quarter resulted in increased interest expense year-over-year of over $17.2 million. Offsetting the increased interest expense from the Credit Facility was a year over year decrease in interest expense from the Company's working capital facilities in international markets. The average balance of our working capital facilities increased year-over-year by approximately $2.0 million.

Non-Operating (Loss)/Income

Non-operating loss in the second quarter of 2023 decreased to $3.6 million as compared to $0.4 million in the prior year. These expenses in 2023 and 2022 are attributable to non-operating expenses in our international operations.

Foreign Currency Exchange Gain (Loss)

The Company recorded a net foreign currency exchange gain for the three months ended June 30, 2023 in the amount of $0.8 million which consisted of net gains realized and unrealized upon the settlement of receivables or payables and re-measurement of cash balances denominated in currencies other than the functional currency of the respective operating division recording the instrument.

Income Taxes

Table of Contents

The Company recorded net income tax expense of $164 thousand (12.74%) during the three months ended June 30, 2023, which included tax expense of $1.6 million from certain discrete items related to stock compensation and uncertain tax positions. The income tax expense, exclusive of discrete items, was $1,405 thousand (15.67%) during the three months ended June 30, 2023. The Company expects its full year effective tax rate to be in the range of 8% to 10%.

Liquidity and Capital Resources

Our principal sources of liquidity are the cash flows provided by our operating activities and cash and cash equivalents on hand. The Credit Facility is due to mature on September 30, 2023. As a result, at June 30, 2023 the outstanding balance of the Credit Facility, $616.8 million, was classified as a current liability. The Company has a negative working capital position of $470.4 as of June 30, 2023. The Company expects to address the maturity of the Credit Facility prior to the Credit Facility Maturity Date, and intends to do so in conjunction with the resolution of the anticipated IPO of EbixCash described below. Any refinancing of the Credit Facility will require the Company to successfully access the debt and/or equity capital markets in the U.S. or Internationally. However, there are no assurances that such financing will be available in amounts or on terms acceptable to us, if at all, or that the proceeds received by Ebix, Inc. from the IPO (described below) will be in the amount currently expected.

The Company’s Indian subsidiary, EbixCash, filed a Draft Red Herring Prospectus ("DRHP") with the Securities and Exchange Board of India on March 9, 2022, for an initial public offering aggregating up to ₹60,000 million or $787 million (the “IPO”). The Company received SEBI Final Observation letter on April 10, 2023 allowing it to raise funds through IPO. As per DRHP, an amount up to approximately $360 million could be utilized towards purchase of outstanding compulsorily convertible debentures from Ebix Asia Holdings Inc, Mauritius and in turn remittance to Ebix, Inc., which is proposed to be used towards reduction of Ebix Inc.’s outstanding debt. Approximately $130 million as per DRHP, is proposed to be utilized for working capital requirements of EbixCash and its subsidiaries. The remaining proceeds as per DRHP, are to be utilized towards, inter alia, growth-related initiatives of EbixCash, including acquisitions and other investments. No assurances can be given when the IPO will be completed, if at all, or if it will be completed on terms acceptable to the Company.

The Company also recently announced that it is pursuing other strategic options, and The Board of Directors has formed a special independent committee, the Strategic Investment Committee (SIC), in part to assist it in further evaluating all alternatives to address the capital required to refinance the Credit Facility. Accordingly, SIC appointed an investment banker to assist in a prospective part-asset sale exercise. The SIC has already received commercial offers from multiple bidding parties with potential proceeds from the asset sale, being possibly sufficient to repay 100% of the Company’s bank debt. Currently the strategic and financial bidders are conducting due diligence, which are in different stages of review.

The Company is also pursuing multiple other capital raising strategies to address the refinancing requirements of the Credit Facility, including debt, equity, and hybrid debt/equity options at the corporate level and within the international operations.

Our current ratio decreased to 0.43 at June 30, 2023 from 0.46 at December 31, 2022 and our working capital position decreased to $(470.4) million at June 30, 2023 from $(447.0) million at December 31, 2022 due to the classification of the Credit Facility as a current liability at June 30, 2023. Our current ratio and working capital position, net of the impact of the classification of debt as current liabilities and assuming similar current maturities of debt at December 31, 2022, would have been approximately 1.7 and $146.7 million, respectively, at June 30, 2023.

We believe that the anticipated cash flows provided by our operating activities, together with current cash balances, will be sufficient to meet our projected cash requirements for managing day to day business operations through June 2024 other than the debt repayment due on September 30 2023. However, there can be no assurance that additional capital will not be required sooner. Any projections of future cash needs, cash flows, and the general market conditions for debt and equity securities is subject to substantial uncertainty.

Our unrestricted cash and cash equivalents were $62.2 million and $110.6 million at June 30, 2023 and December 31, 2022, respectively. The Company holds material cash and cash equivalent balances overseas in foreign jurisdictions. The free flow of cash from certain countries where we hold such balances may be subject to repatriation tax effects and other restrictions. Furthermore, the repatriation of earnings from some of our foreign subsidiaries would result in the application of withholding taxes at the foreign source and taxation at the U.S. parent level upon receipt of the repatriation amounts.

The approximate cash, cash equivalents, restricted cash, and short-term investments balances held in our domestic U.S. operations and each of our foreign subsidiaries as of August 7, 2023 are presented in the table below:

Table of Contents


Country/Region	Cash, Restricted Cash and Short-Term Investments
	(In thousands)
North America	$	7,226
International	$	78,117

Total	$	85,343

To the extent we have available capital, we intend to continue to utilize cash flows generated by our ongoing operating activities towards the refinancing of our Credit Facility, in combinations with the possible issuance of additional debt or equity, a prospective EbixCash IPO, and a prospective part-asset sale to retire outstanding indebtedness and to fund organic growth initiatives and capital expenditures. However, the maturity of the Credit Facility as well as the covenants in that Credit Facility could have the effect of adversely affecting our ability to run our business in good standing.

Business Combinations

The Company seeks to execute accretive business acquisitions in combination with organic growth initiatives as part of its comprehensive business growth and expansion strategy. The Company looks to acquire businesses that are complementary to Ebix's existing products and services.

During the six months ending June 30, 2023, the Company completed no business acquisitions.

During the twelve months ended December 31, 2022, the Company completed no business acquisitions.

Operating Activities

Net cash provided by our operating activities was $8.4 million for the six months ended June 30, 2023. The primary components of the cash provided by our operating activities during the six-month period consisted of net income of $7.4 million, $9.9 million of depreciation and amortization, $1.3 million of non-cash share-based compensation, $2.1 million of right-of-use assets amortization, a $-0.8 million increase in contract liabilities, a $(27.7) million impact from the provision for deferred taxes, and $19.6 million of working capital requirements, primarily due to an increase in accounts receivable and a decrease in accounts payable and accrued expenses, offset in part by increases in payables to service agents, other liabilities and contract liabilities. During the six months ended June 30, 2023, the Company made $25.1 million of tax payments.

Net cash provided by our operating activities was $21.4 million for the six months ended June 30, 2022. The primary components of the cash provided by our operating activities during the six-month period consisted of net income of $38.5 million, $9.2 million of depreciation and amortization, $1.9 million of non-cash share-based compensation, $1.8 million of right-of-use assets amortization, $1.5 million of amortization of capitalized software development costs, and $1.8 million of working capital requirements, primarily due to increased accounts receivable and receivables from services provides, an increase in the other assets, and decreased accounts payable and accrued expenses. During the six months ended June 30, 2022, the Company made $24.2 million of tax payments.

Investing Activities

Net cash used for investing activities during the six months ended June 30, 2023 was $9.3 million, and consisted primarily of $7.9 million for capital expenditures, $0.5 million for software development costs that were capitalized and an increase in marketable securities of $0.9 million (specifically bank certificates of deposit).

Net cash used for investing activities during the six months ended June 30, 2022 was $17.0 million, and consisted primarily of $4.2 million for software development costs that were capitalized, $9.6 million for capital expenditures, and decreases in marketable securities of $3.2 million (specifically bank certificates of deposit).

Financing Activities

During the six months ended June 30, 2023, net cash used in financing activities was $49.9 million, which consisted primarily of $41.0 million used to make principal payments on the existing term loan, a $1.7 million increase in EbixCash working capital facilities.

Table of Contents

During the six months ended June 30, 2022, net cash used in financing activities was $24.1 million, which consisted primarily of an $1.7 million reduction in international working capital facilities, $15.9 million used to make scheduled payments on the existing term loan and $4.6 million of dividends to our common stockholders.

Credit Facility

The Company's Credit Facility provides a $445 million Revolver as well as a Term Loan, which at June 30, 2023 had a balance of $171.9 million. The Credit Facility is set to mature on September 30, 2023. As a result of the impending maturity within the next twelve months from the June 30, 2023 financial statements date herein, the outstanding balance of the Credit Facility, $616.8 million, is classified as a current liability within the Condensed Consolidated Balance Sheets. Because of this classification of the Credit Facility as a current liability, the Company has a negative working capital position of $470.4 million.

On February 21, 2023, the Company entered into Amendment No. 13 to its Credit Facility. Amendment No. 13 provided for, among other things, an extension of the maturity date from February 21, 2023 to May 23, 2023. The Company was required to make a $5 million prepayment of the Revolver on February, 21, 2023 and an amortization payment on the Term Loan in the amount of $5 million on March 31, 2023. Any repayments under the Revolver will be accompanied by a corresponding reduction in the aggregate revolving commitments. Lastly, amendment No. 13 modified certain other provisions within the Credit Agreement and has resulted in an approximately 1% per annum interest rate increase beginning February 21, 2023.

Table of Contents

ended December 31, 2020. Amendment No. 11 also modified certain covenants contained in the Credit Facility, including with respect to certain permitted restricted payments and investments.

As of June 30, 2023, the outstanding balance on the Revolver was $444.9 million and the Revolver carried an interest rate of 11.95% at June 30, 2023. The balance on the Revolver is included in the current liabilities section of the condensed consolidated balance sheets. During the six months ended June 30, 2023, the average and maximum outstanding balances of the Revolver were both $444.9 million. At December 31, 2022, the outstanding balance on the Revolver was $449.9 million and the Revolver carried an interest rate of 9.69%. During 2022, the average and maximum outstanding balances on the Revolver were both $444.9 million.

As of June 30, 2023, the outstanding balance on the Term Loan was $171.9 million, of which $171.9 million is due within the next twelve months. $17.5 million of principal payments were made during the six months ended June 30, 2023, of which $0.0 million were scheduled amortization payments. This Term Loan also carried an interest rate of 11.95% at June 30, 2023, subject to the same above mentioned increase in interest rate as the Revolver. The Term Loan is included in the current liabilities section of the condensed consolidated balance sheets. At December 31, 2022, the outstanding balance on the Term Loan was $189.4 million, of which $189.4 million was due within twelve months. The Term Loan also carried an interest rate of 9.69% at December 31, 2022.

Contractual Obligations

For a presentation regarding material changes outside the ordinary course of business to the Company's contractual obligations please refer to Notes 4 and 5 of the Condensed Notes to Condensed Consolidated Financial Statements in this Form 10-Q.

Off-Balance Sheet Arrangements

We do not engage in off balance sheet financing arrangements.

Recent Accounting Pronouncements

For information about new accounting pronouncements and the potential impact on our Consolidated Financial Statements, see Note 1 of the Condensed Notes to the Condensed Consolidated Financial Statements in this Form 10-Q and Note 1 of the Notes to Consolidated Financial Statements in our Annual Report on Form 10-K for the fiscal year ended December 31, 2022.

Critical Accounting Policies and Estimates

The preparation of financial statements in conformity with GAAP, as promulgated in the U.S., requires our management to make significant estimates and assumptions that affect the reported amounts of assets and liabilities, revenues and expenses, and related disclosures in our Condensed Consolidated Financial Statements and accompanying notes. We believe the most complex and sensitive judgments, because of their significance to the Condensed Consolidated Financial Statements, result primarily from the need to make estimates and assumptions about the effects of matters that are inherently uncertain. These accounting policies involve the use of “critical accounting estimates” because they are particularly dependent on estimates and assumptions made by management about matters that are uncertain at the time the accounting estimates are made. In addition, while we have used our best estimates based on facts and circumstances available to us at the time, different estimates reasonably could have been used in the current period, and changes in the accounting estimates that we used are reasonably likely to occur from period to period both of which may have a material impact on our financial condition and results of operations. For additional information about these policies, see Note 1 of the Condensed Notes to the Condensed Consolidated Financial Statements in this Form 10-Q. Although we believe that our estimates, assumptions and judgments are reasonable, they are limited based upon information presently available. Actual results may differ significantly from these estimates under different assumptions, judgments, or conditions.

COVID-19 and other global events, such as other global economic conditions and the invasion of Ukraine by Russia beginning in February 2022, has created and may continue to create significant uncertainty in global financial markets, which may reduce demand for our services, impact the productivity of our workforce, reduce our access to capital, and harm our business and results of operations. As of the date of our Condensed Consolidated Financial Statements, we are not aware of any specific event or circumstance that would require us to update our estimates or judgments, or to revise the carrying value of our assets or liabilities. However, these estimates may change as new events occur and additional information is obtained, which may result in changes being recognized in our consolidated financial statements in future periods. While we considered the effects of COVID-19, other global events and economic conditions in our estimates and assumptions, due to the current level of

Table of Contents

uncertainty over the longevity of the economic and operational impacts of COVID-19 and other global events on our business, there may be other judgments and assumptions that were not currently considered. Such judgments and assumptions could result in a meaningful impact to our financial statements in future periods. Actual results could differ from those estimates and any such differences may have a material impact on our financial statements.

There have been no significant changes to our critical accounting policies and estimates from the information provided in Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” included in the Annual Report on Form 10-K for the fiscal year ended December 31, 2022.

Table of Contents

Item 3: QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

The Company is exposed to foreign currency exchange rate risk related to our foreign-based operations where certain transactions are denominated in other than the foreign entity's functional currency and are subject to market risk with respect to fluctuations in the relative value of those currencies. The Company’s operations based in the U.S., Dubai, and Singapore use the U.S. dollar as their functional currency, as that is the predominant currency used to transact the majority of their operations. The Company’s other foreign operations in India, Australia, the United Kingdom, Canada, Brazil, Philippines, and Indonesia utilize their local currencies as their functional currency as that accurately reflects the currency used to conduct their commercial activities in each of these countries. There can be no assurance that fluctuations in the value of foreign currencies will not have a material adverse effect on the Company’s business, operating results, revenues, or financial condition. During the six months ended June 30, 2023 and 2022, the net change in the cumulative foreign currency translation account, which is a component of accumulated other comprehensive loss within stockholders’ equity, were unrealized (losses) gains of $10.1 million and $(54.6) million, respectively. The Company considered the historical trends in currency exchange rates and determined that it was reasonably possible that adverse changes in our respective foreign currency exchange rates of 20% could be experienced in the near term. Such an adverse change in currency exchange rates would have resulted in reduction to pre-tax income of approximately $4.7 million and $6.9 million for the six months ended June 30, 2023 and 2022, respectively.

The Company's exposure to interest rate risk relates to its interest expense on outstanding debt obligations and to its interest income on existing cash balances. As of June 30, 2023, the Company had $616.8 million of outstanding debt obligations under its corporate syndicated credit facilities, which consisted of a $171.9 million term loan, and a $444.9 million balance drawn on our commercial banking revolving line of credit. The Company's term loan and revolving line of credit carries a leverage-based on SOFR related interest rate, and stood at 11.95% at June 30, 2023. The Company is exposed to market risk in relation to this line of credit in regards to the potential increase in interest expense arising from adverse changes in interest rates. This interest rate risk is estimated as the potential decrease in earnings resulting from a hypothetical 30% increase in the SOFR rate. Such an adverse change in the SOFR rate would have resulted in a reduction to pre-tax income of approximately $3.7 million and $0.7 million for the six months ended June 30, 2023 and 2022, respectively. The Company's average cash balances (including restricted) and short term and long term investments (in the form of fixed deposits) during the six months ended June 30, 2023 were approximately $115.9 million and its existing cash balances as of June 30, 2023 were $62.2 million. The Company is exposed to market risk in relation to these cash balances in regards to the potential loss of interest income arising from adverse changes in interest rates. This interest rate risk is estimated as the potential decrease in earnings resulting from a hypothetical 20% decrease in interest rates earned on deposited funds. Such an adverse change in these interest rates would have resulted in a reduction to pre-tax income of approximately $0.1 million and $0.1 million for the six months ended June 30, 2023 and 2022, respectively.

There were no other material changes to our market risk exposure during the six months ended June 30, 2023 and 2022. For additional information regarding our exposure to certain market risks, see “Quantitative and Qualitative Disclosures about Market Risk,” in Part II, Item 7A of our Annual Report on Form 10-K for the fiscal year ended December 31, 2022.

Table of Contents

Item 4: CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

We maintain a system of disclosure controls and procedures designed to provide reasonable assurance that the information required to be disclosed by the Company in reports that we file and submit under the Exchange Act is recorded, processed, summarized, and reported accurately within the time periods specified in the SEC's rules and forms. Disclosure controls also are designed to reasonably assure that such information is accumulated and communicated to management, including the Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosures. Disclosure controls include components of internal control over financial reporting, which consists of control processes designated to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements in accordance with GAAP.

We monitor and evaluate on an ongoing basis our disclosure controls and procedures in order to improve their overall effectiveness. In the course of these evaluations, we modify and refine our internal processes and controls as conditions warrant.

Our management, including our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of our “disclosure controls and procedures” (as defined in Rule 13a-15(e) promulgated under the Exchange Act) as of June 30, 2023. Based on this evaluation the Company’s Chief Executive Officer and Chief Financial Officer have concluded that these disclosure controls and procedures are effective. There were no changes in our internal control over financial reporting during the quarter ended June 30, 2023 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting. We have not experienced any material changes to our internal controls over financial reporting despite the fact that all non-essential employees are working remotely due to the COVID-19 pandemic. We are continually monitoring the impact of COVID-19 on the operating effectiveness of our internal control over financial reporting.

Part II — OTHER INFORMATION

Item 1: LEGAL PROCEEDINGS

Table of Contents

On December 29, 2021, Sunil Shah, a purported shareholder of the Company, filed a derivative action in the Superior Court of Fulton County of the State of Georgia on behalf of Ebix captioned Shah v. Raina, et. al., Civil Action File No. 2022-cv-358481 (the "Shah Action") against the same defendants as the Consolidated Derivative Action and Lilienfeld Actions. The complaint similarly asserts a claim of breach of fiduciary duty related to the RSM resignation against all of the individual defendants. The Shah Action is currently stayed by agreement of the parties and order of the Court. On July 26, 2023, Mr. Shah dismissed the Shah Action without prejudice.

EbixCash along with Ebix Singapore Pte. Ltd. (the “Ebix Group”) had purchased 80% Equity Shares of Ebix Payment Services Private Limited (“ItzCash”) with effect from April 1, 2017. During the Financial Year 2020, the erstwhile shareholders of ItzCash raised a dispute with the Ebix Group alleging breaches of the share purchase agreement and shareholders’ agreement entered into between the parties and demanding for termination of the shareholders’ agreement, payment of earn out consideration and buyout of minority shareholding. The matter is under arbitration in accordance with the rules of the Singapore International Arbitration Centre. The arbitration proceedings have concluded, and the arbitral tribunal has passed a partial order dated June 1, 2023 (“Partial Award”) which inter alia states the following (i) the termination of the shareholders agreement executed amongst the Company, Ebix Singapore, Ebix World Money, Vyoman, Ashok Kumar Goel and Ebix Payment Services dated May 12, 2017 (“SHA”) by Vyoman and Mr. Goel was justified (ii) our Company and Ebix World Money (and failing performance, Ebix Singapore) are jointly and severally obliged to purchase the existing shareholding of Vyoman and Mr. Goel under the SHA at a price determined by an independent valuer, once such determination has been made in accordance with the relevant provisions of the SHA and (iii) Claimants were not entitled to specific performance to receive payment of the first and second earn-out thresholds under the aforementioned agreements; and (iv) our Company, Ebix Singapore, Ebix World Money and Ebix Payment Services were found in breach of certain clauses of the aforementioned agreements. Due to absence of explanation of how Claimants incurred or may have incurred losses pursuant to such breaches of the above mentioned agreements the Partial Award directed payment of nominal damages by the Respondents in an joint and several manner to the Claimants as follows: (i) SGD 200 each to Vyoman and Ashok Kumar Goel in respect to the breaches of the SHA and (ii) SGD 100 to each of the 17 other claimants in respect to breaches of the Promoter SPA, Employee SPA and Investor SPA. The Partial Award also states that the directions in relation to the arbitration costs will be dealt in the final award. The matter is currently pending.

Item 1A: RISK FACTORS

In addition to the other information set forth in this Quarterly Report on Form 10-Q, you should carefully consider the factors discussed in Part I, “Item 1A. Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2022, filed with the Securities and Exchange Commission on March 10, 2022 which could materially affect the Company's business, financial condition or future results. The following risk factor is an update to our previously disclosed risk factors and should be considered in conjunction with the Risk Factors section in our Annual Report on Form 10-K for the year ended December 31, 2022.

Item 2: REPURCHASES OF EQUITY SECURITIES

Effective February 6, 2017, the Company's Board of Directors unanimously approved an additional authorized share repurchase plan of $150.0 million. The Board directed that the repurchases be funded with available cash balances and cash generated by the Company's operating activities. Under certain circumstances, the aggregate amount of repurchases of the Company's equity shares may be limited by the terms and underlying financial covenants regarding the Company's commercial

bank financing facility.

There were no share repurchases during the fiscal second quarter ended June 30, 2023, and the maximum number (or approximate dollar value) of shares that may yet be purchased under the current program is $80.1 million. During the second quarter ended June 30, 2023, a total of 1,309 shares were forfeited from the vesting of restricted stock to satisfy individual tax obligations. For the year-to-date period ended June 30, 2023, a total of 2,282 shares were forfeited from the vesting of restricted stock to satisfy individual tax obligations.

Table of Contents

Item 3: DEFAULTS UPON SENIOR SECURITIES

None.

Item 4: MINE SAFETY DISCLOSURES

Not applicable.

Item 5: OTHER INFORMATION

None.

Item 6: EXHIBITS

The exhibits filed herewith or incorporated by reference herein are listed in the Exhibit Index attached hereto.

Table of Contents

EXHIBITS INDEX


Exhibits
3.1						Certificate of Incorporation, as amended, of Ebix, Inc. (filed as Exhibit 3.1 to the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2009 and incorporated herein by reference).
3.2						Amendment to Certificate of Incorporation of Ebix, Inc. dated May 25, 2017 (incorporated by reference to Exhibit 3.2 to the Company's Annual Report on Form 10-K for the year ended December 31, 2017).
3.3						Amended and Restated Bylaws of Ebix, Inc., effective immediately following the Company’s Annual Meeting of Stockholders, held on January 9, 2015 (incorporated by reference to Exhibit 3.1 to the Company's Current Report on Form 8-K dated August 18, 2020).
3.4						Amendment to Certificate of Incorporation of Ebix, Inc. filed November 21, 2018 (incorporated by reference to Exhibit 3.4 to the Company's Annual Report on Form 10-K for the year ended December 31, 2018).
3.5						Certificate of Designations, Number, Voting Powers, Preferences and Rights of Series Y Convertible Preferred Stock (incorporated by reference to Exhibit 3.1 to the Company's Current Report on Form 8-K dated July 25, 2019).
10.1						Amendment No. 13 to Credit Documents dated as of February 21, 2023, entered into by and among Ebix, Inc, as Borrower, certain subsidiaries of the Company party thereto, as Guarantors, Regions Bank, as Administrative Agent and Collateral Agent, and the lenders party thereto (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed February 22, 2023).
10.2						Amendment No. 14 to Credit Documents dated as of May 23, 2023, entered into by and among Ebix, Inc, as Borrower, certain subsidiaries of the Company party thereto, as Guarantors, Regions Bank, as Administrative Agent and Collateral Agent, and the lenders party thereto (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed May 24 , 2023).
10.3						Amendment No. 15 to Credit Documents dated as of July 21, 2023, entered into by and among Ebix, Inc, as Borrower, certain subsidiaries of the Company party thereto, as Guarantors, Regions Bank, as Administrative Agent and Collateral Agent, and the lenders party thereto (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed July 2 4 , 2023).
31.1*						Certification of Chief Executive Officer Pursuant to Rule 13a-14(a) (Section 302 of the Sarbanes-Oxley Act of 2002).
31.2*						Certification of Chief Financial Officer Pursuant to Rule 13a-14(a) (Section 302 of the Sarbanes-Oxley Act of 2002).
32.1*						Certification of Chief Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2*						Certification of Chief Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS*						XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
101.SCH*						XBRL Taxonomy Extension Schema Document.
101.CAL*						XBRL Taxonomy Extension Calculation Linkbase Document.
101.DEF*						XBRL Taxonomy Extension Definition Linkbase Document.
101.LAB*						XBRL Taxonomy Extension Label Linkbase Document.
101.PRE*						XBRL Taxonomy Extension Presentation Linkbase Document.
104.0						Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)


* Filed herewith

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Ebix, Inc.

Date:

August 9, 2023

By:

/s/ Robin Raina

Robin Raina

Chief Executive Officer

(Principal Executive Officer)

Date:

August 9, 2023

By:

/s/ Amit Kumar Garg

Amit Kumar Garg

Chief Financial Officer

(Principal Financial and Accounting Officer)

Exhibit 31.1

Certification Pursuant to Section 302

of the Sarbanes-Oxley Act of 2002

for the Chief Executive Officer

I, Robin Raina, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Ebix, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's second fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors:

(a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date:

August 9, 2023

/s/ Robin Raina

Robin Raina

Chief Executive Officer

Exhibit 31.2

Certification Pursuant to Section 302

of the Sarbanes-Oxley Act of 2002

for the Chief Financial Officer

I, Amit Kumar Garg, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Ebix, Inc.;

(b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date:

August 9, 2023

/s/ Amit Kumar Garg

Amit Kumar Garg

Chief Financial Officer

Exhibit 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906

OF THE SARBANES-OXLEY ACT OF 2002

I, Robin Raina, state and attest that:


(1)						I am the Chief Executive Officer of Ebix, Inc. (the “Registrant”).
(2)						In connection with the Quarterly Report of the Registrant on Form 10-Q for the quarter ended June 30, 2023 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Report containing financial statements fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant as of, and for, the periods presented.


By:			/s/ Robin Raina
			Name: Robin Raina
			Chief Executive Officer
			August 9, 2023

Exhibit 32.2

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906

OF THE SARBANES-OXLEY ACT OF 2002

I, Amit Kumar Garg, state and attest that:


(1)						I am the Global Chief Financial Officer of Ebix, Inc. (the “Registrant”).
(2)						In connection with the Quarterly Report of the Registrant on Form 10-Q for the quarter ended June 30, 2023 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Report containing financial statements fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant as of, and for, the periods presented.


By:			/s/ Amit Kumar Garg
			Name: Amit Kumar Garg
			Global Chief Financial Officer
			August 9, 2023

Cover - shares	6 Months Ended
Cover - shares	Jun. 30, 2023	Aug. 07, 2023
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Jun. 30, 2023
Document Transition Report	false
Entity File Number	0-15946
Entity Registrant Name	EBIX INC
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	77-0021975
Entity Address, Address Line One	1 Ebix Way
Entity Address, City or Town	Johns Creek,
Entity Address, State or Province	GA
Entity Address, Postal Zip Code	30097
City Area Code	678
Local Phone Number	281-2020
Title of 12(b) Security	Common stock, $0.10 par value per share
Trading Symbol	EBIX
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		30,901,440
Entity Central Index Key	0000814549
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q2
Amendment Flag	false

Condensed Consolidated Statements of Income - USD ($)
shares in Thousands, $ in Thousands

3 Months Ended

6 Months Ended

Jun. 30, 2023

^[1]

Jun. 30, 2022

^[1]

Jun. 30, 2023

Jun. 30, 2022

Income Statement [Abstract]

Operating revenue

$ 118,430

$ 250,781

$ 361,191

$ 537,034

Operating expenses:

Cost of services provided

33,757

169,330

190,236

380,173

Product development

10,947

10,223

20,930

20,481

Sales and marketing

3,582

4,511

6,913

8,276

General and administrative, net

36,110

31,736

73,577

58,649

Amortization and depreciation

4,893

4,874

9,909

9,238

Total operating expenses

89,289

220,674

301,565

476,817

Operating income

29,141

30,107

59,626

60,217

Interest income

133

128

Interest expense

24,614

11,664

46,877

21,915

Non-operating (loss) income

(3,647)

(408)

(3,977)

(1,142)

Foreign currency exchange gain (loss)

(840)

3,229

(2,060)

4,123

Income before income taxes

21,330

6,845

41,411

Income tax (expense) benefit

164

2,478

787

4,182

Net income including noncontrolling interest

(72)

18,852

6,058

37,229

Net loss attributable to noncontrolling interest

(380)

(491)

(1,323)

(1,305)

Net income attributable to Ebix, Inc.

$ 308

$ 19,343

$ 7,381

$ 38,534

Basic earnings per common share attributable to Ebix, Inc. (in dollars per share)

$ 0.01

$ 0.63

$ 0.24

$ 1.25

Diluted earnings per common share attributable to Ebix, Inc. (in dollars per share)

$ 0.01

$ 0.63

$ 0.24

$ 1.25

Basic weighted average shares outstanding (in shares)

30,866

30,745

30,854

30,729

Diluted weighted average shares outstanding (in shares)

30,869

30,756

30,856

30,756

[1]

Beginning April 1, 2023 Prepaid card revenues are presented on a net basis (based on new contractual changes) while periods preceding April 1, 2023 reflect prepaid card revenues on a gross basis. Please see (non- GAAP financials) table with both periods recast on a net basis, for comparison purposes under heading "Condensed Consolidated Statements of Income prepared on Net Basis for Comparative Purposes Only (Non GAAP)".

Condensed Consolidated Statements of Income prepared on Net Basis for Comparative Purposes Only (Non GAAP) - USD ($)
shares in Thousands, $ in Thousands

3 Months Ended

6 Months Ended

Jun. 30, 2023

Jun. 30, 2022

Jun. 30, 2023

Jun. 30, 2022

Operating revenue

$ 118,430

^[1]

$ 250,781

^[1]

$ 361,191

$ 537,034

Operating expenses:

Cost of services provided

33,757

^[1]

169,330

^[1]

190,236

380,173

Product development

10,947

^[1]

10,223

^[1]

20,930

20,481

Sales and marketing

3,582

^[1]

4,511

^[1]

6,913

8,276

General and administrative, net

36,110

^[1]

31,736

^[1]

73,577

58,649

Amortization and depreciation

4,893

^[1]

4,874

^[1]

9,909

9,238

Total operating expenses

89,289

^[1]

220,674

^[1]

301,565

476,817

Operating income

29,141

^[1]

30,107

^[1]

59,626

60,217

Interest income

^[1]

133

128

Interest expense

(24,614)

^[1]

(11,664)

^[1]

(46,877)

(21,915)

Non-operating (loss) income

(3,647)

^[1]

(408)

^[1]

(3,977)

(1,142)

Foreign currency exchange gain (loss)

(840)

^[1]

3,229

^[1]

(2,060)

4,123

Income before income taxes

^[1]

21,330

^[1]

6,845

41,411

Income tax (expense) benefit

(164)

^[1]

(2,478)

^[1]

(787)

(4,182)

Net income including noncontrolling interest

(72)

^[1]

18,852

^[1]

6,058

37,229

Net loss attributable to noncontrolling interest

(380)

^[1]

(491)

^[1]

(1,323)

(1,305)

Net income attributable to Ebix, Inc.

$ 308

^[1]

$ 19,343

^[1]

$ 7,381

$ 38,534

Basic earnings per common share attributable to Ebix, Inc. (in dollars per share)

$ 0.01

^[1]

$ 0.63

^[1]

$ 0.24

$ 1.25

Diluted earnings per common share (in dollars per share)

$ 0.01

^[1]

$ 0.63

^[1]

$ 0.24

$ 1.25

Basic weighted average shares outstanding (in shares)

30,866

^[1]

30,745

^[1]

30,854

30,729

Diluted weighted average shares outstanding (in shares)

30,869

^[1]

30,756

^[1]

30,856

30,756

Net Basis

Operating revenue

$ 118,430

$ 114,924

$ 234,503

$ 214,444

Operating expenses:

Cost of services provided

33,757

33,473

63,549

57,583

Product development

10,947

10,223

20,930

20,481

Sales and marketing

3,582

4,511

6,913

8,276

General and administrative, net

36,110

31,736

73,577

58,649

Amortization and depreciation

4,893

4,874

9,909

9,238

Total operating expenses

89,289

84,817

174,878

154,227

Operating income

29,141

30,107

59,625

60,217

Interest income

133

128

Interest expense

(24,614)

(11,664)

(46,877)

(21,915)

Non-operating (loss) income

(3,647)

(408)

(3,977)

(1,142)

Foreign currency exchange gain (loss)

(840)

3,229

(2,060)

4,123

Income before income taxes

21,330

6,844

41,411

Income tax (expense) benefit

(164)

(2,478)

(787)

(4,182)

Net income including noncontrolling interest

(72)

18,852

6,057

37,229

Net loss attributable to noncontrolling interest

(380)

(491)

(1,323)

(1,305)

Net income attributable to Ebix, Inc.

$ 308

$ 19,343

$ 7,380

$ 38,534

Basic earnings per common share attributable to Ebix, Inc. (in dollars per share)

$ 0.01

$ 0.63

$ 0.24

$ 1.25

Diluted earnings per common share (in dollars per share)

$ 0.01

$ 0.63

$ 0.24

$ 1.25

Basic weighted average shares outstanding (in shares)

30,866

30,745

30,854

30,729

Diluted weighted average shares outstanding (in shares)

30,869

30,756

30,856

30,756

[1]

Condensed Consolidated Statements of Comprehensive Income - USD ($)
$ in Thousands

3 Months Ended

6 Months Ended

Jun. 30, 2023

Jun. 30, 2022

Jun. 30, 2023

Jun. 30, 2022

Statement of Comprehensive Income [Abstract]

Net income including noncontrolling interest

$ (72)

^[1]

$ 18,852

^[1]

$ 6,058

$ 37,229

Other comprehensive income (loss):

Foreign currency translation adjustments

2,393

(43,343)

10,113

(54,627)

Total other comprehensive income (loss)

2,393

(43,343)

10,113

(54,627)

Comprehensive income

2,321

(24,491)

16,171

(17,398)

Comprehensive loss attributable to noncontrolling interest

(380)

(491)

(1,323)

(1,305)

Comprehensive income attributable to Ebix, Inc.

$ 2,701

$ (24,000)

$ 17,494

$ (16,093)

[1]

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 62,165	$ 110,637
Receivables from service providers	542	4,223
Short-term investments	14,392	17,438
Restricted cash	8,282	8,210
Fiduciary funds - restricted	1,735	2,092
Trade accounts receivable, less allowances of $18,885 and $18,167, respectively	163,166	154,533
Other current assets	98,598	87,387
Total current assets	348,880	384,520
Property and equipment, net	53,695	52,448
Right-of-use assets	8,695	9,636
Goodwill	887,101	881,676
Intangibles, net	47,995	50,900
Indefinite-lived intangibles	16,647	16,647
Capitalized software development costs, net	15,886	15,342
Deferred tax asset, net	124,289	96,290
Other assets	37,320	30,096
Total assets	1,540,508	1,537,555
Current liabilities:
Accounts payable and accrued liabilities	95,617	99,194
Payables to service agents	18,737	11,299
Accrued payroll and related benefits	13,367	10,652
Working capital facility	5,043	3,367
Fiduciary funds - restricted	1,735	2,092
Revolving line of credit	444,902	449,902
Short-term debt	608	3,000
Current portion of long term debt and financing lease obligations, net of deferred financing costs of $934 and $469, respectively	172,857	190,866
Contract liabilities	37,769	32,029
Lease liability	3,024	3,354
Other current liabilities	25,629	25,783
Total current liabilities	819,288	831,538
Revolving line of credit	0	0
Long term debt and financing lease obligations, less current portion, net of deferred financing costs of $0 and $0, respectively	87	160
Contingent liability for accrued earn-out acquisition consideration	2,315	2,298
Contract liabilities	7,717	14,098
Lease liability	6,002	6,612
Deferred tax liability, net	1,150	1,150
Other liabilities	27,092	22,259
Total liabilities	863,651	878,115
Stockholders’ equity:
Common stock, $0.10 par value, 220,000,000 shares authorized, 30,877,258 issued and outstanding, at June 30, 2023, and 30,819,533 issued and outstanding at December 31, 2022	3,088	3,082
Additional paid-in capital	20,041	18,801
Retained earnings	822,162	814,781
Accumulated other comprehensive loss	(209,326)	(219,439)
Total Ebix, Inc. stockholders’ equity	635,965	617,225
Noncontrolling interest	40,892	42,215
Total stockholders’ equity	676,857	659,440
Total liabilities and stockholders’ equity	1,540,508	1,537,555
Preferred Stock
Stockholders’ equity:
Preferred stock, $0.10 par value, 500,000 shares authorized, no shares issued and outstanding at June 30, 2023 and December 31, 2022	0	0
Series Y Convertible preferred stock
Stockholders’ equity:
Series Y Convertible preferred stock, $0.10 par value, 350,000 shares authorized, no shares issued and outstanding at June 30, 2023 and December 31, 2022	$ 0	$ 0

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022
Allowance for doubtful accounts	$ 18,885	$ 18,167
Unamortized deferred financing costs, current	934	469
Unamortized deferred financing costs, noncurrent	$ 0	$ 0
Common stock, par value (in dollars per share)	$ 0.10	$ 0.10
Common stock, shares authorized (in shares)	220,000,000	220,000,000
Common stock, shares issued (in shares)	30,877,258	30,819,533
Common stock, shares outstanding (in shares)	30,877,258	30,819,533
Preferred Stock
Preferred stock, par value (in dollars per share)	$ 0.10	$ 0.10
Preferred stock, shares authorized (in shares)	500,000	500,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Series Y Convertible preferred stock
Preferred stock, par value (in dollars per share)	$ 0.10	$ 0.10
Preferred stock, shares authorized (in shares)	350,000	350,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0

Condensed Consolidated Statement of Stockholders' Equity - USD ($)
$ in Thousands

Total

Common Stock

Additional Paid-in Capital

Retained Earnings

Accumulated Other Comprehensive Loss

Noncontrolling interest

Beginning balance (in shares) at Dec. 31, 2021

30,683,393

Beginning balance at Dec. 31, 2021

$ 699,554

$ 3,068

$ 15,068

$ 759,208

$ (122,022)

$ 44,232

Increase (Decrease) in Stockholders' Equity [Roll Forward]

Net income attributable to Ebix, Inc.

38,534

Net loss attributable to noncontrolling interest

(1,305)

Cumulative translation adjustment

(54,627)

Vesting of restricted stock (in shares)

74,164

Vesting of restricted stock

$ 7

(7)

Share based compensation

$ 1,934

1,934

Forfeiture of certain shares to satisfy exercise costs and the recipients' income tax obligations related to stock options exercised and restricted stock vested (in shares)

(2,057)

Forfeiture of certain shares to satisfy exercise costs and the recipients' income tax obligations related to stock options exercised and restricted stock vested

$ (64)

(64)

Common stock dividends paid (in dollars per share)

$ 0.075

Common stock dividends paid

$ (4,636)

(4,636)

Ending balance (in shares) at Jun. 30, 2022

30,755,500

Ending balance at Jun. 30, 2022

679,390

$ 3,075

16,931

793,106

(176,649)

42,927

Beginning balance (in shares) at Mar. 31, 2022

30,722,267

Beginning balance at Mar. 31, 2022

705,259

$ 3,072

15,994

776,081

(133,306)

43,418

Increase (Decrease) in Stockholders' Equity [Roll Forward]

Net income attributable to Ebix, Inc.

19,343

^[1]

19,343

Net loss attributable to noncontrolling interest

(491)

^[1]

(491)

Cumulative translation adjustment

(43,343)

Vesting of restricted stock (in shares)

34,183

Vesting of restricted stock

$ 3

(3)

Share based compensation

970

Forfeiture of certain shares to satisfy exercise costs and the recipients' income tax obligations related to stock options exercised and restricted stock vested (in shares)

(950)

Forfeiture of certain shares to satisfy exercise costs and the recipients' income tax obligations related to stock options exercised and restricted stock vested

$ (30)

(30)

Common stock dividends paid (in dollars per share)

$ 0.075

Common stock dividends paid

$ (2,318)

(2,318)

Ending balance (in shares) at Jun. 30, 2022

30,755,500

Ending balance at Jun. 30, 2022

679,390

$ 3,075

16,931

793,106

(176,649)

42,927

Beginning balance (in shares) at Dec. 31, 2022

30,819,533

Beginning balance at Dec. 31, 2022

659,440

$ 3,082

18,801

814,781

(219,439)

42,215

Increase (Decrease) in Stockholders' Equity [Roll Forward]

Net income attributable to Ebix, Inc.

7,381

Net loss attributable to noncontrolling interest

(1,323)

Cumulative translation adjustment

10,113

Vesting of restricted stock (in shares)

60,007

Vesting of restricted stock

$ 6

(6)

Share based compensation

$ 1,288

1,288

Forfeiture of certain shares to satisfy exercise costs and the recipients' income tax obligations related to stock options exercised and restricted stock vested (in shares)

(2,282)

Forfeiture of certain shares to satisfy exercise costs and the recipients' income tax obligations related to stock options exercised and restricted stock vested

$ (42)

(42)

Common stock dividends paid (in dollars per share)

$ 0.000

Common stock dividends paid

$ 0

Ending balance (in shares) at Jun. 30, 2023

30,877,258

Ending balance at Jun. 30, 2023

676,857

$ 3,088

20,041

822,162

(209,326)

40,892

Beginning balance (in shares) at Mar. 31, 2023

30,851,314

Beginning balance at Mar. 31, 2023

673,910

$ 3,085

19,418

821,854

(211,719)

41,272

Increase (Decrease) in Stockholders' Equity [Roll Forward]

Net income attributable to Ebix, Inc.

308

^[1]

308

Net loss attributable to noncontrolling interest

(380)

^[1]

(380)

Cumulative translation adjustment

2,393

Vesting of restricted stock (in shares)

26,917

Vesting of restricted stock

$ 3

(3)

Share based compensation

644

Forfeiture of certain shares to satisfy exercise costs and the recipients' income tax obligations related to stock options exercised and restricted stock vested (in shares)

(973)

Forfeiture of certain shares to satisfy exercise costs and the recipients' income tax obligations related to stock options exercised and restricted stock vested

$ (18)

(18)

Common stock dividends paid (in dollars per share)

$ 0.000

Common stock dividends paid

$ 0

Ending balance (in shares) at Jun. 30, 2023

30,877,258

Ending balance at Jun. 30, 2023

$ 676,857

$ 3,088

$ 20,041

$ 822,162

$ (209,326)

$ 40,892

[1]

Condensed Consolidated Statement of Stockholders' Equity (Parenthetical) - $ / shares	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Statement of Stockholders' Equity [Abstract]
Common stock dividends paid (in dollars per share)	$ 0.000	$ 0.075	$ 0.000	$ 0.075

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022
Cash flows from operating activities:
Net income attributable to Ebix, Inc.	$ 7,381	$ 38,534
Net loss attributable to noncontrolling interest	(1,323)	(1,305)
Adjustments to reconcile net income to net cash provided by operating activities:
Amortization and depreciation	9,909	9,238
Provision (benefit) for deferred taxes	(27,654)	(24,354)
Share-based compensation	1,288	1,934
(Benefit) provision for doubtful accounts	1,832	1,702
Amortization of right-of-use assets	2,051	1,765
Amortization of capitalized software development costs	103	1,511
Changes in assets and liabilities, net of effects from acquisitions:
Accounts receivable	(9,322)	(16,223)
Receivables from service providers	3,681	(2,194)
Payables to service agents	7,438	1,174
Other assets	(5,749)	(9,826)
Accounts payable and accrued expenses	14,620	8,525
Accrued payroll and related benefits	2,617	1,004
Contract liabilities	(786)	8,766
Lease liabilities	(2,080)	(1,670)
Reserve for potential uncertain income tax return positions	0	0
Other liabilities	4,433	2,863
Net cash provided by operating activities	8,439	21,444
Cash flows from investing activities:
Capitalized software development costs	(546)	(4,170)
Maturities (purchases) of unrestricted marketable securities, net	(870)	(3,214)
Capital expenditures	(7,921)	(9,607)
Net cash (used in) provided by investing activities	(9,337)	(16,991)
Cash flows from financing activities:
Prepayments related to Debt Refinancing	(7,704)	0
Proceeds from term loan	0	0
Principal payments of term loan obligation	(40,961)	(15,933)
Forfeiture of certain shares to satisfy exercise costs and the recipients' income tax obligations related to stock options exercised and restricted stock vested	(42)	(64)
Dividend payments	0	(4,636)
Payments of debt obligations, net	(2,780)	(1,672)
(Payments) of/Borrowings under working capital facility, net	1,660	(1,704)
Payments of financing lease obligations, net	(86)	(106)
Net cash used in financing activities	(49,913)	(24,115)
Effect of foreign exchange rates on cash	2,251	(11,767)
Net change in cash and cash equivalents, and restricted cash	(48,560)	(31,429)
Cash and cash equivalents, and restricted cash at the beginning of the period	124,959	114,764
Cash and cash equivalents, and restricted cash at the end of the period	76,399	83,335
Supplemental disclosures of cash flow information:
Interest paid	36,283	19,088
Income taxes paid	$ 25,055	$ 24,222

Condensed Consolidated Statements of Cash Flows (Parenthetical) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022
Statement of Cash Flows [Abstract]
Forfeiture of certain shares to satisfy exercise costs and the recipients' income tax obligations related to stock options exercised and restricted stock vested (in shares)	2,282	2,057
Forfeiture of certain shares to satisfy exercise costs and the recipients' income tax obligations related to stock options exercised and restricted stock vested	$ 42	$ 64

Description of Business and Summary of Significant Accounting Policies

6 Months Ended

Jun. 30, 2023

Accounting Policies [Abstract]

Description of Business and Summary of Significant Accounting Policies

Summary of Significant Accounting Policies

Reclassification — Certain prior year amounts have been reclassified to be consistent with current year presentation within our financial statements.



	As of
	June 30,
	2023		2022
	(In thousands)
Cash and cash equivalents	$	62,165	$	67,511
Restricted cash	8,282		9,415
Restricted cash included in other long-term assets	$	5,952	$	6,409
Total cash, cash equivalents, and restricted cash shown in the condensed consolidated statement of cash flows	$	76,399	$	83,335

•Level 1 Inputs - Unadjusted quoted prices available in active markets for identical investments to the reporting entity at the measurement date.

A financial instrument's level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement.

As of June 30, 2023, the Company had the following financial instruments to which it had to consider both fair values and make fair value assessments:

Additional information regarding the Company's assets and liabilities that are measured at fair value on a recurring basis is presented in the following tables:


	Fair Values at Reporting Date Using*
Descriptions	Balance, June 30, 2023		Quoted Prices in Active Markets for Identical Assets or Liabilities (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
	(In thousands)
Assets
Commercial bank certificates of deposits ($10.2 million is recorded in the long term asset section of the condensed consolidated balance sheets in "Other assets")	$	32,730	$	—	$	32,730	$	—
Mutual funds (recorded in the long term asset section of the condensed consolidated balance sheets in "Other assets")	106		106		—		—
Total assets measured at fair value	$	32,836	$	106	$	32,730	$	—

Liabilities


Contingent accrued earn-out acquisition consideration (a)	$	2,315	$	—	$	—	$	2,315
Total liabilities measured at fair value	$	2,315	$	—	$	—	$	2,315

(a) The income valuation approach is applied and the valuation inputs include the contingent payment arrangement terms, projected revenues and cash flows, rate of return, and probability assessments.
* During the six months ended June 30, 2023, there were no transfers between fair value Levels 1, 2, or 3.


	Fair Values at Reporting Date Using*
Descriptions	Balance, December 31, 2022		Quoted Prices in Active Markets for Identical Assets or Liabilities (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
	(In thousands)
Assets
Commercial bank certificates of deposits ($6.4 million is recorded in the long term asset section of the condensed consolidated balance sheets in "Other assets")	$	37,434	$	—	$	37,434	$	—
Mutual funds	$	98	$	98	$	—	$	—
Total assets measured at fair value	$	37,532	$	98	$	37,434	$	—

Liabilities


Contingent accrued earn-out acquisition consideration (a)	$	2,299	$	—	$	—	$	2,299
Total liabilities measured at fair value	$	2,299	$	—	$	—	$	2,299

(a) The income valuation approach is applied and the valuation inputs include the contingent payment arrangement terms, projected revenues and cash flows, rate of return, and probability assessments.
* During the year ended December 31, 2021, there were no transfers between fair value Levels 1, 2, or 3.


Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
Contingent Liability for Accrued Earn-out Acquisition Consideration	June 30, 2023		December 31, 2022
	(In thousands)

Beginning balance	$	2,299	$	—

Total remeasurement adjustments:

Remeasurement against goodwill	—		2,299
Foreign currency translation adjustments **	16		—

Acquisitions and settlements
Business settlements	—		—

Ending balance	$	2,315	$	2,299

The amount of total (gains) losses for the period included in earnings or changes to net assets, attributable to changes in unrealized gains relating to assets or liabilities still held at period-end.	$	—	$	—


** recorded as a component of other comprehensive income within stockholders' equity

Quantitative Information about Level 3 Fair Value Measurements

The significant unobservable inputs used in the fair value measurement of the Company's contingent consideration liabilities designated as Level 3 are as follows:

(In thousands)

Fair Value at June 30, 2023

Valuation Technique

Significant
Unobservable
Input

Contingent acquisition consideration:

$2,315

Discounted cash flow

Projected revenue and
probability of achievement

(In thousands)

Fair Value at December 31, 2022

Valuation Technique

Significant
Unobservable
Input

Contingent acquisition consideration:

$2,299

Discounted cash flow

Projected revenue and
probability of achievement

Sensitivity to Changes in Significant Unobservable Inputs

The Company determines revenue recognition by applying the following steps:

•identification of the contract, or contracts, with a customer;

•identification of the performance obligations in the contract;

•determination of the transaction price;

•allocation of the transaction price to the performance obligations in the contract; and

•recognition of revenue when, or as, we satisfy a performance obligation.

The Company assesses the terms of customer contracts, including termination rights, penalties (implied or explicit), and renewal rights.

EbixCash Exchanges

Gift Cards

EbixCash Travel Exchanges

EbixCash Money Transfer

Foreign Exchange and Outward Remittance Services

Consumer Payment Services

EbixCash Technology Services

Insurance Exchanges

Software-as-a-Service

Software Licenses

Software license revenues attributable to a software license that is a separate performance obligation are recognized at the point in time that the customer obtains control of the license.

Subscription Services

Transaction Fees

Professional Services

Risk Compliance Solutions ("RCS")

COI Creation and Tracking

Consulting Services

Disaggregation of Revenue

The following tables present revenue disaggregated by primary geographical regions and product/service channels for the three and six months ended June 30, 2023 and 2022:


	Three Months Ended June 30,				Six Months Ended June 30,
Revenue:	2023		2022		2023		2022
	(In thousands)
North America	37,720		39,645		76,590		79,671
International	80,710		213,061		284,601		457,363
	$	118,430	$	250,781	$	361,191	$	537,034

Geographical regions on net basis for comparative purposes (Non GAAP) for the three and six months ended June 30, 2023 and 2022:


	Three Months Ended June 30,				Six Months Ended June 30,
Revenue:	2023		2022		2023		2022
	(In thousands)
North America	37,720		39,645		76,590		79,671
International	80,710		75,279		157,913		134,773
	$	118,430	$	114,924	$	234,503	$	214,444

The Company’s revenues are derived from two product/service groups: Exchanges and Risk Compliance Solutions.

Presented in the table below is the breakout of our revenue groups for each of those product/service channels for the three and six months ended June 30, 2023 and 2022.


	Three Months Ended				Six Months Ended
	June 30,				June 30,
	2023		2022		2023		2022
	(In thousands)

Exchanges	98,078		230,943		319,944		498,859
Risk Compliance Solutions	20,352		19,838		41,247		38,175
Totals	$	118,430	$	250,781	$	361,191	$	537,034

Product/Services channels on net basis for Comparative purposes (Non GAAP) for the three and six months ended June 30, 2023 and 2022:


	Three Months Ended				Six Months Ended
	June 30,				June 30,
	2023		2022		2023		2022
	(In thousands)

Exchanges	98,078		95,086		193,256		176,269
Risk Compliance Solutions	20,352		19,838		41,247		38,175
Totals	$	118,430	$	114,924	$	234,503	$	214,444

Costs to Obtain and Fulfill a Contract


	June 30, 2023		December 31, 2022
	(Unaudited)
	(In thousands)
Balance, beginning of period	$	1,284	$	1,822
Costs recognized from the beginning balance	(265)		(968)
Additions, net of costs recognized	208		430
Balance, end of period	$	1,227	$	1,284

Contract Liabilities


	June 30, 2023		December 31, 2022
	(Unaudited)
	(In thousands)
Balance, beginning of period	$	46,127	$	41,357
Revenue recognized from beginning balance	(26,392)		(30,460)

Additions, net of revenue recognized and currency translation	25,751		35,230
Balance, end of period	$	45,486	$	46,127


Category						Life (yrs)
Airport contracts						4 - 20
Brand						3 - 15
Customer relationships						9
Database						5
Dealer networks						15 - 20
Developed technology						3 - 15
Non-compete agreements						3 - 15
Store networks						5 - 7
Trademarks						10

Foreign Currency Translation — The functional currency is the U.S. Dollar for the Company's foreign subsidiaries in Dubai and Singapore.

Earnings per Share

6 Months Ended

Jun. 30, 2023

Earnings Per Share [Abstract]

Earnings Per Share

Earnings per Share

A reconciliation between basic and diluted earnings per share ("EPS") is as follows:


	Three Months Ended				Six Months Ended
	June 30,				June 30,
	2023		2022		2023		2022
	(In thousands, except per share data)
Net income attributable to Ebix, Inc.	$	308	$	19,343	$	7,381	$	38,534
Basic weighted average shares outstanding	30,866		30,745		30,854		30,729
Dilutive effect of stock options and restricted stock awards	3		11		2		27
Diluted weighted average shares outstanding	30,869		30,756		30,856		30,756
Basic earnings per common share	$	0.01	$	0.63	$	0.24	$	1.25
Diluted earnings per common share	$	0.01	$	0.63	$	0.24	$	1.25

Business Combinations	6 Months Ended
Business Combinations	Jun. 30, 2023
Business Combination and Asset Acquisition [Abstract]
Business Combinations	Business Combinations As part of its comprehensive business growth and expansion strategy, the Company seeks to execute accretive business acquisitions that are, in most cases, complementary to Ebix's existing products and services. During the six months ending June 30, 2023, the Company completed no business acquisitions. During the twelve months ended December 31, 2022, the Company completed no business acquisitions. A significant component of the purchase price consideration for many of the Company's business acquisitions is a potential subsequent cash earn-out payment based on reaching certain specified future revenue targets. The terms for the contingent earn-out payments in most of the Company's business acquisitions typically address the GAAP recognizable revenues achieved by the acquired entity over a one-, two-, and/or three-year period subsequent to the effective date of their acquisition by Ebix. These terms typically establish a minimum threshold revenue target to achieve over the agreed upon period post acquisition to earn the specified cash earn out payment. The Company applies these terms in its calculation and determination of the fair value of contingent earn out liabilities for purchased businesses as part of the related valuation and purchase price allocation exercise for the corresponding acquired assets and liabilities. The Company recognizes these potential obligations as contingent liabilities and are reported as such on its condensed consolidated balance sheets. As discussed in more detail in Note 1, these contingent consideration liabilities are recorded at fair value on the acquisition date and are remeasured quarterly based on the then assessed fair value and adjusted if necessary. As of both June 30, 2023 and December 31, 2022, the total of these contingent consideration liabilities was $2.3 million. Consideration paid by the Company for the businesses it purchases is allocated to the assets and liabilities acquired based upon their estimated fair values as of the date of the acquisition. The excess of the purchase price over the estimated fair values of assets acquired (including identified intangible assets acquired) and liabilities assumed is recorded as goodwill.

Debt	6 Months Ended
Debt	Jun. 30, 2023
Debt Disclosure [Abstract]
Debt	Debt The Company maintains a senior secured syndicated credit facility, dated August 5, 2014, among Ebix, Inc., as borrower, its subsidiaries party thereto from time to time as guarantors, Regions Bank (as administrative agent and collateral agent) and the lenders party thereto from time to time (as amended from time to time, the "Credit Facility") that provides a $450 million revolving line of credit (the "Revolver") as well as a term loan (the "Term Loan"), which at June 30, 2023 had a balance of $171.9 million. The Credit Facility was set to mature on February 2023; however, in May 2023, the company entered into Amendment No. 14 to its Credit Facility, which provides for, among other things, an extension of the maturity date from May 23, 2023 to September 30, 2023 ("Credit Facility Maturity Date"), as discussed in more details below. At June 30, 2023 the outstanding balance of the Credit Facility, $616.8 million, was classified as a current liability. The Company expects to address the Credit Facility maturity prior to the Credit Facility Maturity Date, and intends to do so in conjunction with the resolution of the anticipated IPO of EbixCash, as further described within Item 2 "Management's Discussion and Analysis of Financial Conditions and Results of Operations - Liquidity and Capital Resources". The refinancing of the Credit Facility will require the Company to successfully access the debt and/or equity capital markets in the U.S. or internationally. However, there are no assurances that such financing will be available in amounts or on terms acceptable to us, if at all, or that the proceeds received by Ebix, Inc. from the IPO of EbixCash will be in the amount currently expected. Further, no assurances can be given when the IPO will be completed, if at all, or if it will be completed on terms acceptable to the Company. On July 21, 2023, the Company entered into an amendment No. 15 that specifically provided for, among other things, the deletion of the event of default deadline for the mandatory public opening of subscription to investors of the shares of the Company’s subsidiary EbixCash on the Indian stock market on or by prior to July 31, 2023. Also, Amendment 15 that changed the possible additional amendment fee (the “Amendment Fee”) that had been included as part of Amendment No. 14, as discussed below, from an amount equal to 1.50% of the aggregate principal amount of the outstanding term loan (the “Term Loan and the lenders’ commitments under the revolving line of credit (the “Revolver”), whether or not utilized, to 2%. The Amendment Fee will be waived if all of the Revolver has been terminated and the Term Loan and all other obligations due the lenders are fully repaid on or before August 31, 2023. On May 23, 2023, the company signed an amendment (“Amendment No. 14”) to its existing credit agreement, extending the maturity date to September 30, 2023. Amendment No. 14 provided for, among other things, an extension of the maturity date for both the Revolver and the term loan the Term Loan, each as existing under the Credit Agreement. It was conditioned, among other things, upon the Company (i) making a $5,000,000 payment of the Term Loan by June 30, 2023 and (ii) paying a customary consent fee which will be payable over time and partially waived if certain conditions are met. Amendment No. 14 also specifically provided for the application of a certain percentage of the proceeds from certain liquidity events towards payment of outstanding principal and interest obligations at that time. These events would have included the public listing of the shares of the Company’s subsidiary EbixCash on the Indian stock market by July 31, 2023, the proceeds from the issuance of any additional debt and/or securities if raised by the Company and the proceeds from the monetization of any asset sale, if carried out by the Company. Amendment No. 14 (i) increased the applicable margin for the facilities under the Credit Agreement to (x) 7.50% per annum for SOFR loans and letter of credit fees, (y) 6.50% per annum for base rate loans, and (ii) further increases the applicable margin for the facilities under the Credit Agreement on August 31, 2023 to (x) 8.00% per annum for SOFR loans and letter of credits fees, and (y) 7.00% per annum for base rate loans. Amendment 14 also included the Amendment Fee of 1.50%. On February 21, 2023, the company entered into Amendment No. 13 to its Credit Facility, which provides for, among other things, an extension of the maturity date from February 21, 2023 to May 23, 2023 ("Credit Facility Maturity Date"). Amendment No. 13 to the Credit Facility required the Company to make a $5 million prepayment of the Revolver on February, 21, 2023 and a $5 million amortization payment on the Term Loan on March 31, 2023. Any repayments under the Revolver will be accompanied by a corresponding reduction in the aggregate revolving commitments. Lastly, amendment No. 13 modified certain other provisions within the Credit Agreement and has resulted in an approximately 1% per annum interest rate increase beginning February 21, 2023. On April 9, 2021, The Company entered into Amendment No. 12 to its Credit Facility. Amendment No. 12 provided for, among other things, a waiver of any potential event of default arising under the Credit Facility from the failure to timely deliver the Company's audited financial consolidated financial statements and related compliance certificate for the year ended December 31, 2020, provided that there is no good faith determination by the requisite lenders under the Credit Facility of a "Material Circumstance" (as defined and further described in Amendment No. 12), which determination (if any) may only be made within a specified period described in Amendment No. 12 and is subject to certain cure rights of the Company. Amendment No. 12 also modified the applicable margin that applies from the date of the amendment forward, modified certain mandatory prepayment provisions, as well as certain other covenants related to restricted payments, investments and certain reporting requirements. On March 31, 2021, Ebix entered into Amendment No. 11 to the Credit Facility. Amendment No. 11 provided, for, among other things, a limited waiver through April 10, 2021, of any potential event of default arising under the Credit Facility from failure to deliver the Company's audited consolidated financial statements and related compliance certificate for the year ended December 31, 2020. Amendment No. 11 also modified certain covenants contained in the Credit Facility, including with respect to certain permitted restricted payments and investments. As of June 30, 2023, the Company's condensed consolidated balance sheets include $2.3 million of remaining deferred financing costs in connection with the Credit Facility, which are being amortized as a component of interest expense through the Credit Facility Maturity Date. $1.4 million of such deferred financing costs pertain to the Revolver, and $0.9 million pertains to the Term Loan, which is netted against the current portion of the Term Loan as reported on the condensed consolidated balance sheets. At December 31, 2022, the Company's Consolidated Balance Sheets included $1.2 million of remaining deferred financing costs in connection with the Credit Facility, with $0.7 million pertaining to the Revolver, and $0.5 million pertaining to the Term Loan, of which $0.5 million was netted against the current portion of the Term Loan. As of June 30, 2023, the outstanding balance on the Revolver was $444.9 million and the Revolver carried an interest rate of 11.95% at June 30, 2023. The balance on the Revolver is included in the current liabilities section of the condensed consolidated balance sheets. During the six months ended June 30, 2023, the average and maximum outstanding balances of the revolving line of credit component of the Credit Facility were both $444.9 million. At December 31, 2022, the outstanding balance on the Revolver was $449.9 million and the Revolver carried an interest rate of 9.69%. As of June 30, 2023, the outstanding balance on the Term Loan was $171.9 million, of which $171.9 million is due within the next twelve months. $17.5 million of principal payments were made during the six months ended June 30, 2023, of which $0.0 million were scheduled amortization payments. This Term Loan also carried an interest rate of 11.95% at June 30, 2023. The Term Loan is included in the current liabilities section of the condensed consolidated balance sheets at June 30, 2023. At December 31, 2022, the outstanding balance on the Term Loan was $189.4 million, of which $189.4 million was due within twelve months. The Term Loan also carried an interest rate of 9.69% at December 31, 2022. The Company maintains working capital debt facilities with banks in international markets for working capital funding requirements to support our foreign exchange and payment remittance businesses. We are required to extend short term credits to franchisee networks (B2B) and corporate customers. Additionally we are required to maintain minimum levels of foreign currency inventory across branches and airport operations. Typically, these facilities carry interest rates of 9.00% to 10%, are rupee-denominated working capital lines, and are collateralized against the receivables of these businesses and existing foreign currency inventory on hand. As of June 30, 2023 and December 31, 2022, the total of these working capital facilities was $5.0 million and $3.4 million, respectively, and is included in current liabilities in the Company's condensed consolidated balance sheets.

Commitments and Contingencies	6 Months Ended
Commitments and Contingencies	Jun. 30, 2023
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies On February 22, 2021, Christine Marie Teifke, a purported purchaser of Ebix securities, filed a putative class action in the United States District Court for the Southern District of New York, captioned Teifke v. Ebix, Inc., et. al., Case No. 1:21-cv-01589-JMF, on behalf of herself and others who purchased or acquired Ebix securities between November 9, 2020 and February 19, 2021. The complaint asserts claims against the Company, Robin Raina, and Steven M. Hamil (“Defendants”), for purported violations of Section 10(b) of the Securities Exchange Act of 1934, alleging that Ebix made false and misleading statements and failed to disclose material adverse facts about an audit of the company's gift card business in India and its internal controls over the gift and prepaid card revenue transaction cycle. The complaint alleges that Ebix's stock price fell as a result of the revelation that Ebix's independent auditor, RSM US LLP (“RSM”), had resigned, citing concerns with the company's internal controls and disagreements over other accounting issues. The complaint also asserts a claim against Robin Raina and Steven M. Hamil for purported violations of Section 20(a) of the Exchange Act arising out of the same facts. The complaint seeks, among other relief, damages and attorneys' fees and costs. On May 11, 2021, the court issued an order appointing Rahul Saraf, another purported purchaser of Ebix, Inc. securities, as lead plaintiff in the action, and the caption in the action was changed to Saraf v. Ebix, Inc., et. al., Case No. 1:21-cv-01589-JMF (the "Class Action"). On July 17, 2023, the Court dismissed the Class Action in its entirety with prejudice for failure to state a claim. On May 14, 2021, Javier Calvo, a purported shareholder of the Company, filed a derivative action in the United States District Court for the Southern District of New York on behalf of Ebix captioned Calvo v. Raina, et. al., Case No. 21-cv-4380-JMF (the "Calvo Action"), against individual defendants Robin Raina, Steven M Hamil, Hans U. Benz, Rolf Herter, Neil D. Eckert, Pavan Bhalla, Hans Ueli Keller, and George W. Hebard, and nominal defendant Ebix asserting claims related to the RSM resignation. On July 13, 2021, Peter Votto, another purported Ebix shareholder, filed an additional derivative action in the United States District Court for the Southern District of New York on behalf of Ebix, captioned Votto v. Raina, et. al., Case No. 21-cv-5982-JMF (the "Votto Action"), asserting claims against the same defendants as the Calvo Action. The complaint asserts claims relating to the RSM resignation against all of the individual defendants for breach of fiduciary duties, unjust enrichment, waste of corporate assets, and rescission under Section 29(b) of the Securities Exchange Act of 1934, and claims for contribution under Sections 10(b) and 21D of the Securities Exchange Act of 1934 against Robin Raina and Steven M Hamil. The Consolidated Derivative Action is currently stayed by agreement of the parties and order of the Court. On November 5, 2021, Daniel Lilienfeld, a purported shareholder of the Company, filed a derivative action in the United States District Court for the Northern District of Georgia on behalf of Ebix captioned Lilienfeld v. Raina, et. al., Case No. 1:21-cv-04590-ELR (the "Lilienfeld Action"), asserting claims against the same defendants as the Consolidated Derivative Action. The complaint similarly asserts a claim of breach of fiduciary duty related to the RSM resignation against all of the individual defendants. On July 26, 2023, Mr. Lilienfeld dismissed the Lilienfeld Action without prejudice. On December 29, 2021, Sunil Shah, a purported shareholder of the Company, filed a derivative action in the Superior Court of Fulton County of the State of Georgia on behalf of Ebix captioned Shah v. Raina, et. al., Civil Action File No. 2022-cv-358481 (the "Shah Action") against the same defendants as the Consolidated Derivative Action and Lilienfeld Actions. The complaint similarly asserts a claim of breach of fiduciary duty related to the RSM resignation against all of the individual defendants. The Shah Action was stayed by agreement of the parties and order of the Court. On July 26, 2023, Mr. Shah dismissed the Shah Action without prejudice. The Company along with Ebix Singapore Pte. Ltd. (the “Ebix Group”) had purchased 80% Equity Shares of Ebix Payment Services Private Limited (“ItzCash”) with effect from April 1, 2017. During the Financial Year 2020, the erstwhile shareholders of ItzCash raised a dispute with the Ebix Group alleging breaches of the share purchase agreement and shareholders’ agreement entered into between the parties and demanding for termination of the shareholders’ agreement, payment of earn out consideration and buyout of minority shareholding. The matter is under arbitration in accordance with the rules of the Singapore International Arbitration Centre (“SIAC”). The arbitration proceedings have concluded, and the arbitral tribunal has passed a partial order dated June 1, 2023 (“Partial Award”) which inter alia states the following (i) the termination of the shareholders agreement executed amongst the Company, Ebix Singapore, Ebix World Money, Vyoman, Ashok Kumar Goel and Ebix Payment Services dated May 12, 2017 (“SHA”) by Vyoman and Mr. Goel was justified (ii) our Company and Ebix World Money (and failing performance, Ebix Singapore) are jointly and severally obliged to purchase the existing shareholding of Vyoman and Mr. Goel under the SHA at a price determined by an independent valuer, once such determination has been made in accordance with the relevant provisions of the SHA and (iii) Claimants were not entitled to specific performance to receive payment of the first and second earn-out thresholds under the aforementioned agreements; and (iv) our Company, Ebix Singapore, Ebix World Money and Ebix Payment Services were found in breach of certain clauses of the aforementioned agreements. Due to absence of explanation of how Claimants incurred or may have incurred losses pursuant to such breaches of the above mentioned agreements the Partial Award directed payment of nominal damages by the Respondents in an joint and several manner to the Claimants as follows: (i) SGD 200 each to Vyoman and Ashok Kumar Goel in respect to the breaches of the SHA and (ii) SGD 100 to each of the 17 other claimants in respect to breaches of the Promoter SPA, Employee SPA and Investor SPA. The Partial Award also states that the directions in relation to the arbitration costs will be dealt in the final award. The matter is currently pending. The Company is involved in various other claims and legal actions arising in the ordinary course of business, which in the opinion of management, the ultimate likely disposition of these matters will not have a material adverse effect on the Company’s consolidated financial position, results of operations or liquidity.

Income Taxes	6 Months Ended
Income Taxes	Jun. 30, 2023
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes The Company recorded a net income tax expense of $164 thousand and $787 thousand (12.74%) during the three and six months ended June 30, 2023, which included tax expense of $1.6 million and $1.8 million from certain discrete items related to stock compensation and uncertain tax positions. The income tax benefit, exclusive of discrete items, was $1.4 million and $971 thousand (15.67%) for the three and six months ended June 30, 2023. During the three and six months ended June 30, 2023 and June 30, 2022, there was an increase of $1.4 million and $146 thousand to this liability reserve, respectively. The Company expects its full year effective tax rate to be in the range of 8% to 10%. As of June 30, 2023 and December 31, 2022 a liability of $7.8 million and $6.4 million for uncertain tax positions is included in other long-term liabilities of the Company's condensed consolidated balance sheets. The Company recognizes interest accrued and penalties related to unrecognized tax benefits as part of income tax expense.

Geographic Information

6 Months Ended

Jun. 30, 2023

Segment Reporting [Abstract]

Geographic Information

The following enterprise-wide information relates to the Company's geographic locations:


	Six Months Ended		As of		Six Months Ended		As of
	June 30, 2023		June 30, 2023		June 30, 2022		December 31, 2022
	External Revenues		Long-lived assets		External Revenues		Long-lived assets
	(In thousands)
North America	76,590		388,113		79,671		374,891
International	284,601		803,515		457,363		785,746
	$	361,191	$	1,191,628	$	537,034	$	1,160,637

Enterprise-wide information relates to the Company's geographic locations on net basis for Comparative Purposes (Non GAAP)


	Six Months Ended		As of		Six Months Ended		As of
	June 30, 2023		June 30, 2023		June 30, 2022		December 31, 2022
	External Revenues		Long-lived assets		External Revenues		Long-lived assets
	(In thousands)
North America	76,590		388,113		79,671		374,891
International	157,913		803,515		134,773		785,746
	$	234,503	$	1,191,628	$	214,444	$	1,160,637

Investment in Joint Ventures	6 Months Ended
Investment in Joint Ventures	Jun. 30, 2023
Equity Method Investments and Joint Ventures [Abstract]
Investment in Joint Ventures	Investment in Joint Ventures Effective February 2016, Ebix and Vayam Technologies Ltd ("Vayam") formed a joint venture named Ebix Vayam Limited JV. This joint venture was established to carry out IT projects in the government sector of the country of India, particularly in regards to the implementation of e-governance projects in the areas of education and healthcare. Ebix has a 51% equity interest in the joint venture, and Vayam has a 49% equity interest in the joint venture. Ebix is fully consolidating the operations of Ebix Vayam Limited JV into the Company's financial statements and separately reporting the Vayam minority, non-controlling interest in the joint venture's net income and equity. Vayam is also a customer of Ebix Vayam Limited JV, and, during the three and six months ended June 30, 2023, Ebix Vayam Limited JV recognized $105 thousand and $206 thousand, respectively, of revenue from Vayam. During the three and six months ended June 30, 2022, Ebix Vayam Limited JV recognized $245 thousand and $521 thousand, respectively, of revenue from Vayam. As of June 30, 2023, Ebix Vayam Limited JV had $11.8 million of accounts receivable with Vayam, net of the estimated allowance for doubtful accounts receivable in the amount of $5.7 million. As of December 31, 2022, Ebix Vayam Limited JV had $11.6 million of accounts receivable with Vayam, net of the estimated allowance for doubtful accounts receivable in the amount of $5.7 million. Effective September 2015, Ebix and Independence Holding Company ("IHC") formed the joint venture EbixHealth JV. This joint venture was primarily established to promote and market an administrative data exchange for health insurance lines of business in the U.S. Ebix has a 51% equity interest in the joint venture and IHC has a 49% equity interest the joint venture. Ebix is fully consolidating the operations of EbixHealth JV into the Company's financial statements and separately reporting EbixHealth JV non-controlling interest in the joint venture's net income and equity. IHC is also a customer of EbixHealth JV, and, during the three and six months ended June 30, 2023, EbixHealth JV recognized $238 thousand and $491 thousand, respectively, of revenue from IHC. During the three and six months ended June 30, 2022, EbixHealth JV recognized $300 thousand and $614 thousand of revenue from IHC. As of June 30, 2023 and December 31, 2022, EbixHealth JV had $76 thousand and $74 thousand of accounts receivable from IHC, respectively. Furthermore, as a related party, IHC also has been and continues to be a customer of Ebix, and during the three and six months ended June 30, 2023 the Company recognized $26 thousand and $43 thousand, respectively, of revenue from IHC. During the three and six months ended June 30, 2022, the Company recognized $20 thousand and $40 thousand of revenue from IHC. As of June 30, 2023 and December 31, 2022, Ebix had $47 thousand and $44 thousand of accounts receivable with IHC. EbixHealth JV has a $1.8 million note due to IHC. The Company recorded $125 thousand in amortization expense related to the IHC customer relationship intangible during the six months ending June 30, 2023.

Goodwill, Finite-Lived, and Indefinite-Lived Intangibles

6 Months Ended

Jun. 30, 2023

Goodwill and Intangible Assets Disclosure [Abstract]

Goodwill, Finite-Lived, and Indefinite-Lived Intangibles

Goodwill, Finite-Lived, and Indefinite-Lived Intangibles Changes in the carrying amount of goodwill for the six months ended June 30, 2023 and the year ended December 31, 2022 are reflected in the following table:


	June 30, 2023		December 31, 2022
	(Unaudited)
	(In thousands)
Beginning Balance	$	881,676	$	939,249
Additions	—		—
Purchase accounting adjustments	—		—
Foreign currency translation adjustments	$	5,425	(57,573)
Ending Balance	$	887,101	$	881,676

The carrying value of finite-lived and indefinite-lived intangible assets at June 30, 2023 and December 31, 2022 are as follows:


	June 30, 2023		December 31, 2022
	(Unaudited)
	(In thousands)
Finite-lived intangible assets:
Customer relationships	$	101,333	$	101,401
Developed technology	37,139		34,427
Dealer network	6,067		5,877
Airport contracts	4,021		3,992
Trademarks	2,667		2,651
Store networks	2,169		2,153
Brand	797		791
Non-compete agreements	704		702
Database	212		212
Backlog	140		140
Total intangibles	155,249		152,346
Accumulated amortization	(107,254)		(101,446)
Finite-lived intangibles, net	$	47,995	$	50,900

Indefinite-lived intangibles:	.
Customer/territorial relationships	16,647		16,647

Capitalized Software Development Costs	6 Months Ended
Capitalized Software Development Costs	Jun. 30, 2023
Capitalized Software Development Costs Disclosure [Abstract]
Capitalized Software Development Costs	Capitalized Software Development Costs In accordance with ASC 350-40 “Internal-Use Software” and/or ASC 350-985 “Software”, the Company has capitalized certain software and product related development costs associated with the Company’s continuing medical education service offerings; development of the P&C underwriting insurance data exchange platform servicing the London markets; development of SaaS based Asset Management and Collection platforms having global application; development of single sign on agent and customer portal, including mobile application, and content development work related to the e-learning business. During the three and six months ended June 30, 2023, the Company capitalized $(0.4) million and $0.5 million, respectively. During the three and six months ended June 30, 2022, the Company capitalized $1.5 million and $4.2 million of such development costs. At June 30, 2023 and December 31, 2022, a total of $15.9 million and $15.3 million, respectively, of remaining unamortized development costs are reported on the Company’s condensed consolidated balance sheets. During the three and six months ended June 30, 2023, the Company recognized $0.1 million and $0.1 million, respectively, of amortization expense with regards to these capitalized software development costs. During the three and six months ended June 30, 2022, related amortization expense was $0.8 million and $1.5 million respectively.

Other Current Assets

6 Months Ended

Jun. 30, 2023

Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]

Other Current Assets

Other current assets at June 30, 2023 and December 31, 2022 consisted of the following:


	June 30, 2023		December 31, 2022
	(Unaudited)
	(In thousands)


Prepaid expenses	$	79,365	$	71,449
Sales taxes receivable from customers	5,723		3,289
Other third party receivables	678		1,034
Credit card merchant account balance receivable	712		704
Short term portion of capitalized costs to obtain and fulfill contracts	474		486
Accrued interest receivable	598		651
Other	11,048		9,774
Total	$	98,598	$	87,387

Leases

6 Months Ended

Jun. 30, 2023

Leases [Abstract]

Leases


Year	Operating Leases		Financing Leases		Total
	(in thousands)
2023	1,958		71		2,029
2024	2,979		133		3,112
2025	2,221		19		2,240
2026	1,394				1,394
2027	637		—		637
Thereafter	1,141		—		1,141
Total	10,330		223		10,553
Less: present value discount*	(1,304)		(9)		(1,313)
Present value of lease liabilities	9,026		214		9,240

Less: current portion of lease liabilities	(3,024)				(3,024)
Total long-term lease liabilities	$	6,002	$	214	$	6,216

* The discount rate used was the incremental borrowing rates respective to the country where the assets are located.


	Three Months Ended				Six Months Ended
	June 30,				June 30,
	2023		2022		2023		2022
	(in thousands)				(in thousands)
Operating Lease Cost	$	1,063	$	989	$	2,129	$	1,980
Finance Lease Cost:
Amortization of Lease Assets	34		46		74		94
Interest on Lease Liabilities	3		6		7		13
Finance Lease Cost	37		52		81		107
Sublease Income	—		(23)		(24)		(46)
Total Net Lease Cost	$	1,100	$	1,018	$	2,186	$	2,041

Other information about lease amounts recognized in our condensed consolidated statement of income is summarized as follows:


	June 30, 2023
Weighted Average Lease Term - Operating Leases	1.62 years
Weighted Average Lease Term - Finance Leases	3.89 years
Weighted Average Discount Rate - Operating Leases	5.4	%
Weighted Average Discount Rate - Finance Leases	8.2	%


Year	Commitments
	(in thousands)
2023 (Remaining six months)	$	5,208
2024	3,214
Thereafter	$	516
Total	$	8,938

Leases


Year	Operating Leases		Financing Leases		Total
	(in thousands)
2023	1,958		71		2,029
2024	2,979		133		3,112
2025	2,221		19		2,240
2026	1,394				1,394
2027	637		—		637
Thereafter	1,141		—		1,141
Total	10,330		223		10,553
Less: present value discount*	(1,304)		(9)		(1,313)
Present value of lease liabilities	9,026		214		9,240

Less: current portion of lease liabilities	(3,024)				(3,024)
Total long-term lease liabilities	$	6,002	$	214	$	6,216

* The discount rate used was the incremental borrowing rates respective to the country where the assets are located.


	Three Months Ended				Six Months Ended
	June 30,				June 30,
	2023		2022		2023		2022
	(in thousands)				(in thousands)
Operating Lease Cost	$	1,063	$	989	$	2,129	$	1,980
Finance Lease Cost:
Amortization of Lease Assets	34		46		74		94
Interest on Lease Liabilities	3		6		7		13
Finance Lease Cost	37		52		81		107
Sublease Income	—		(23)		(24)		(46)
Total Net Lease Cost	$	1,100	$	1,018	$	2,186	$	2,041

Other information about lease amounts recognized in our condensed consolidated statement of income is summarized as follows:


	June 30, 2023
Weighted Average Lease Term - Operating Leases	1.62 years
Weighted Average Lease Term - Finance Leases	3.89 years
Weighted Average Discount Rate - Operating Leases	5.4	%
Weighted Average Discount Rate - Finance Leases	8.2	%


Year	Commitments
	(in thousands)
2023 (Remaining six months)	$	5,208
2024	3,214
Thereafter	$	516
Total	$	8,938

Concentrations of Credit Risk	6 Months Ended
Concentrations of Credit Risk	Jun. 30, 2023
Concentrations of Credit Risk [Abstract]
Concentrations of Credit Risk	Concentrations of Credit Risk The Company is potentially subject to concentrations of credit risk in its accounts receivable. Credit risk is the risk of an unexpected loss if a customer fails to meet its contractual obligations. The Company can be directly affected by the financial condition of its customers, the loss or substantial reduction in business activity with its customers, or the inability of customers to pay its invoices. While customer activity and financial condition could have a material impact on the Company’s financial statements, management does not believe significant credit risk exists at June 30, 2023.

Other Current Liabilities

6 Months Ended

Jun. 30, 2023

Other Liabilities Disclosure [Abstract]

Other Current Liabilities

Other Current Liabilities Other current liabilities at June 30, 2023 and December 31, 2022 consisted of the following:


	June 30, 2023		December 31, 2022
	(Unaudited)
	(In thousands)
Customer advances (deposits)	$	24,023	$	23,630
Acquisition obligations (upfront purchase and contingent consideration)	1,606		2,153


Total	$	25,629	$	25,783

Subsequent Events	6 Months Ended
Subsequent Events	Jun. 30, 2023
Subsequent Events [Abstract]
Subsequent Events	Subsequent EventsNone.

Description of Business and Summary of Significant Accounting Policies (Policies)

6 Months Ended

Jun. 30, 2023

Accounting Policies [Abstract]

Basis of Presentation

Use of Estimates

Reclassification

Reclassification — Certain prior year amounts have been reclassified to be consistent with current year presentation within our financial statements.

Cash and Cash Equivalents

Short-Term Investments

Restricted Cash

Fiduciary Funds-Restricted

Advertising

Fair Value of Financial Instruments

•Level 1 Inputs - Unadjusted quoted prices available in active markets for identical investments to the reporting entity at the measurement date.

A financial instrument's level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement.

As of June 30, 2023, the Company had the following financial instruments to which it had to consider both fair values and make fair value assessments:

Revenue Recognition and Contract Liabilities, EbixCash Exchanges, Insurance Exchanges, and Risk Compliance Solutions

The Company determines revenue recognition by applying the following steps:

•identification of the contract, or contracts, with a customer;

•identification of the performance obligations in the contract;

•determination of the transaction price;

•allocation of the transaction price to the performance obligations in the contract; and

•recognition of revenue when, or as, we satisfy a performance obligation.

The Company assesses the terms of customer contracts, including termination rights, penalties (implied or explicit), and renewal rights.

EbixCash Exchanges

Gift Cards

EbixCash Travel Exchanges

EbixCash Money Transfer

Foreign Exchange and Outward Remittance Services

Consumer Payment Services

EbixCash Technology Services

Insurance Exchanges

Software-as-a-Service

Software Licenses

Software license revenues attributable to a software license that is a separate performance obligation are recognized at the point in time that the customer obtains control of the license.

Subscription Services

Transaction Fees

Professional Services

Risk Compliance Solutions ("RCS")

COI Creation and Tracking

Consulting Services

Costs to Obtain and Fulfill a Contract The Company’s capitalized costs are primarily derived from the fulfillment of SaaS-related setup and customizations, from which the customer receives benefit through continued access to and use of the SaaS product platforms. In accordance with the guidance in ASC 340-40-25-5, we capitalize the costs directly related to the setup and development of these customizations, which satisfy the Company’s performance obligation with respect to access to the Company’s underlying product platforms. The capitalized costs primarily consist of the salaries of the developers directly involved in fulfilling the project and are solely based on the time spent on that project. The Company amortizes the capitalized costs ratably over the expected useful life of the related customizations, matching our treatment for the related revenue, and the capitalized costs are recoverable from profit margin included in the contract.

Contract Liabilities

Accounts Receivable and the Allowance for Doubtful Accounts Receivable

The Company records a contract asset when revenue recognized on a contract exceeds the billings. The contract asset is transferred to receivables when the entitlement to payment becomes unconditional. These contract assets are primarily related to project-based revenue where we recognize revenue using the input method calculated using expected hours to complete the project measured against the actual hours completed to date.

Accounts Receivable and the Allowance for Doubtful Accounts Receivable

Management specifically analyzes accounts receivable, historical bad debts, write-offs, customer concentrations, customer credit-worthiness, current economic trends, and changes in our customer payment terms when evaluating the adequacy of the allowance for doubtful accounts.

Capitalized Software Development Costs

Capitalized Software Development Costs — In accordance with ASC 350-40 "Internal-Use Software" and ASC 350-985 "Software" the Company expenses costs as they are incurred until technological feasibility has been established, at and after which time those costs are capitalized until the product is available for general release to customers. Costs incurred to enhance our software products, after general market release of the services using the products, are expensed in the period they are incurred. The periodic expense for the amortization of previously capitalized software development costs is included in cost of services provided.

Costs of Services Provided

Goodwill and Indefinite-Lived Intangible Assets

Finite-lived Intangible Assets


Category						Life (yrs)
Airport contracts						4 - 20
Brand						3 - 15
Customer relationships						9
Database						5
Dealer networks						15 - 20
Developed technology						3 - 15
Non-compete agreements						3 - 15
Store networks						5 - 7
Trademarks						10

Foreign Currency Translation

Foreign Currency Translation — The functional currency is the U.S. Dollar for the Company's foreign subsidiaries in Dubai and Singapore.

Income Taxes

Income Taxes — Deferred income taxes are recorded to reflect the estimated future tax effects of differences between the financial statement and tax basis of assets, liabilities, operating losses, and tax credit carry forwards using the tax rates expected to be in effect when the temporary differences reverse. Valuation allowances, if any, are recorded to reduce deferred tax assets to the amount management considers more likely than not to be realized. Such valuation allowances are recorded for the portion of the deferred tax assets that are not expected to be realized based on the levels of historical taxable income and projections for future taxable income over the periods in which the temporary differences will be deductible. The Company applies the relevant Financial Accounting Standards Board ("FASB") accounting guidance on accounting for uncertainty in income taxes positions. This guidance clarifies the accounting for uncertainty in income taxes by prescribing the minimum recognition threshold a tax position is required to meet before being recognized in the financial statements. In this regard we recognize the tax benefit from uncertain tax positions only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position.

Recent Relevant Accounting Pronouncements

Description of Business and Summary of Significant Accounting Policies (Tables)

6 Months Ended

Jun. 30, 2023

Accounting Policies [Abstract]

Schedule of Cash and Cash Equivalents and Restricted Cash



	As of
	June 30,
	2023		2022
	(In thousands)
Cash and cash equivalents	$	62,165	$	67,511
Restricted cash	8,282		9,415
Restricted cash included in other long-term assets	$	5,952	$	6,409
Total cash, cash equivalents, and restricted cash shown in the condensed consolidated statement of cash flows	$	76,399	$	83,335

Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis

Additional information regarding the Company's assets and liabilities that are measured at fair value on a recurring basis is presented in the following tables:


	Fair Values at Reporting Date Using*
Descriptions	Balance, June 30, 2023		Quoted Prices in Active Markets for Identical Assets or Liabilities (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
	(In thousands)
Assets
Commercial bank certificates of deposits ($10.2 million is recorded in the long term asset section of the condensed consolidated balance sheets in "Other assets")	$	32,730	$	—	$	32,730	$	—
Mutual funds (recorded in the long term asset section of the condensed consolidated balance sheets in "Other assets")	106		106		—		—
Total assets measured at fair value	$	32,836	$	106	$	32,730	$	—

Liabilities


Contingent accrued earn-out acquisition consideration (a)	$	2,315	$	—	$	—	$	2,315
Total liabilities measured at fair value	$	2,315	$	—	$	—	$	2,315

(a) The income valuation approach is applied and the valuation inputs include the contingent payment arrangement terms, projected revenues and cash flows, rate of return, and probability assessments.
* During the six months ended June 30, 2023, there were no transfers between fair value Levels 1, 2, or 3.


	Fair Values at Reporting Date Using*
Descriptions	Balance, December 31, 2022		Quoted Prices in Active Markets for Identical Assets or Liabilities (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
	(In thousands)
Assets
Commercial bank certificates of deposits ($6.4 million is recorded in the long term asset section of the condensed consolidated balance sheets in "Other assets")	$	37,434	$	—	$	37,434	$	—
Mutual funds	$	98	$	98	$	—	$	—
Total assets measured at fair value	$	37,532	$	98	$	37,434	$	—

Liabilities


Contingent accrued earn-out acquisition consideration (a)	$	2,299	$	—	$	—	$	2,299
Total liabilities measured at fair value	$	2,299	$	—	$	—	$	2,299

(a) The income valuation approach is applied and the valuation inputs include the contingent payment arrangement terms, projected revenues and cash flows, rate of return, and probability assessments.
* During the year ended December 31, 2021, there were no transfers between fair value Levels 1, 2, or 3.

Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation


Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
Contingent Liability for Accrued Earn-out Acquisition Consideration	June 30, 2023		December 31, 2022
	(In thousands)

Beginning balance	$	2,299	$	—

Total remeasurement adjustments:

Remeasurement against goodwill	—		2,299
Foreign currency translation adjustments **	16		—

Acquisitions and settlements
Business settlements	—		—

Ending balance	$	2,315	$	2,299

The amount of total (gains) losses for the period included in earnings or changes to net assets, attributable to changes in unrealized gains relating to assets or liabilities still held at period-end.	$	—	$	—


** recorded as a component of other comprehensive income within stockholders' equity

Fair Value, Significant Unobservable Inputs Used in Measurement of Contingent Consideration Liabilities

The significant unobservable inputs used in the fair value measurement of the Company's contingent consideration liabilities designated as Level 3 are as follows:

(In thousands)

Fair Value at June 30, 2023

Valuation Technique

Significant
Unobservable
Input

Contingent acquisition consideration:

$2,315

Discounted cash flow

Projected revenue and
probability of achievement

(In thousands)

Fair Value at December 31, 2022

Valuation Technique

Significant
Unobservable
Input

Contingent acquisition consideration:

$2,299

Discounted cash flow

Projected revenue and
probability of achievement

Schedule of Disaggregation of Revenue

The following tables present revenue disaggregated by primary geographical regions and product/service channels for the three and six months ended June 30, 2023 and 2022:


	Three Months Ended June 30,				Six Months Ended June 30,
Revenue:	2023		2022		2023		2022
	(In thousands)
North America	37,720		39,645		76,590		79,671
International	80,710		213,061		284,601		457,363
	$	118,430	$	250,781	$	361,191	$	537,034

Geographical regions on net basis for comparative purposes (Non GAAP) for the three and six months ended June 30, 2023 and 2022:


	Three Months Ended June 30,				Six Months Ended June 30,
Revenue:	2023		2022		2023		2022
	(In thousands)
North America	37,720		39,645		76,590		79,671
International	80,710		75,279		157,913		134,773
	$	118,430	$	114,924	$	234,503	$	214,444

Schedule of Revenue by Product/Service Groups

Presented in the table below is the breakout of our revenue groups for each of those product/service channels for the three and six months ended June 30, 2023 and 2022.


	Three Months Ended				Six Months Ended
	June 30,				June 30,
	2023		2022		2023		2022
	(In thousands)

Exchanges	98,078		230,943		319,944		498,859
Risk Compliance Solutions	20,352		19,838		41,247		38,175
Totals	$	118,430	$	250,781	$	361,191	$	537,034

Product/Services channels on net basis for Comparative purposes (Non GAAP) for the three and six months ended June 30, 2023 and 2022:


	Three Months Ended				Six Months Ended
	June 30,				June 30,
	2023		2022		2023		2022
	(In thousands)

Exchanges	98,078		95,086		193,256		176,269
Risk Compliance Solutions	20,352		19,838		41,247		38,175
Totals	$	118,430	$	114,924	$	234,503	$	214,444

Contract with Customer, Asset and Liability


	June 30, 2023		December 31, 2022
	(Unaudited)
	(In thousands)
Balance, beginning of period	$	1,284	$	1,822
Costs recognized from the beginning balance	(265)		(968)
Additions, net of costs recognized	208		430
Balance, end of period	$	1,227	$	1,284

This portion is recognized over the expected useful life of the customizations.


	June 30, 2023		December 31, 2022
	(Unaudited)
	(In thousands)
Balance, beginning of period	$	46,127	$	41,357
Revenue recognized from beginning balance	(26,392)		(30,460)

Additions, net of revenue recognized and currency translation	25,751		35,230
Balance, end of period	$	45,486	$	46,127

Schedule of Finite-Lived Intangible Assets by Major Class, Estimated Useful Lives

We amortize these intangible assets on a straight-line basis over their estimated useful lives, as follows:


Category						Life (yrs)
Airport contracts						4 - 20
Brand						3 - 15
Customer relationships						9
Database						5
Dealer networks						15 - 20
Developed technology						3 - 15
Non-compete agreements						3 - 15
Store networks						5 - 7
Trademarks						10

Earnings per Share (Tables)

6 Months Ended

Jun. 30, 2023

Earnings Per Share [Abstract]

Schedule of Reconciliation Between Basic and Diluted Earnings Per Share

A reconciliation between basic and diluted earnings per share ("EPS") is as follows:


	Three Months Ended				Six Months Ended
	June 30,				June 30,
	2023		2022		2023		2022
	(In thousands, except per share data)
Net income attributable to Ebix, Inc.	$	308	$	19,343	$	7,381	$	38,534
Basic weighted average shares outstanding	30,866		30,745		30,854		30,729
Dilutive effect of stock options and restricted stock awards	3		11		2		27
Diluted weighted average shares outstanding	30,869		30,756		30,856		30,756
Basic earnings per common share	$	0.01	$	0.63	$	0.24	$	1.25
Diluted earnings per common share	$	0.01	$	0.63	$	0.24	$	1.25

Geographic Information (Tables)

6 Months Ended

Jun. 30, 2023

Segment Reporting [Abstract]

Schedule of Revenue by Geographic Locations

The following enterprise-wide information relates to the Company's geographic locations:


	Six Months Ended		As of		Six Months Ended		As of
	June 30, 2023		June 30, 2023		June 30, 2022		December 31, 2022
	External Revenues		Long-lived assets		External Revenues		Long-lived assets
	(In thousands)
North America	76,590		388,113		79,671		374,891
International	284,601		803,515		457,363		785,746
	$	361,191	$	1,191,628	$	537,034	$	1,160,637

Enterprise-wide information relates to the Company's geographic locations on net basis for Comparative Purposes (Non GAAP)


	Six Months Ended		As of		Six Months Ended		As of
	June 30, 2023		June 30, 2023		June 30, 2022		December 31, 2022
	External Revenues		Long-lived assets		External Revenues		Long-lived assets
	(In thousands)
North America	76,590		388,113		79,671		374,891
International	157,913		803,515		134,773		785,746
	$	234,503	$	1,191,628	$	214,444	$	1,160,637

Goodwill, Finite-Lived, and Indefinite-Lived Intangibles (Tables)

6 Months Ended

Jun. 30, 2023

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of Goodwill

Changes in the carrying amount of goodwill for the six months ended June 30, 2023 and the year ended December 31, 2022 are reflected in the following table:


	June 30, 2023		December 31, 2022
	(Unaudited)
	(In thousands)
Beginning Balance	$	881,676	$	939,249
Additions	—		—
Purchase accounting adjustments	—		—
Foreign currency translation adjustments	$	5,425	(57,573)
Ending Balance	$	887,101	$	881,676

Schedule of Finite-Lived Intangible Assets

The carrying value of finite-lived and indefinite-lived intangible assets at June 30, 2023 and December 31, 2022 are as follows:


	June 30, 2023		December 31, 2022
	(Unaudited)
	(In thousands)
Finite-lived intangible assets:
Customer relationships	$	101,333	$	101,401
Developed technology	37,139		34,427
Dealer network	6,067		5,877
Airport contracts	4,021		3,992
Trademarks	2,667		2,651
Store networks	2,169		2,153
Brand	797		791
Non-compete agreements	704		702
Database	212		212
Backlog	140		140
Total intangibles	155,249		152,346
Accumulated amortization	(107,254)		(101,446)
Finite-lived intangibles, net	$	47,995	$	50,900

Indefinite-lived intangibles:	.
Customer/territorial relationships	16,647		16,647

Schedule of Indefinite-Lived Intangible Assets

The carrying value of finite-lived and indefinite-lived intangible assets at June 30, 2023 and December 31, 2022 are as follows:


	June 30, 2023		December 31, 2022
	(Unaudited)
	(In thousands)
Finite-lived intangible assets:
Customer relationships	$	101,333	$	101,401
Developed technology	37,139		34,427
Dealer network	6,067		5,877
Airport contracts	4,021		3,992
Trademarks	2,667		2,651
Store networks	2,169		2,153
Brand	797		791
Non-compete agreements	704		702
Database	212		212
Backlog	140		140
Total intangibles	155,249		152,346
Accumulated amortization	(107,254)		(101,446)
Finite-lived intangibles, net	$	47,995	$	50,900

Indefinite-lived intangibles:	.
Customer/territorial relationships	16,647		16,647

Other Current Assets (Tables)

6 Months Ended

Jun. 30, 2023

Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]

Schedule of Other Current Assets

Other current assets at June 30, 2023 and December 31, 2022 consisted of the following:


	June 30, 2023		December 31, 2022
	(Unaudited)
	(In thousands)


Prepaid expenses	$	79,365	$	71,449
Sales taxes receivable from customers	5,723		3,289
Other third party receivables	678		1,034
Credit card merchant account balance receivable	712		704
Short term portion of capitalized costs to obtain and fulfill contracts	474		486
Accrued interest receivable	598		651
Other	11,048		9,774
Total	$	98,598	$	87,387

Leases (Tables)

6 Months Ended

Jun. 30, 2023

Leases [Abstract]

Schedule of Maturity of Finance Lease Liability

At June 30, 2023, the maturity of lease liabilities under Topic 842 "Leases" are as follows:


Year	Operating Leases		Financing Leases		Total
	(in thousands)
2023	1,958		71		2,029
2024	2,979		133		3,112
2025	2,221		19		2,240
2026	1,394				1,394
2027	637		—		637
Thereafter	1,141		—		1,141
Total	10,330		223		10,553
Less: present value discount*	(1,304)		(9)		(1,313)
Present value of lease liabilities	9,026		214		9,240

Less: current portion of lease liabilities	(3,024)				(3,024)
Total long-term lease liabilities	$	6,002	$	214	$	6,216

* The discount rate used was the incremental borrowing rates respective to the country where the assets are located.

Schedule of Maturity of Operating Lease Liability

At June 30, 2023, the maturity of lease liabilities under Topic 842 "Leases" are as follows:


Year	Operating Leases		Financing Leases		Total
	(in thousands)
2023	1,958		71		2,029
2024	2,979		133		3,112
2025	2,221		19		2,240
2026	1,394				1,394
2027	637		—		637
Thereafter	1,141		—		1,141
Total	10,330		223		10,553
Less: present value discount*	(1,304)		(9)		(1,313)
Present value of lease liabilities	9,026		214		9,240

Less: current portion of lease liabilities	(3,024)				(3,024)
Total long-term lease liabilities	$	6,002	$	214	$	6,216

* The discount rate used was the incremental borrowing rates respective to the country where the assets are located.

Schedule of Lease Cost

The lease cost is recognized in our condensed consolidated statements of income in the category of general and administrative and is summarized as follows:


	Three Months Ended				Six Months Ended
	June 30,				June 30,
	2023		2022		2023		2022
	(in thousands)				(in thousands)
Operating Lease Cost	$	1,063	$	989	$	2,129	$	1,980
Finance Lease Cost:
Amortization of Lease Assets	34		46		74		94
Interest on Lease Liabilities	3		6		7		13
Finance Lease Cost	37		52		81		107
Sublease Income	—		(23)		(24)		(46)
Total Net Lease Cost	$	1,100	$	1,018	$	2,186	$	2,041

Schedule of Other Operating and Finance Lease Information

Other information about lease amounts recognized in our condensed consolidated statement of income is summarized as follows:


	June 30, 2023
Weighted Average Lease Term - Operating Leases	1.62 years
Weighted Average Lease Term - Finance Leases	3.89 years
Weighted Average Discount Rate - Operating Leases	5.4	%
Weighted Average Discount Rate - Finance Leases	8.2	%

Schedule of Other Commitments

Such arrangements represent further commitments of approximately $8.9 million as follows:


Year	Commitments
	(in thousands)
2023 (Remaining six months)	$	5,208
2024	3,214
Thereafter	$	516
Total	$	8,938

Other Current Liabilities (Tables)

6 Months Ended

Jun. 30, 2023

Other Liabilities Disclosure [Abstract]

Schedule of Other Current Liabilities

Other current liabilities at June 30, 2023 and December 31, 2022 consisted of the following:


	June 30, 2023		December 31, 2022
	(Unaudited)
	(In thousands)
Customer advances (deposits)	$	24,023	$	23,630
Acquisition obligations (upfront purchase and contingent consideration)	1,606		2,153


Total	$	25,629	$	25,783

Description of Business and Summary of Significant Accounting Policies - Description of Business (Details)	6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022
Revenue Benchmark \| Geographic Concentration Risk \| International
Fair Value, Concentration of Risk, Financial Statement Captions [Line Items]
Concentration risk, percentage	78.80%	85.20%

Description of Business and Summary of Significant Accounting Policies - Short-Term Investments (Details) - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022
Accounting Policies [Abstract]
Short-term investments	$ 14,392	$ 17,438

Description of Business and Summary of Significant Accounting Policies - Restricted Cash (Details) - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022	Jun. 30, 2022
Accounting Policies [Abstract]
Restricted cash	$ 8,282	$ 8,210	$ 9,415

Description of Business and Summary of Significant Accounting Policies - Cash, Cash Equivalents, and Restricted Cash Shown in the Statement of Cash Flows (Details) - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022	Jun. 30, 2022	Dec. 31, 2021
Accounting Policies [Abstract]
Cash and cash equivalents	$ 62,165	$ 110,637	$ 67,511
Restricted cash	8,282	8,210	9,415
Restricted cash included in other long-term assets	5,952		6,409
Total cash, cash equivalents, and restricted cash shown in the condensed consolidated statement of cash flows	$ 76,399	$ 124,959	$ 83,335	$ 114,764

Description of Business and Summary of Significant Accounting Policies - Fiduciary Funds (Details) - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022
Accounting Policies [Abstract]
Fiduciary funds - restricted	$ 1,735	$ 2,092

Description of Business and Summary of Significant Accounting Policies - Advertising Costs (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Accounting Policies [Abstract]
Advertising expense	$ 1.8	$ 2.4	$ 3.1	$ 4.3

Description of Business and Summary of Significant Accounting Policies - Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022
Assets
Total assets measured at fair value	$ 32,836	$ 37,532
Liabilities
Contingent accrued earn-out acquisition consideration	2,315	2,299
Total liabilities measured at fair value	2,315	2,299
Quoted Prices in Active Markets for Identical Assets or Liabilities (Level 1)
Assets
Total assets measured at fair value	106	98
Liabilities
Contingent accrued earn-out acquisition consideration	0	0
Total liabilities measured at fair value	0	0
Significant Other Observable Inputs (Level 2)
Assets
Total assets measured at fair value	32,730	37,434
Liabilities
Contingent accrued earn-out acquisition consideration	0	0
Total liabilities measured at fair value	0	0
Significant Unobservable Inputs (Level 3)
Assets
Total assets measured at fair value	0	0
Liabilities
Contingent accrued earn-out acquisition consideration	2,315	2,299
Total liabilities measured at fair value	2,315	2,299
Certificates of Deposit
Assets
Available-for-sale Securities	32,730	37,434
Certificates of Deposit \| Fair Value, Recurring
Assets
Available-for-sale Securities	10,200	6,400
Certificates of Deposit \| Quoted Prices in Active Markets for Identical Assets or Liabilities (Level 1)
Assets
Available-for-sale Securities	0	0
Certificates of Deposit \| Significant Other Observable Inputs (Level 2)
Assets
Available-for-sale Securities	32,730	37,434
Certificates of Deposit \| Significant Unobservable Inputs (Level 3)
Assets
Available-for-sale Securities	0	0
Mutual funds
Assets
Available-for-sale Securities	106	98
Mutual funds \| Quoted Prices in Active Markets for Identical Assets or Liabilities (Level 1)
Assets
Available-for-sale Securities	106	98
Mutual funds \| Significant Other Observable Inputs (Level 2)
Assets
Available-for-sale Securities	0	0
Mutual funds \| Significant Unobservable Inputs (Level 3)
Assets
Available-for-sale Securities	$ 0	$ 0

Description of Business and Summary of Significant Accounting Policies - Assets and Liabilities Measured at Fair Value on a Recurring Basis using Significant Unobservable Inputs (Details) - USD ($) $ in Thousands	3 Months Ended	6 Months Ended	12 Months Ended
	Mar. 31, 2023	Jun. 30, 2023	Dec. 31, 2022
Contingent Liability for Accrued Earn-out Acquisition Consideration
Beginning balance	$ 2,299	$ 2,299	$ 0
Remeasurement against goodwill		$ 0	2,299
Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Liability, Gain (Loss), Statement of Other Comprehensive Income or Comprehensive Income [Extensible Enumeration]	Foreign currency translation adjustments	Foreign currency translation adjustments
Foreign currency translation adjustments		$ 16	0
Business settlements		0	0
Ending balance		2,315	2,299
The amount of total (gains) losses for the period included in earnings or changes to net assets, attributable to changes in unrealized gains relating to assets or liabilities still held at period-end.		$ 0	$ 0

Description of Business and Summary of Significant Accounting Policies - Quantitative Information about Level 3 Fair Value Measurements (Details) - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022	Dec. 31, 2021
Accounting Policies [Abstract]
Contingent acquisition consideration	$ 2,315	$ 2,299	$ 0

Description of Business and Summary of Significant Accounting Policies - Revenue Recognition (Details)

3 Months Ended

6 Months Ended

Jun. 30, 2023

USD ($)

productServiceGroup

Jun. 30, 2022

USD ($)

Jun. 30, 2023

USD ($)

revenueStream

productServiceGroup

Jun. 30, 2022

USD ($)

Jun. 30, 2023

INR (₨)

productServiceGroup

Disaggregation of Revenue [Line Items]

Number of product service channels | productServiceGroup

Maximum limit per gift card

$ 122

₨ 10,000

Term of virtual gift card

15 months

Term of physical gift card

3 years

Number of revenue streams | revenueStream

Operating revenue

118,430,000

^[1]

$ 250,781,000

^[1]

$ 361,191,000

$ 537,034,000

Subscription contract term

3 years

Subscription contract renewal term

1 year

Exchanges

Disaggregation of Revenue [Line Items]

Operating revenue

98,078,000

230,943,000

$ 319,944,000

498,859,000

Risk Compliance Solutions

Disaggregation of Revenue [Line Items]

Operating revenue

20,352,000

19,838,000

41,247,000

38,175,000

Net Basis

Disaggregation of Revenue [Line Items]

Operating revenue

118,430,000

114,924,000

234,503,000

214,444,000

Net Basis | Exchanges

Disaggregation of Revenue [Line Items]

Operating revenue

98,078,000

95,086,000

193,256,000

176,269,000

Net Basis | Risk Compliance Solutions

Disaggregation of Revenue [Line Items]

Operating revenue

20,352,000

19,838,000

41,247,000

38,175,000

North America

Disaggregation of Revenue [Line Items]

Operating revenue

37,720,000

39,645,000

76,590,000

79,671,000

North America | Net Basis

Disaggregation of Revenue [Line Items]

Operating revenue

37,720,000

39,645,000

76,590,000

79,671,000

International

Disaggregation of Revenue [Line Items]

Operating revenue

80,710,000

213,061,000

284,601,000

457,363,000

International | Net Basis

Disaggregation of Revenue [Line Items]

Operating revenue

$ 80,710,000

$ 75,279,000

$ 157,913,000

$ 134,773,000

[1]

Description of Business and Summary of Significant Accounting Policies - Costs to Obtain and Fulfill a Contract (Details) - USD ($) $ in Thousands	6 Months Ended	12 Months Ended
	Jun. 30, 2023	Dec. 31, 2022
Accounting Policies [Abstract]
Capitalized contract costs, net, current	$ 474	$ 486
Capitalized contract costs, net, noncurrent	752	797
Deferred Contract Costs [Roll Forward]
Balance, beginning of period	1,284	1,822
Costs recognized from the beginning balance	(265)	(968)
Additions, net of costs recognized	208	430
Balance, end of period	$ 1,227	$ 1,284

Description of Business and Summary of Significant Accounting Policies - Contract Liabilities (Details) - USD ($) $ in Thousands	6 Months Ended	12 Months Ended
	Jun. 30, 2023	Dec. 31, 2022
Accounting Policies [Abstract]
Deferred revenue included in accounts receivables	$ 9,400	$ 8,000
Change in Contract Liabilities
Balance, beginning of period	46,127	41,357
Revenue recognized from beginning balance	(26,392)	(30,460)
Additions, net of revenue recognized and currency translation	25,751	35,230
Balance, end of period	$ 45,486	$ 46,127

Description of Business and Summary of Significant Accounting Policies - Accounts Receivable and Allowance for Doubtful Accounts (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022	Dec. 31, 2022
Accounts, Notes, Loans and Financing Receivable [Line Items]
Accounts receivable	$ 163,166		$ 163,166		$ 154,533
Allowance for doubtful accounts	18,885		18,885		18,167
Bad debt expense (recovery)	1,400	$ 2,100	1,832	$ 1,702
Billed Revenues
Accounts, Notes, Loans and Financing Receivable [Line Items]
Accounts receivable	163,200		163,200		154,500
Unbilled Revenues
Accounts, Notes, Loans and Financing Receivable [Line Items]
Accounts receivable	$ 52,800		$ 52,800		$ 55,200

Description of Business and Summary of Significant Accounting Policies - Goodwill and Finite-lived Intangible Assets (Details)	6 Months Ended	12 Months Ended
	Jun. 30, 2023 USD ($) segment reportingUnit	Dec. 31, 2022 USD ($)
Finite-Lived and Indefinite-Lived Intangible Assets [Line items]
Goodwill, impairment loss \| $	$ 0	$ 0
Number of operating segments \| segment	1
Number of reporting units \| reportingUnit	1
Maximum
Finite-Lived and Indefinite-Lived Intangible Assets [Line items]
Finite-lived intangible asset, useful life	15 years
Airport contracts \| Minimum
Finite-Lived and Indefinite-Lived Intangible Assets [Line items]
Finite-lived intangible asset, useful life	4 years
Airport contracts \| Maximum
Finite-Lived and Indefinite-Lived Intangible Assets [Line items]
Finite-lived intangible asset, useful life	20 years
Brand \| Minimum
Finite-Lived and Indefinite-Lived Intangible Assets [Line items]
Finite-lived intangible asset, useful life	3 years
Brand \| Maximum
Finite-Lived and Indefinite-Lived Intangible Assets [Line items]
Finite-lived intangible asset, useful life	15 years
Customer/territorial relationships \| Minimum
Finite-Lived and Indefinite-Lived Intangible Assets [Line items]
Finite-lived intangible asset, useful life	9 years
Database
Finite-Lived and Indefinite-Lived Intangible Assets [Line items]
Finite-lived intangible asset, useful life	5 years
Dealer networks \| Minimum
Finite-Lived and Indefinite-Lived Intangible Assets [Line items]
Finite-lived intangible asset, useful life	15 years
Dealer networks \| Maximum
Finite-Lived and Indefinite-Lived Intangible Assets [Line items]
Finite-lived intangible asset, useful life	20 years
Developed technology \| Minimum
Finite-Lived and Indefinite-Lived Intangible Assets [Line items]
Finite-lived intangible asset, useful life	3 years
Developed technology \| Maximum
Finite-Lived and Indefinite-Lived Intangible Assets [Line items]
Finite-lived intangible asset, useful life	15 years
Non-compete agreements \| Minimum
Finite-Lived and Indefinite-Lived Intangible Assets [Line items]
Finite-lived intangible asset, useful life	3 years
Store networks \| Minimum
Finite-Lived and Indefinite-Lived Intangible Assets [Line items]
Finite-lived intangible asset, useful life	5 years
Store networks \| Maximum
Finite-Lived and Indefinite-Lived Intangible Assets [Line items]
Finite-lived intangible asset, useful life	7 years
Trademarks \| Minimum
Finite-Lived and Indefinite-Lived Intangible Assets [Line items]
Finite-lived intangible asset, useful life	10 years

Description of Business and Summary of Significant Accounting Policies - Foreign Currency Translation (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Intercompany Foreign Currency Balance [Line Items]
Foreign currency translation adjustments	$ 2,393	$ (43,343)	$ 10,113	$ (54,627)

Earnings per Share - Reconciliation between Basic and Diluted Earnings per Share (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands

3 Months Ended

6 Months Ended

Jun. 30, 2023

Jun. 30, 2022

Jun. 30, 2023

Jun. 30, 2022

Earnings Per Share [Abstract]

Net income attributable to Ebix, Inc.

$ 308

^[1]

$ 19,343

^[1]

$ 7,381

$ 38,534

Basic weighted average shares outstanding (in shares)

30,866

^[1]

30,745

^[1]

30,854

30,729

Dilutive effect of stock options and restricted stock awards (in shares)

Diluted weighted average shares outstanding (in shares)

30,869

^[1]

30,756

^[1]

30,856

30,756

Basic earnings per common share (in dollars per share)

$ 0.01

^[1]

$ 0.63

^[1]

$ 0.24

$ 1.25

Diluted earnings per common share (in dollars per share)

$ 0.01

^[1]

$ 0.63

^[1]

$ 0.24

$ 1.25

Potentially issuable shares with respect to stock option (in shares)

180

138

180

138

[1]

Business Combinations (Details) $ in Thousands	6 Months Ended	12 Months Ended
Business Combinations (Details) $ in Thousands	Jun. 30, 2023 USD ($) company	Dec. 31, 2022 USD ($) company	Dec. 31, 2021 USD ($)
Business Combination and Asset Acquisition [Abstract]
Number of businesses acquired \| company	0	0
Contingent acquisition consideration \| $	$ 2,315	$ 2,299	$ 0

Debt (Details) - USD ($)					6 Months Ended		12 Months Ended
Debt (Details) - USD ($)	Aug. 31, 2023	Jul. 21, 2023	May 23, 2023	Feb. 21, 2023	Jun. 30, 2023	Jun. 30, 2022	Dec. 31, 2022	Aug. 05, 2014
Line of Credit Facility [Line Items]
Revolving line of credit					$ 444,902,000		$ 449,902,000
Prepayment of debt					7,704,000	$ 0
Deferred costs, current					934,000		469,000
Principal payments					40,961,000	$ 15,933,000
Working capital facility					$ 5,043,000		3,367,000
Bank Overdrafts \| Minimum \| India
Line of Credit Facility [Line Items]
Interest rate during period					9.00%
Bank Overdrafts \| Maximum \| India
Line of Credit Facility [Line Items]
Interest rate during period					10.00%
Regions Bank
Line of Credit Facility [Line Items]
Credit agreement, amount outstanding					$ 171,900,000
Revolving line of credit					616,800,000
Debt payments				$ 5,000,000
Regions Bank \| Secured Syndicated Credit Facility, Ninth Amendment
Line of Credit Facility [Line Items]
Credit card origination costs					$ 2,300,000
Regions Bank \| Secured Syndicated Credit Facility, Eighth Amendment
Line of Credit Facility [Line Items]
Credit card origination costs							1,200,000
Regions Bank \| Revolving Credit Facility
Line of Credit Facility [Line Items]
Credit agreement, maximum borrowing capacity								$ 450,000,000
Annual increase in percentage rate			1.50%	1.00%
Prepayment of debt				$ 5,000,000
Regions Bank \| Revolving Credit Facility \| Secured Overnight Financing Rate (SOFR)
Line of Credit Facility [Line Items]
Credit agreement, applicable margins (as a percent)			7.50%
Regions Bank \| Revolving Credit Facility \| Base Rate
Line of Credit Facility [Line Items]
Credit agreement, applicable margins (as a percent)			6.50%
Regions Bank \| Revolving Credit Facility \| Subsequent Event
Line of Credit Facility [Line Items]
Annual increase in percentage rate		2.00%
Regions Bank \| Revolving Credit Facility \| Subsequent Event \| Secured Overnight Financing Rate (SOFR)
Line of Credit Facility [Line Items]
Credit agreement, applicable margins (as a percent)	8.00%
Regions Bank \| Revolving Credit Facility \| Subsequent Event \| Base Rate
Line of Credit Facility [Line Items]
Credit agreement, applicable margins (as a percent)	7.00%
Credit agreement, amendment fee percentage	0.0150
Regions Bank \| Revolving Credit Facility \| Secured Syndicated Credit Facility, Ninth Amendment
Line of Credit Facility [Line Items]
Line of credit, interest rate percentage					11.95%
Credit agreement, average amount outstanding during period					$ 444,900,000
Regions Bank \| Revolving Credit Facility \| Secured Syndicated Credit Facility, Eighth Amendment
Line of Credit Facility [Line Items]
Credit card origination costs					1,400,000		700,000
Regions Bank \| Revolving Credit Facility \| Secured Syndicated Credit Facility
Line of Credit Facility [Line Items]
Credit agreement, amount outstanding					444,900,000		$ 449,900,000
Line of credit, interest rate percentage							9.69%
Regions Bank \| Secured Term Loan \| Secured Syndicated Credit Facility, Ninth Amendment
Line of Credit Facility [Line Items]
Credit agreement, required payment					$ 5,000,000
Line of credit, interest rate percentage					11.95%
Outstanding balance					$ 171,900,000
Loans payable, current					$ 171,900,000
Line of credit facility, due					12 months
Principal payments					$ 17,500,000
Scheduled amortization payment					0
Regions Bank \| Secured Term Loan \| Secured Syndicated Credit Facility, Eighth Amendment
Line of Credit Facility [Line Items]
Credit card origination costs					$ 900,000		$ 500,000
Deferred costs, current							500,000
Outstanding balance							189,400,000
Loans payable, current							$ 189,400,000
Line of credit facility, due							12 months
Debt, weighted average interest rate							9.69%

Commitments and Contingencies (Details)	Apr. 01, 2017
Ebix Payment Services Private Limited
Business Acquisition [Line Items]
Ownership percentage	80.00%

Income Taxes (Details) - USD ($)
$ in Thousands

3 Months Ended

6 Months Ended

Jun. 30, 2023

Jun. 30, 2022

Jun. 30, 2023

Jun. 30, 2022

Dec. 31, 2022

Operating Loss Carryforwards

Income tax (expense) benefit

$ 164

^[1]

$ 2,478

^[1]

$ 787

$ 4,182

Effective income tax rate percent

12.74%

Income tax expense related to discrete items

$ 1,600

$ 1,800

Income tax benefit before discrete items

1,400

$ 971

Effective income tax rate excluding discrete items percent

(15.67%)

Additions for tax positions related to current year

1,400

$ 146

$ 1,400

$ 146

Unrecognized tax benefits

$ 7,800

$ 6,400

Minimum

Operating Loss Carryforwards

Effective income tax rate percent

8.00%

Maximum

Operating Loss Carryforwards

Effective income tax rate percent

10.00%

[1]

Geographic Information - Revenue by Geographic Locations (Details)
$ in Thousands

3 Months Ended

6 Months Ended

Jun. 30, 2023

USD ($)

Jun. 30, 2022

USD ($)

Jun. 30, 2023

USD ($)

segment

Jun. 30, 2022

USD ($)

Dec. 31, 2022

USD ($)

Revenues from External Customers and Long-Lived Assets [Line Items]

Number of reportable segments | segment

External Revenues

$ 118,430

^[1]

$ 250,781

^[1]

$ 361,191

$ 537,034

Long-lived assets

1,191,628

$ 1,160,637

Net Basis

Revenues from External Customers and Long-Lived Assets [Line Items]

External Revenues

118,430

114,924

234,503

214,444

Long-lived assets

1,191,628

1,160,637

North America

Revenues from External Customers and Long-Lived Assets [Line Items]

External Revenues

37,720

39,645

76,590

79,671

Long-lived assets

388,113

374,891

North America | Net Basis

Revenues from External Customers and Long-Lived Assets [Line Items]

External Revenues

37,720

39,645

76,590

79,671

Long-lived assets

388,113

374,891

International

Revenues from External Customers and Long-Lived Assets [Line Items]

External Revenues

80,710

213,061

284,601

457,363

Long-lived assets

803,515

785,746

International | Net Basis

Revenues from External Customers and Long-Lived Assets [Line Items]

External Revenues

80,710

$ 75,279

157,913

$ 134,773

Long-lived assets

$ 803,515

$ 785,746

[1]

Investment in Joint Ventures (Details) - USD ($)
$ in Thousands

1 Months Ended

3 Months Ended

6 Months Ended

Feb. 29, 2016

Sep. 30, 2015

Jun. 30, 2023

Jun. 30, 2022

Jun. 30, 2023

Jun. 30, 2022

Dec. 31, 2022

Schedule of Equity Method Investments [Line Items]

Revenues

$ 118,430

^[1]

$ 250,781

^[1]

$ 361,191

$ 537,034

Allowance for doubtful accounts

18,885

$ 18,167

Amortization of acquired intangible assets

3,500

2,500

7,000

5,000

Related Party | IHC

Schedule of Equity Method Investments [Line Items]

Revenues

Accounts receivable

Ebix Vayam JV | Related Party | Vayam

Schedule of Equity Method Investments [Line Items]

Revenues

105

245

206

521

Accounts receivable

11,800

11,600

Allowance for doubtful accounts

5,700

EbixHealth JV | Related Party | IHC

Schedule of Equity Method Investments [Line Items]

Revenues

238

$ 300

491

$ 614

Accounts receivable

$ 74

Ebix Vayam JV

Schedule of Equity Method Investments [Line Items]

Ownership percentage

51.00%

Percentage of membership interest in joint venture by other party

49.00%

EbixHealth JV

Schedule of Equity Method Investments [Line Items]

Ownership percentage

51.00%

Percentage of membership interest in joint venture by other party

49.00%

EbixHealth JV | Related Party | IHC

Schedule of Equity Method Investments [Line Items]

Notes payable

1,800

$ 1,800

EbixHealth JV | Related Party | Customer relationships | IHC

Schedule of Equity Method Investments [Line Items]

Amortization of acquired intangible assets

$ 125

[1]

Goodwill, Finite-Lived, and Indefinite-Lived Intangibles - Goodwill (Details) - USD ($) $ in Thousands	6 Months Ended	12 Months Ended
	Jun. 30, 2023	Dec. 31, 2022
Goodwill [Roll Forward]
Beginning Balance	$ 881,676	$ 939,249
Additions	0	0
Purchase accounting adjustments	0	0
Foreign currency translation adjustments	5,425	(57,573)
Ending Balance	$ 887,101	$ 881,676

Goodwill, Finite-Lived, and Indefinite-Lived Intangibles - Finite-Lived and Indefinite-Lived Intangible Assets (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022	Dec. 31, 2022
Finite-lived intangible assets:
Finite-lived intangible assets, gross	$ 155,249		$ 155,249		$ 152,346
Accumulated amortization	(107,254)		(107,254)		(101,446)
Finite-lived intangibles, net	47,995		47,995		50,900
Indefinite-lived intangibles:
Indefinite-lived intangibles	16,647		16,647		16,647
Amortization of acquired intangible assets	3,500	$ 2,500	7,000	$ 5,000
Customer/territorial relationships
Indefinite-lived intangibles:
Indefinite-lived intangibles	16,647		16,647		16,647
Customer/territorial relationships
Finite-lived intangible assets:
Finite-lived intangible assets, gross	101,333		101,333		101,401
Developed technology
Finite-lived intangible assets:
Finite-lived intangible assets, gross	37,139		37,139		34,427
Dealer network
Finite-lived intangible assets:
Finite-lived intangible assets, gross	6,067		6,067		5,877
Airport contracts
Finite-lived intangible assets:
Finite-lived intangible assets, gross	4,021		4,021		3,992
Trademarks
Finite-lived intangible assets:
Finite-lived intangible assets, gross	2,667		2,667		2,651
Store networks
Finite-lived intangible assets:
Finite-lived intangible assets, gross	2,169		2,169		2,153
Brand
Finite-lived intangible assets:
Finite-lived intangible assets, gross	797		797		791
Non-compete agreements
Finite-lived intangible assets:
Finite-lived intangible assets, gross	704		704		702
Database
Finite-lived intangible assets:
Finite-lived intangible assets, gross	212		212		212
Backlog
Finite-lived intangible assets:
Finite-lived intangible assets, gross	$ 140		$ 140		$ 140

Capitalized Software Development Costs (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022	Dec. 31, 2022
Capitalized Software Development Costs Disclosure [Abstract]
Capitalized software development costs for software sold to customers	$ 400	$ 1,500	$ 500	$ 4,200
Capitalized software development costs, net	15,900		15,900		$ 15,300
Amortization of capitalized software development costs	$ 100	$ 800	$ 103	$ 1,511

Other Current Assets (Details) - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Prepaid expenses	$ 79,365	$ 71,449
Sales taxes receivable from customers	5,723	3,289
Other third party receivables	678	1,034
Credit card merchant account balance receivable	712	704
Short term portion of capitalized costs to obtain and fulfill contracts	474	486
Accrued interest receivable	598	651
Other	11,048	9,774
Total	$ 98,598	$ 87,387

Leases - Operating and Finance Lease Liability (Details) - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022
Operating Leases
2023	$ 1,958
2024	2,979
2025	2,221
2026	1,394
2027	637
Thereafter	1,141
Total	10,330
Less: present value discount	(1,304)
Present value of lease liabilities	9,026
Less: current portion of lease liabilities	$ (3,024)	$ (3,354)
Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]	Other current liabilities
Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]	Other liabilities
Lease liability	$ 6,002	$ 6,612
Financing Leases
2023	71
2024	133
2025	19
2026
2027	0
Thereafter	0
Total	223
Less: present value discount	(9)
Present value of lease liabilities	214
Less: current portion of lease liabilities
Total long-term lease liabilities	214
Operating And Finance Lease Liabilities, Payments Due [Abstract]
2023	2,029
2024	3,112
2025	2,240
2026	1,394
2027	637
Thereafter	1,141
Total	10,553
Less: present value discount	(1,313)
Present value of lease liabilities	9,240
Less: current portion of lease liabilities	(3,024)
Total long-term lease liabilities	$ 6,216

Leases - Narrative (Details) - USD ($) $ in Thousands	6 Months Ended
Leases - Narrative (Details) - USD ($) $ in Thousands	Jun. 30, 2023	Jun. 30, 2022	Dec. 31, 2022
Lessee, Lease, Description [Line Items]
Right-of-use assets	$ 8,700		$ 9,600
Present value of lease liabilities	9,240
Other commitment	8,938
Operating lease, rent expense	$ 10,300	$ 18,600
Minimum \| Computer Equipment
Lessee, Lease, Description [Line Items]
Lease term	3 years
Maximum \| Computer Equipment
Lessee, Lease, Description [Line Items]
Lease term	5 years

Leases - Lease Costs (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
Leases - Lease Costs (Details) - USD ($) $ in Thousands	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Leases [Abstract]
Operating Lease Cost	$ 1,063	$ 989	$ 2,129	$ 1,980
Amortization of Lease Assets	34	46	74	94
Interest on Lease Liabilities	3	6	7	13
Finance Lease Cost	37	52	81	107
Sublease Income	0	(23)	(24)	(46)
Total Net Lease Cost	$ 1,100	$ 1,018	$ 2,186	$ 2,041

Leases - Other Operating and Finance Lease Information (Details)	Jun. 30, 2023
Leases [Abstract]
Weighted Average Lease Term - Operating Leases	1 year 7 months 13 days
Weighted Average Lease Term - Finance Leases	3 years 10 months 20 days
Weighted Average Discount Rate - Operating Leases	5.40%
Weighted Average Discount Rate - Finance Leases	8.20%

Leases - Non Lease Arrangements Future Commitments (Details) $ in Thousands	Jun. 30, 2023 USD ($)
Leases [Abstract]
2023 (Remaining six months)	$ 5,208
2024	3,214
Thereafter	516
Total	$ 8,938

Other Current Liabilities (Details) - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022
Other Liabilities Disclosure [Abstract]
Customer advances (deposits)	$ 24,023	$ 23,630
Acquisition obligations (upfront purchase and contingent consideration)	1,606	2,153
Total	$ 25,629	$ 25,783

Ebix (NASDAQ:EBIX)
Historical Stock Chart
From Oct 2024 to Nov 2024

Ebix (NASDAQ:EBIX)
Historical Stock Chart
From Nov 2023 to Nov 2024

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

EBIX Ebix Inc

Latest EBIX Messages

Loading Messages....

Ebix Inc News

Loading Messages....

Your Recent History

Company

Business

Popular

Get The App

Trending Now

Toplists

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

EBIX Ebix Inc

Latest EBIX Messages

Loading Messages....

Ebix Inc News

Loading Messages....

Your Recent History

Company

Business

Popular

Get The App